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Chapter 1: General Introduction and Outline of Thesis 
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Abstract 
The peritoneum mesothelium is a nearly invisible single cell thick layer covering the 
abdominal wall and the organs within the abdomen, forming the largest serous membrane in 
the human body. Abdominal surgery per definition traumatizes this peritoneum. Such 
operations are frequently performed by a multitude of specialists, such as general, vascular, 
urological and gynaecological surgeons. In the SCAR study, 54 380 patients included during 
one year had abdominal surgery in Scotland which was more than one per cent of the entire 
population. In the Netherlands more than 24 000 operations of the lower gastro- intestinal 
tract are performed annually, procedures with high risk of adhesion formation. 
Adhesions form in 60% to 90% of patients after abdominal surgery. Postoperative adhesions 
cause a life-long risk of different complications including small bowel obstruction, difficulties 
at re-operations, chronic abdominal pain, and secondary female infertility. These 
complications can be found after all types of abdominal surgery, performed by surgeons, 
gynaecologists or urologists. 
Till date most reports on the clinical and socioeconomic impact of adhesion related 
complications has focused solely on adhesive small bowel obstruction. Adhesiolysis at repeat 
surgery has received much less attention in literature. Underestimation of the related 
morbidity , may account for the paucity of reports on the consequences of adhesiolysis. 
Adhesion prevention is also seldom applied. Since the 90's several adhesion barriers have 
been developed and marketed. Still, many questions exist among surgeons and gynaecologists 
on the use of adhesion barriers. Only a minority of surgeons have applied an adhesion barrier. 
In the current thesis the awareness of clinicians of adhesion related complications is 
investigated, the impact of adhesions at repeat surgery is extensively studied and the current 
knowledge of adhesion prevention is systematically reviewed.  
  
12 
 
Adhesions in historical perspective 
The oldest reference of adhesions as a response to tissue injury in literature dates back to the 
year 440; adhesions of the lung were described in the Talmud, a central textbook of Jewish 
law, as a sign of pleural perforation rendering an animal carcass unsuitable for human 
consumption (Fig 1). From then it took centuries before adhesions caught the attention of 
clinicians. It was until the late 19th century when laparotomy became a fairly safe procedure 
by advances in anaesthesia and antisepsis, that peritoneal adhesions were increasingly 
recognized as a cause of late complications in abdominal surgery. 
In 1872 Bryant described one of the first cases of bowel obstruction caused by peritoneal 
adhesions, which in this case followed upon ovarian surgery.(1) An unsuccessful attempt to 
surgically relieve a bowel obstruction four years after ovarian surgery was described in 
1883.(2) Shortly thereafter surgeons started attempts to prevent adhesions using different 
methods, from distending the abdomen with fluid, to omental grafts, and a solution of sodium 
salicylate to dissolve fibrin.(3-5)   
All these efforts did not seem to reduce the problem of intra-abdominal adhesion formation. 
With these failures came disappointment and pessimism about adhesion prevention.(6) 
Subsequently, clinical interest and research on peritoneal adhesion formation and prevention 
had declined for many decades.  
A revival of interest in adhesions came about when Ellis et al. in 1999 published land mark 
data on the consequences of adhesions from a large epidemiological study. In the first ten 
years after surgery as many as 34.7% of patients were readmitted to hospital for complications 
that were probably adhesion related.(7) Biomedical industry developed several barriers to 
prevent adhesion formation, some of which seemed effective in reducing adhesion formation 
and were registered for clinical use.(8-12) Several trials assessing efficacy of such barriers 
were conducted, the largest of which included 1791 patients undergoing colorectal surgery.(9)  
In the Netherlands several surgical groups started to perform research on etiology, 
epidemiology and prevention of adhesions. The group from Nijmegen was one of the first to 
study the problem of adhesiolysis in repeat surgery;(13;14) The group from Rotterdam 
studied laparoscopic adhesiolysis for chronic pain;(15) Adhesions to meshes used for 
incisional hernia repair is focus of research in Maastricht;(16;17) The group from Leiden 
studied pathophysiology of adhesions and the role of tissue plasminogen activator in 
gynaecological surgery.(18;19)  
Despite these efforts and the development of new biomaterials that reduce adhesion 
formation, use of adhesion barriers remains low.(20;21) Questions remain whether reducing 
adhesion formation will alleviate the burden of adhesion related complications, whether or not 
adhesion barriers are cost- effective, and if adhesion barriers are beneficial in addition to 
minimal surgical trauma such as in laparoscopy.(11;12;20;21) 
In 2008 the Dutch Adhesion Group was founded to increase awareness of adhesion related 
problems and prevention, and to stimulate research on adhesions in the Netherlands. In this 
group surgeons and gynaecologists act together to combat adhesions. Research ideas 
generated within this group are elaborated in the epidemiological studies in this thesis.  
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Figure 1 Passage from the Talmud on pleural adhesions. 
 
Babylonian Talmud, Tractate Chullin, page 46b. Translation of the passage ` Raba further said: If two lobes of the lungs 
adhere to each other [by fibrous tissue], no examination thereof can avail [to render the animal permitted]. This is so, 
however, only if the lobes were not adjacent, but if they were adjacent [it is permitted, for] this is their natural position.  ´  
 
Pathology of Peritoneal Adhesion Formation 
The peritoneum mesothelium is a nearly invisible single cell thick layer covering the 
abdominal wall and the organs within the abdomen, forming the largest serous membrane in 
the human body. Abdominal surgery per definition traumatizes this peritoneum. Such 
operations are frequently performed by a multitude of specialists, such as general, vascular, 
urological and gynaecological surgeons. Exact enumeration of peritoneal operations is 
difficult because of different coding systems used. For example, in the year 1986, 54 380 
patients had abdominal surgery in Scotland which is more than one per cent of the entire 
population.(7) In the Netherlands more than 24 000 operations of the lower gastro- intestinal 
tract are performed annually [PRISMANT], procedures with high risk of adhesion formation. 
In any abdominal operation, whether performed via laparotomy or laparoscopy, damage to the 
peritoneum is inevitable (Table 1). Usually, the peritoneum quickly restores from surgical 
injury. Already in 1919 Hertzler found that, unlike the relative slow healing from the borders 
in tissues such as skin "the entire surface of the peritoneum becomes ‘epithialized’ 
simultaneously and not gradually from the borders".(22) Raftery showed that this healing 
process is complete in about one week in rats.(23)  
 
Table 1 List of factors contributing to peritoneal injury during abdominal surgery 
Factor: 
Disruption of peritoneum at entry (incision or trocar) 
Local ischemia 
Foreign bodies (stitches, mesh, powder) 
Contamination (faecal, blood) 
Electrocoagulation devices 
Tissue handling 
Evaporation (exposure to dry air, pneumoperitoneum) 
Light 
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Several hypothesis have been formed on the origin of the colonizing cells that cover the 
peritoneal defect:(24) 
1. Growth from peripheral cells 
2. Transformation of underlying mesenchymal (stem) cells 
3. Transplantation of mesothelial cells from adjacent structures or free floating mesenchymal 
cells 
4. Transformation of cells from the peripheral fluid.  
After peritoneal damage fibrinous bands, connecting opposing damaged areas, are formed as 
part of the healing process. Physiologically, such band are resolved by the fibrinolytic system 
resulting in 'ad integrum' repair. This fibrinolytic system is activated by the action of tissue 
plasminogen activator (tPA). tPA turns plasminogen into the active plasmin that splits the 
fibrinous bands.(25) During inflammation the fibrionolytic system is inhibited by release of 
plasminogen activator inhibitor (PAI) and if the net result of fibrinolysisis activators and 
inhibitors is decreased,  fibrinous bands will turn into more permanent fibrous bands named 
adhesions.(26) Morphology of adhesions can widely differ from loose rag-like bands to dense 
matted adhesions with ingrowths of blood vessels en nerve tissue.  
The amount of PAI secreted seems to correlate with the degree of tissue injury and 
inflammation. The equilibrium between fibrinolytic activity and its inhibtion is influenced by 
many factors, which mechanism is not fully understood. However, it is clear that the release 
of many inflammatory cytokines, growth factors and enzymes such as matrix 
metalloproteases, TGF-beta1, TGF-beta3, tachykinins, and INF-gamma contribute to 
adhesion formation.(27-29) 
 
Clinical implications of adhesion formation 
Adhesions form in 60% to 90% of patients after abdominal surgery.(30;31) Adhesions are the 
most common cause for long term morbidity following abdominal surgery. Postoperative 
adhesions cause a life-long risk of different complications including small bowel obstruction, 
difficulties at re-operations, chronic abdominal pain, and secondary female infertility. These 
complications can be found after all types of abdominal surgery, performed by surgeons, 
gynaecologists or urologists.(7;32;33)  
Three SCAR studies report results on the burden of adhesions.(7;32;33) The first SCAR study 
described a cohort of 29,790 patients who underwent peritoneal surgery in 1986 and had no 
history of prior surgery in the last 5 years. After 10 years follow-up, overall, 34.7% of patients 
were readmitted to a hospital with a mean of 2.1 episodes of readmission per patient. Among 
these readmission, a rate of 4.1 readmissions directly related to adhesions per 100 initial 
procedures was found at ten years follow-up and a rate of 27.7 readmissions possibly related 
to adhesions. Moreover, forty reinterventions per 100 patients were carried out that might 
have been complicated by adhesions.  
Such reinterventions can be time consuming, difficult and potentially dangerous as a result of 
adhesion formation. In a study by van der Krabben et al. almost one in five patients 
undergoing abdominal repeat surgery sustained inadvertent bowel injury.(13) Most 
readmissions directly related to adhesion formation are for adhesive small bowel injury. 
Hospital mortality from adhesive small bowel obstruction is estimated at 4.0 to 7.5%.(34;35)  
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A conservative estimate of the costs associated with an episode of readmission for small 
bowel obstruction is between EUR€1500- 2600 when conservatively treated and between 
EUR€3300- 7500 when operatively treated.(36-38) In the United States this results in US$2 
billion of annual health-care costs associated with adhesive small bowel obstruction.(39) 
Extrapolated to the Dutch situation, this corresponds with EUR€10 million annually. Chronic 
pelvic pain affect nearly 15% of women between 18 and 50 years of age, resulting in almost 
US$ 900 million of annual costs from gynaecological consultations in the United States.(40) 
However, not all of these cases of chronic pain is caused by adhesions.  
Ellis reported a series of articles on medicolegal claims related to abdominal adhesions in a 
small series of articles (Table 4).(41-43) A total of 173 claims was analyzed. Visceral injury 
following adhesiolysis was the most frequent reason to claim; 69 (39.3%) claims. In five 
claims related to visceral injury the patient died, in four of these the claim was granted. Other 
frequent reasons for claims were failed diagnosis, pain and infertility. At least 29 of 67 claims 
that are registered at the National Health Service Litigation Authority between 1995 and 2007 
have been granted. The incidence of adhesion related complications is well above the 
threshold at which providing no information during informed consent can be deemed 
negligence. The data regarding adhesion related claims illustrates the legislative consequences 
of such negligence. 
 
Repeat surgery and adhesions 
Till date most reports on the clinical and socioeconomic impact of adhesion related 
complications has focused on adhesive small bowel obstruction. Adhesiolysis at repeat 
surgery has received much less attention in literature. Underestimation of the related 
morbidity and the passiveness of many physicians, who consider adhesiolysis an annoying but 
unavoidable part of redo surgery, may account for the paucity of reports on the consequences 
of adhesiolysis. 
However, adhesiolysis might actually cause a higher burden of morbidity and costs than 
adhesive small bowel obstruction. Although morbidity from adhesive small bowel obstruction 
is high, the incidences are relatively low. Today, as many as 40- 66% of elective procedures 
in general surgery are reoperations.(9;44;45) Prolonged operation time, bleeding, trocar 
injury, conversion from laparoscopy to laparotomy and damage to peritoneal organs such as 
bowel, liver, spleen, bladder, or ureter, are all well-known intra-operative complications of 
adhesiolysis.(46) 
All these intra- operative complications contribute to higher morbidity and prolonged 
convalescence in patients undergoing repeated abdominal surgery compared patients with no 
history of abdominal surgery undergoing to the same procedure. In open abdominal surgery, 
39% major complications and 8% mortality were found in a mixed group of 270 patients who 
underwent abdominal re-operation through a pre-existent scar.(13) 
This number of repeat abdominal operations is only expected to rise because of a longer life 
expectancy and newer technologies. A better understanding of the morbidity and costs 
associated with repeat surgery and adhesiolysis is necessary to properly inform patients and 
evaluate cost effectiveness of adhesion reducing strategies.  
 
Adhesion prevention 
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Albeit limited, the available data on the burden of adhesion related complications prompt 
action to reduce postoperative adhesion formation. The actual burden of adhesions is probably 
even much higher than the estimates from literature. Almost all epidemiological and 
socioeconomical studies to the impact of adhesions have used rather conservative methods 
and available cost models have also not taking into account repeat surgery problems, sick 
leaves, therapies for secondary fertility etc.  
Adhesion reducing agents can grossly be divided into two groups, systemic acting 
pharmacological agents and local acting adhesion barriers. The use of systemic acting agents, 
mainly steroids, has been abandoned because of disappointing results in trials and the risk of 
serious adverse events.(12) 
The concept of local acting adhesion barriers is that they do not interfere with normal tissue 
healing, but rather act as a spacer separating opposing sites of regenerating peritoneal and 
serosal layers. Such barriers are made in several biochemical formulas: solid membrane, 
viscous gel or liquid. The latter two are more practically applied in laparoscopy. 
Safety has been established in large clinical studies for several of these barriers.(9;47;48) 
Meta-analysis from randomized trials also have demonstrated that some of these barriers have 
the potential to reduce adhesion formation.(11;12) 
Still, many questions exist among surgeons and gynaecologists on the use of adhesion 
barriers. Only a minority of surgeons have applied an adhesion barrier.(20;21) Most barriers 
have only been studied in gynaecological surgery. Hyaluronate carboxy methylcellulose is the 
only barrier studies in a large trial of patients undergoing colorectal surgery.(9) Moreover, 
surgeons question whether the reduction in adhesion formation will also truly alleviate the 
burden of adhesion related disease, if reduced adhesion formation will not interfere with 
anastomotic healing and if adhesions barriers are cost- effective. 
 
In summary, postoperative adhesions remains an almost neglected problem by both clinicians, 
policy maker and patients, and anti-adhesive strategies seems still in their infancy of 
acceptance and routine use. 
In the current thesis the awareness of clinicians of adhesion related complications is 
investigated, the impact of adhesions at repeat surgery is extensively studied and the current 
knowledge of adhesion prevention is systematically reviewed.  
 
Part I: Awareness of adhesion related complications  
To obtain successful implementation of evidence based adhesion prevention strategies both 
knowledge and attitude of physicians regarding clinical impact of adhesions need to be 
addressed. Current epidemiological knowledge mainly comes from studies defining 
readmissions as a proxy for the impact of adhesions, which lacks detailed information 
regarding the morbidity and impact of several complications of adhesions.(7;32;33) Data on 
the separate clinical entities related to adhesion formation (small bowel obstruction, infertility, 
difficulties at re-operations and chronic abdominal pain), are difficult to overview, and 
different outcome measures are used in literature. A comprehensive review of these separate 
clinical entities provides a more readily interpretable estimate of the disease burden related to 
adhesions and will increase awareness. In chapter 2 we systematically reviewed and analyzed 
the incidence of the four most important complications of postoperative adhesion formation 
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(small bowel obstruction, difficulties at repeated abdominal surgery, female infertility, and 
chronic pain) following all types of abdominal surgery.   
 
Patients with adhesion related complications are often treated years later by other specialists 
than the surgeon who performed the first operation. The first surgeon therefore remains 
unaware of the complication. This may significantly impact the knowledge of surgeons of (the 
prevalence of) adhesion related complications, as well as awareness and attitude of surgeons 
towards the clinical impact of adhesions and the value of adhesion prevention. We 
investigated in chapter 3 the knowledge and awareness of surgeons regarding adhesion 
related complications and the prevention of adhesions by a nationwide survey.  
 
In chapter 4 we investigated the accuracy by which adhesions were identified during 
reoperations and the complications from adhesiolysis were reported, by comparing the text in 
the operative reports with the real time operative findings in a prospective observational 
study. The accuracy at which adhesions and related complications are reported may reflect the 
awareness of the surgeon about the operative significance of adhesions and adhesiolysis.  
 
Part II: Difficulties of adhesions during reoperations 
In the second part of this thesis the focus is on morbidity resulting from adhesiolysis during 
repeat operations. There is marked paucity on data regarding this complication of adhesion 
formation including factors that predict adhesiolysis related morbidity. Chapter 5 and 6 
describe the morbidity and socio-economic costs resulting from adhesiolysis and subsequent 
organ injury in a large prospective cohort of elective abdominal operations. In chapter 7 we 
report the development of a prognostic model predicting the risk for bowel injury in elective 
abdominal surgery. 
 
Part III: Adhesion prevention 
In the third part strategies to prevent adhesion formation are reviewed. The first step in 
preventing post-operative adhesions is considered a so-called ‘good surgical technique’ 
minimizing injury to serosal surfaces and the parietal peritoneum. The significance of 
minimizing peritoneal injury has been emphasized in numerous reports, however, without 
substantiating what constitutes a good surgical technique or measure. Aspects of surgical 
technique often mentioned in literature to be associated with (a reduction of) adhesion 
formation are laparoscopy, closure of the parietal peritoneum, foreign bodies (e.g. glove 
powder, sutures and meshes), electrocautery, infection(prevention) and peritoneal lavage. 
Some studies show conflicting results. In chapter 8 the available evidence on the impact of 
surgical technique on adhesion formation is evaluated in a systematic review. 
In chapter 9 local and remote experimental peritoneal injury is compared by using 
microdialysis, between two routinely used haemostatic and dissection devices, the 
electrocautery knife and the harmonic scalpel. 
Many specialists operating in the abdominal  cavity are unfamiliar with the indication and use 
of adhesion prevention agents, despite numerous clinical trials and three Cochrane reviews. 
The many questions that exist about the indications for adhesion barriers, whether reducing 
adhesions is also correlated with reduction in adhesion related complications, whether barriers 
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are cost-effective, and which barrier should be used in which circumstances are possible 
explanations for the limited routine use of adhesion barriers. In chapter 10 results of a new 
systematic review on adhesion prevention agents that are approved for clinical use by the 
Food and Drug Adminstration are presented using a recently developed error-matrix 
approach. In chapter 11 the results are reported of a pilot study on the efficacy of a 
polyethylene glycol adhesion barrier in gynaecological laparoscopic surgery. The difficulties 
encountered in such an adhesion prevention study are discussed and give insight in the reason 
for bias of some studies reviewed in chapter 10.      
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Abstract 
Objective  
To estimate the disease burden of the most important complications of postoperative 
abdominal adhesions: small bowel obstruction, difficulties at reoperation, infertility, and 
chronic pain. 
Design  
Systematic review and meta-analyses. 
Data sources  
Searches of PubMed, Embase, and Central, from January 1990 to December 2012, without 
restrictions to publication status or language. 
Study selection  
All types of studies reporting on the incidence of adhesion related complications were 
considered. 
Data extraction and analysis  
The primary outcome was the incidence of adhesive small bowel obstruction in patients with 
a history of abdominal surgery. Secondary outcomes were the incidence of small bowel 
obstruction by any cause, difference in operative time, enterotomy during adhesiolysis, and 
pregnancy rate after abdominal surgery. Subgroup and sensitivity analyses were done to study 
the robustness of the results. A random effects model was used to account for heterogeneity 
between studies. 
Results  
We identified 196 eligible papers. Heterogeneity was considerable for almost all meta-
analyses. The origin of heterogeneity could not be explained by study design, study quality, 
publication date, anatomical site of operation, or operative technique. The incidence of small 
bowel obstruction by any cause after abdominal surgery was 9% (95% confidence interval 7% 
to 10%; I2=99%). the incidence of adhesive small bowel obstruction was 2% (2% to 3%; 
I2=93%); presence of adhesions was generally confirmed by emergent reoperation. In patients 
with a known cause of small bowel obstruction, adhesions were the single most common 
cause (56%, 49% to 64%; I2=96%). Operative time was prolonged by 15 minutes (95% 
confidence interval 9.3 to 21.1 minutes; I2=85%) in patients with previous surgery. Use of 
adhesiolysis resulted in a 6% (4% to 8%; I2=89%) incidence of iatrogenic bowel injury. The 
pregnancy rate after colorectal surgery in patients with inflammatory bowel disease was 50% 
(37% to 63%; I2=94%), which was significantly lower than the pregnancy rate in medically 
treated patients (82%, 70% to 94%; I2=97%). 
Conclusions  
This review provides detailed and systematically analysed knowledge of the disease burden of 
adhesions. Complications of postoperative adhesion formation are frequent, have a large 
negative effect on patients’ health, and increase workload in clinical practice. The quantitative 
effects should be interpreted with caution owing to large heterogeneity. 
Registration  
The review protocol was registered through PROSPERO (CRD42012003180). 
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Introduction 
Postoperative adhesion formation is the most common complication of abdominal or pelvic 
surgery, which is frequently performed by general, vascular, and gynaecological surgeons and 
urologists. Unlike other postoperative complications, such as wound infection or anastomotic 
leakage, the consequences of adhesion formation comprise a lifelong risk for various clinical 
entities.(1-6) Patients with adhesion related complications are often treated by specialists 
other than the surgeon who did the first operation. The first surgeon therefore remains 
unaware of the complication, which might explain the gross underestimation of adhesion 
related complications among surgeons and gynaecologists.(7-9) 
Knowledge of complications is vital in surgical decision making, timely recognition of 
complications, and informing the patient properly before surgery. Adhesions may cause acute 
abdomen by bowel obstruction and female infertility, and patients may require reoperation.(5; 
6;10-14) Lysis of adhesions is associated with a prolonged operative time and an increased 
risk of intraoperative and postoperative complications.(5;14) Most of the epidemiological 
knowledge of adhesions has been derived from the extensive work of the Surgical and 
Clinical Adhesions Research (SCAR) Group.(4;15;16) They, however, defined readmissions 
as a proxy for the effect of adhesions, which lacks detailed information on the effect of 
different adhesive complications. Data on adhesion related complications are reported 
incidentally, and different outcome measures have been used. However, when studied 
systematically, the studies published so far will provide a large body of evidence on the effect 
of adhesion formation. 
In this systematic review with meta-analyses, we studied the incidence of the four most 
important complications of postoperative adhesion formation: small bowel obstruction, 
difficulties at repeated abdominal surgery, female infertility, and chronic pain. A more valid 
estimate of the disease burden of adhesions will increase the awareness of this complication, 
which can be used in counselling and clinical practice. 
 
Methods 
Search 
Two researchers (RPGtB and YI) searched the Cochrane Central Register of Controlled 
Trials, PubMed, and Embase from January 1990 to December 2012, using the search terms 
for small bowel obstruction, incidence and morbidity of small bowel obstruction, female 
infertility, chronic pain, and history of abdominal surgery listed in the box. We additionally 
searched the reference lists of included studies, excluded studies, and previous reviews. We 
included studies irrespective of language or publication status. We carried out the review in 
accordance with a protocol that was registered in PROSPERO (CRD42012003180) after a 
first version of this paper was written but before the major revisions were done (Appendix A). 
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Search strategy 
Patients 
Intestinal obstruction[mesh] OR “bowel obstruction”[tiab] OR SBO[tiab] OR infertility, female[mesh] 
OR infertility[tiab] OR enterotomy[tiab] OR abdominal pain[mesh] OR pelvic pain[mesh] OR 
“abdominal pain”[tiab] OR “pelvic pain”[tiab] OR intestinal disease/surgery[mesh] OR 
abdomen/surgery[mesh] OR peritoneum/surgery[mesh] OR Laparoscopy[mesh] OR 
laparotomy[mesh] OR laparo*[tiab] 
Intervention 
Tissue adhesions[mesh] OR adhes*[tiab]) AND (abdo*[tiab] OR abdomen[mesh] OR pelvis[mesh] 
OR pelvi*[tiab] OR periton*[tiab] OR Peritoneum[mesh] OR Laparoscopy[mesh] OR 
laparotomy[mesh] OR laparo*[tiab] OR intestine[mesh] OR intestin*[tiab] 
Control 
— 
Outcome 
epidemiology[subheading] OR etiology[subheading] OR incidence[mesh] OR incidence[tiab] OR 
prevalence[mesh] OR prevalence[tiab] OR economics[subheading] OR legislation and 
jurisprudence[subheading] OR medicoleg*[tiab] OR cost of illness[mesh] OR “operative time”[tiab] 
OR “operation time”[tiab] 
Limits 
Subheadings: NOT (animal NOT human) 
Publication date: 1 January 1990 or later 
[mesh]=medical subheading, controlled vocabulary as used by National Library of Medicine for indexing articles 
[tiab]=word in title or abstract 
*=truncation; retrieves all possible suffix variations of root word indicated 
 
Study selection 
We selected the studies in two rounds: firstly, on title and abstract, independently by two 
reviewers (RPGtB and YI); secondly, on full text, also independently by the same two 
reviewers, against pre-specified criteria. We included studies that reported on adhesion related 
complications after peritoneal surgery. We excluded case series with less than 10 patients and 
studies that did not include (trans)peritoneal abdominal surgery (for example, preperitoneal or 
retroperitoneal surgery). If more than one publication was available, we used either the most 
recent publication or the one with the most relevant information. 
Data extraction 
Two reviewers (RPGtB and YI) extracted and checked the data. From the relevant articles, 
we extracted information on study design, characteristics, number of participants, and 
outcomes reported. 
The primary outcome of interest was the incidence of adhesive small bowel obstruction 
during follow-up after peritoneal surgery, which we defined as any episode of postoperative 
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small bowel obstruction with the presence of adhesions confirmed during reoperation or by 
imaging after exclusion of other causes of bowel obstruction. Secondary outcomes of interest 
related to small bowel obstruction were incidence of postoperative small bowel obstruction by 
any cause, the cross sectional incidence of adhesions in all patients with postoperative small 
bowel obstruction, the number of reoperations for adhesive small bowel obstruction, 
mortality, and length of hospital stay related to adhesive small bowel obstruction. 
Secondary outcomes related to complications during reoperation were the incidence of 
inadvertent enterotomy and the difference in operative time between patients with and without 
previous surgery. Secondary outcomes related to infertility were the pregnancy rate following 
surgery, the pregnancy rate compared before and after surgery, use of fertility treatment 
following surgery, and incidence of adhesions in patients evaluated for infertility after 
surgery. We excluded surgical studies on operations that directly affected fertility, such as 
hysterectomy, bilateral ovariectomy, and sterilisation. The secondary outcomes related to 
chronic pain were the incidence of chronic pain following surgery and the incidence of 
adhesions in patients evaluated for chronic pain. 
Risk of bias assessment 
Two reviewers (RPGtB and YI) independently determined the quality score of non-
randomised studies and of subanalyses and retrospective analyses of randomised controlled 
trials according to the revised version of the Newcastle-Ottawa scale for cohort studies 
(www.ohri.ca/programs/clinical_epidemiology/oxford.htm), with a maximum score of five 
stars. Five stars is considered high quality, three to four stars is considered intermediate 
quality, and one to two stars is considered low quality. We assessed publication bias of 
included studies with funnel plots. 
Data synthesis and analysis 
We plotted individual study estimates of incidences and proportions. We used the inverse 
variance method for pooling the incidences and to calculate the corresponding 95% 
confidence intervals. As recommended in the Cochrane handbook, we used I2 tests to measure 
heterogeneity. We defined an I2 value between 50% and 75% as substantial heterogeneity and 
an I2 value of 75% or above as considerable heterogeneity.(17) As we expected heterogeneity 
between studies, we used a random effects meta-analysis for the primary analyses. Such a 
random effects meta-analysis model involves an assumption that the effects being estimated 
in the different studies are not identical but follow some distribution.(17) If applicable, we 
made additional forest plots and calculated pooled odds ratios to compare incidences between 
subgroups (for example, laparoscopy versus laparotomy) and the various anatomical locations 
(general surgery, upper gastrointestinal tract, lower gastrointestinal tract, hepatobiliary and 
pancreatic surgery, abdominal wall surgery, gynaecological surgery, urological surgery, and 
paediatric surgery). 
We did sensitivity analyses to study best and worst case scenarios for the missing values. 
In the best case scenario analyses, we assumed that all dropouts did not have an adhesion 
related outcome and that all female dropouts became pregnant. In the worst case scenario 
analyses, we assumed that all dropouts had adhesion related outcomes and none became 
pregnant. We also did sensitivity analyses on the effect of risk of bias, the effect of single 
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studies, the effect of the study design (prospective versus retrospective cohort), and the time 
frame (up to 2000 and after 2000) on point estimates. 
We used Review Manager (version 5.0) for all analyses. We followed both the Meta-
analysis of Observational Studies in Epidemiology (MOOSE) and the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines in reporting the 
results. 
 
Results 
Search results 
Figure 1shows the number of studies identified, reviewed, and selected and the reasons for 
exclusion. We retrieved 4152 unique citations, of which we considered 546 to be potentially 
eligible. Twenty three (4.2%) papers could not be retrieved, and we excluded 327 because 
they reported on cohorts already included, no data on relevant endpoints were found, or the 
data could not be extracted for a cohort of patients with abdominal surgery in their history. 
We included 196 studies representing 150 797 patients (Appendix B).  
 
Characteristics of included studies 
Studies were available for the analysis of small bowel obstruction (n=125), difficulties and 
complications at reoperation (n=62), infertility (n=11), and pain (n=5). One hundred and sixty 
seven studies were done in adults and 27 in children; two studies included both children and 
adults. Forty one studies included patients with any surgical history, 11 included 
gynaecological surgery, 13 urological surgery, 79 lower gastrointestinal tract surgery, 21 
upper gastrointestinal tract surgery, 16 hepatobiliary and pancreatic surgery, and 15 
abdominal wall repair. Most of the included studies were judged to be of intermediate quality 
(n=125); 44 had a low risk of bias, and 27 had a high risk of bias (appendix C). 
Adhesive small bowel obstruction 
The incidence of small bowel obstruction following surgery was assessed in 92 studies. 
The incidence of postoperative small bowel obstruction, by any cause, was 9% (95% 
confidence interval 7% to 10%; I2=99%) in 61 studies including 107 949 patients. The 
incidence of adhesive small bowel obstruction was 2.4% (2.1% to 2.8%; I2=93%) in 87 
studies including 110 076 patients. In general, the presence of adhesions could be confirmed 
only in patients requiring reoperation. Not surprisingly, the incidence of reoperations for 
adhesive small bowel obstruction was comparable (2.4%, 2.0% to 2.7%; I2=91%). The cause 
of bowel obstruction could be established in 42 studies (including 5390 patients); adhesions 
seemed to be the most common cause of postoperative small bowel obstruction, accounting 
for 56% (49% to 64%; I2=96%). 
Best and worst case scenarios for the incidence of adhesive small bowel obstruction could 
be done using 67 studies (51 281 patients, of whom 3725 (7.3%) were lost to follow-up). In 
the best case scenario, assuming all patients lost to follow-up did not develop adhesive small 
bowel obstruction, the incidence was 2.5% (2.0% to 2.9%; I2=92%). In the worst case 
scenario, assuming all patients lost to follow-up developed adhesive small bowel obstruction, 
the incidence was 11.7% (10.1% to 13.2%; I2=99%). The incidence of postoperative small 
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bowel obstruction by any cause was 9% (7% to 11%; I2=99%) in the best case scenario and 
15% (12% to 18%; I2=99%) in the worst case scenario. 
The incidence of adhesive small bowel obstruction depended on the anatomical location of 
previous surgery (Fig 2). The incidence was highest in paediatric surgery (4.2%, 2.8% to 
5.5%; I2=86%) and in lower gastrointestinal tract surgery (3.2%, 2.6% to 3.8%; I2=84%). The 
incidence was lowest after abdominal wall surgery (0.5%, 0.0% to 0.9%; I2=0%), upper 
gastrointestinal tract surgery (1.2%, 0.8% to 1.6%; I2=80%), and urological surgery (1.5%, 
0.1% to 3.0%; I2=67%). Similar trends were seen for the incidence of postoperative small 
bowel obstruction by any cause (appendix D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 PRISMA flow chart 
Records identified through database searching(n = 4 822  ) 
Additional records identified through other sources  
(manual search of reference lists of journals not indexed 
in Pubmed, or keywords only in full text) (n = 23) 
Records after duplicates removed (n = 4 152 ) 
Records excluded (n = 3 606  ) 
Full-text articles assessed for eligibility (n = 546 ) 
Unretrieved (n=23) 
Full-text articles excluded (n = 327  ) 
Some articles in multiple categories: 
Multiple publications of same cohort (n=10) 
No relevant endpoints (n=288) 
Not a postoperative cohort (n=154) 
Studies included in qualitative synthesis (n = 196) 
Studies included per category: 
Small bowel obstruction (n=125) 
-  meta-analyses (n=122) 
Difficulties during reoperation (n=62) 
-  meta-analyses (n=50) 
Infertility (n=11) 
 - meta-analyses (n=11) 
Chronic pain (n=5) 
- meta-analysis (n=3) 
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Figure 2 Forest plot of incidence of adhesive small bowel obstruction (ASBO), stratified by 
anatomical location 
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Figure 2 Forest plot of incidence of adhesive small bowel obstruction (ASBO), stratified by 
anatomical location (continued) 
 
laparoscopic cohorts (1.4%, 1.0% to 1.8%; I2=86%) than in 54 open surgery cohorts (3.8%, 
3.1% to 4.4%; I2=82%) (Fig 3).The incidence of adhesive small bowel obstruction was also 
lower after laparoscopic surgery in 10 studies that directly compared laparoscopic and open 
surgery (odds ratio 0.38, 95% confidence interval 0.16 to 0.91; I2=37%). 
The mean length of hospital stay for small bowel obstruction ranged from 4.4 to 13.4 days 
in 15 studies (table 1). In five studies included in the meta-analysis, the pooled mean length of 
stay was7.8 days (95% confidence interval 3.6 to 11.9 days; I2=0%). Pooled in-hospital 
mortality from small bowel obstruction, which could be derived in 19 studies, was 2.5% 
(1.9% to 3.0%; I2=58%). 
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Figure 3 Forest plot of incidence of adhesive small bowel obstruction (ASBO), stratified by 
laparoscopy and laparotomy 
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 Figure 3 Forest plot of incidence of adhesive small bowel obstruction (ASBO), stratified by 
laparoscopy and laparotomy (continued) 
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 Table 1 Qualitative analysis of length of hospital stay for treatment of adhesive small bowel 
obstruction. Values are mean (SD) unless stated otherwise. 
Study Total group Conservative treatment Operative treatment 
 No length of stay  
[mean ± SD] 
No length of stay  
 
No length of stay  
 
Alwan 1999 332 8 (0 -156) *  - - - - 
Beyrout 2006 258 7 (1 – 63) † - - - - 
Borzellino 2004 65 4.4 (1-22) † - - 65 4.4 (1-22) † 
Kawamura 2010 10  11.4 ± 7.4 7 11.1 ± 8.9 3 12.0 ± 1.7 
Khaikin 2007 72 7-13 ‡ - - 72 7-13 ‡ 
Kössi 2004 123 7 ± 0.6 - - - - 
Menzies 2001 110 10.5 (1-45) † 69 7 (1-23) † 41 16.3(2 - 45) † 
Miller 2002 - - 23  6 (2 – 33) * 7 12 (9 – 17) * 
Miller 2000 - - 267 4 ( NA ) * 143 12 ( NA ) * 
Parikh 2008 4555 10.6 ± NA 3429 9.5 ± NA 1126 14 ± NA 
Rosin 2000 21 6.9 ± 5.1 - - 21 6.9 ± 5.1 
Shih 2003 293 6.5 ± 3.0 220 6.9 ± 2.9 73 5.9 ± 2.8 
Sosa 1993 116 13.4 (2 – NA) † 95 13.7 (2 – NA) † 21 12.3 (6 – 48) † 
Suzuki 2003 17 9.9 ± 4.4 - - - - 
Wang 2009 46 8.8 (6 – 20) - - - - 
NA= not available 
*Median(Range) 
† Mean (range), used only for articles that provided insufficient data to extract mean and SD or median and 
range. 
‡ Median length of stay 7 in 31 patients receiving laparoscopic surgery, 8 in 10 patients after conversion, and 13 
in 31 patients receiving open surgery. 
 
Difficulties at reoperation 
The pooled incidence of enterotomy during repeated abdominal surgery was 3.3% (2.5% to 
4.0%; I2=86%) in 39 studies (7654 patients). In 16 studies (2565 procedures) in which the 
need for adhesiolysis could be confirmed, the incidence of enterotomy was 5.8% (3.7% to 
7.9%; I2=89%). The incidence of enterotomy seemed to depend on the type of surgery. The 
incidence was highest in lower gastrointestinal tract surgery (8.7%, 3.8% to 13.6%; I2=84%), 
followed by gynaecological surgery (4.8%, 0.6% to 9.1%; I2= 90%). The lowest incidence of 
enterotomies was found in hepatobiliary and pancreatic surgery (only laparoscopic 
cholecystectomy) (0.4%, 0.0% to 0.8%; I2=84%) (Fig 4). 
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Figure 4 Forest plot of incidence of enterotomy, stratified by anatomical location 
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The incidence of enterotomy was significantly lower in 30 laparoscopic cohorts (1.8%, 
1.2% to 2.4%; I2=67%) than in eight open cohorts (8.9%, 4.2% to 13.6%; I2=95%). The same 
pattern was seen in two studies that compared laparoscopic and open surgery (odds ratio 0.21, 
0.05 to 0.90; I2=0%). 
Difference in operative time was reported in 27 studies, of which 13 could be included in a 
meta-analysis. In 21 studies, operative time was compared between primary and repeat 
abdominal operation. Operative time was increased in the repeat surgery group in 15 studies 
and comparable in six studies. The other six studies compared repeated abdominal surgery in 
which an adhesion barrier had or had not been used during the preceding surgery. In five 
studies, a reduction of operative time was found after barrier use. 
The meta-analysis including 13 studies showed that operative time increased by 15.2 
minutes (95% confidence interval 9.3 to 21.1 minutes; I2=85%) in the repeated surgery group 
and varied with the anatomical location of the surgery (Fig 5). The increase in operative time 
did not differ between open and laparoscopic studies. 
 
Figure 5 Forest plot of operative time, stratified by anatomical location 
 
Infertility/pregnancy 
The pregnancy rate after colorectal surgery for inflammatory bowel disease was 50% (37% 
to 63%; I2=94%) in 10 studies including 1004 patients attempting pregnancy, with a range in 
follow-up from 12 to 158 months. Nine studies compared the fertility rate in patients after the 
operation with that in patients before the operation or with that in patients treated medically. 
In all studies, the fertility rate was significantly lower in the operated group than in the non-
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operated group, in which the pregnancy rate was 82% (70% to 94%; I2=97%); the overall 
odds ratio was 0.15 (0.08 to 0.29; I2=82%) (Fig 6). The pregnancy rate was 65% (52% to 
78%; I2=97%) in the best case scenario and 38% (23% to 53%; I2=98%) in the worst case 
scenario. In three studies, 23% (18% to 29%; I2=19%) of postoperative patients required 
fertility treatment. 
 
Figure 6 Forest plot of pregnancy rate compared between operated and not operated patients 
 
Chronic abdominal pain 
In one study following 198 patients after lower gastrointestinal tract surgery for adhesive 
small bowel obstruction, 40% (34% to 47%; I2=not applicable) of patients developed chronic 
abdominal pain. In four studies following patients with chronic postoperative pain after 
previous surgery, adhesions were identified as the most likely cause of pain during diagnostic 
laparoscopy in 57% (47% to 67%; I2=77%) of patients (Fig 7). 
 
Figure 7 Forest plot of incidence of adhesions in patients with chronic postoperative pain, 
including all studies 
Sensitivity analyses 
Some sensitivity analyses slightly changed the point estimate, but in none of these analyses 
was the change clinically relevant. No other sensitivity analyses changed our results. Studies 
with a high risk of bias presented a significantly lower incidence of adhesive small bowel 
obstruction (1.5%, 0.9% to 2.0%). The incidence of adhesive small bowel obstruction was 
comparable to the presented estimates in studies with low and intermediate risk of bias. 
Discussion 
The results of this study show that adhesion formation has a large negative effect on 
patients’ health and is associated with an increased workload in clinical practice. Many 
patients develop an episode of small bowel obstruction or require emergency surgery with 
adhesiolysis for small bowel obstruction. Adhesiolysis in repeat surgery is associated with an 
increased incidence of inadvertent bowel injury and increases the operating time. Other 
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sequelae of adhesion formation are decreased pregnancy rates, increased fertility treatments, 
and chronic abdominal pain. Considerable heterogeneity of studies was present. 
Strengths and limitations of study 
The major strengths of this review are the systematic approach and the large number of 
studies included. We have provided a comprehensive assessment of the burden of adhesions 
that is relevant to both clinicians and patients. The collected data present a good overview of 
the burden of adhesions at a population level, and the results were robust in extensive 
sensitivity and subgroup analyses. 
Some potential limitations should be discussed. Firstly, the results should be interpreted 
with caution as we found considerable heterogeneity. Local variations in operative techniques, 
environmental factors, and the case mix seem to influence the incidence of adhesion related 
complication. 
Secondly, publication bias cannot be excluded, as we found asymmetry in some funnel 
plots. Part of this asymmetry is explained by clinical heterogeneity between the patient groups 
included in different studies rather than by publication bias. Some asymmetry, however, is 
due to high incidences derived from high quality studies designed to assess incidences of 
small bowel obstruction or enterotomy.(5;10;14;18;19) That is, some smaller low quality 
studies reporting lower incidences were possibly not identified. Our sensitivity analyses, 
however, showed that our results were quite robust, so we do not expect that these smaller 
low quality studies would change our results. 
Thirdly, we excluded studies done before 1990, which might have introduced bias. We 
believe, however, that studies done before 1990 would not provide an estimate that is 
generalisable to current practice because of the broad introduction of laparoscopy in general 
surgery at that time and the increased use of tissue sparing techniques and instruments at the 
end of the 20th century. Furthermore, sensitivity analyses did not show relevant differences 
between the period before and after 2000, suggesting that we could combine the data from the 
studies of the past two decades to provide a more precise estimate. 
Fourthly, about 4% of papers could not be retrieved. We tried to retrieve these papers by 
contacting editors, authors, and other libraries in the Netherlands and abroad. The studies that 
could not be retrieved were small case series. The robustness of our sensitivity analyses shows 
that that these small case series would be unlikely to have changed our results. 
Fifthly, costs and quality of life implications are not included in our analyses as these were 
either not reported at all or reported in such a heterogeneous way that pooling was not 
possible. On the basis of the high incidences of adhesion related complications, adhesions 
might affect the quality of life in many patients and cause a significant economic burden. 
Comparison with other studies 
The landmark publications of the SCAR Group were the first to consider the effect of 
postoperative adhesion formation in a large population.(4;15;16) In the SCAR studies, 
readmissions (defined by identification and diagnostic codes) were used as a proxy for the 
effect of adhesions. Incidence of adhesions will be difficult to confirm using these diagnostic 
codes. In the SCAR studies, many readmissions were classified as possibly related to 
adhesions that could not directly be linked to adhesions. Our study is unique in presenting 
distinct complications from adhesions as outcomes. Such outcomes are more interpretable for 
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clinicians and patients. Additionally, the large number of studies included in our analysis 
represented a fivefold higher number of patients than in the SCAR studies, and our results are 
more complete in analysing adhesion related complications, such as infertility and chronic 
pain, which in general do not require readmission. 
The differences in incidences between laparoscopy and open surgery in this review are in 
agreement with an earlier study from our group, which showed small benefits of laparoscopy 
on adhesion related outcomes.(20) The results of this study contribute to the existing evidence 
that laparoscopy reduces the incidence of adhesion related complications. Notably, 
laparoscopy does not totally prevent adhesion formation, contradicting the opinion that the 
use of anti-adhesive barriers is not needed in laparoscopy.(7) 
Implications for clinical practice 
We have shown that postsurgical adhesion formation has an important risk for morbidity. 
The complications related to adhesions are diverse in nature and clinical consequences, 
varying from emergency reoperations for small bowel obstruction to fertility treatments. 
Informing patients about these risks before abdominal surgery is imperative. Failure to do so 
could result in medicolegal claims.(21) However, less than 10% of surgeons and 
gynaecologists routinely inform their patients of the risks of adhesions.(7;9) 
This study provides important data for the development of guidelines for prevention of 
adhesions. So far, guidelines are present only in gynaecology, which comprises a minority of 
adhesion related problems in comparison with general surgery, particularly gastrointestinal 
and paediatric surgery.(22) Our review shows important relations between type of surgery and 
incidence of adhesion related complications. Evidence shows that adhesion barriers 
effectively reduce adhesion formation in high risk surgery.(13;23;24) The detailed knowledge 
of the disease burden of adhesions now available may be used to power future trials of anti-
adhesive barriers preventing clinically relevant outcomes of adhesions. 
Conclusions 
This review provides detailed and systematically analysed knowledge of the large disease 
burden of adhesions. Complications of postoperative adhesion formation are frequent, have a 
large negative effect on patients’ health, and increase workload in clinical practice. Many 
patients develop an episode of small bowel obstruction or an inadvertent bowel injury due to 
adhesiolysis. The quantitative effects should be interpreted with caution owing to large 
heterogeneity. 
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What is already known on this topic 
Adhesion formation is a common cause of long term complications following abdominal or 
pelvic surgery 
Adhesion related complications comprise various clinical entities including small bowel 
obstruction, female infertility, difficulties at reoperation, and chronic pain 
The incidence and effect of adhesion related complications are not precisely known 
What this study adds 
Detailed and systematically analysed knowledge of the large disease burden of adhesions is 
now available 
This knowledge may be used for better preoperative patient counselling and operative 
management and to power future trials of anti-adhesive barriers 
Studies on adhesion formation and its clinical consequences are heterogeneous 
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Abstract 
Background 
Postoperative adhesions are the most frequent complication of abdominal surgery, leading to 
high morbidity, mortality, and costs. However, the problem seems to be neglected by 
surgeons for largely unknown reasons. 
Methods 
A survey assessing knowledge and personal opinion about the extent and impact of adhesions 
was sent to all Dutch surgeons and surgical trainees. The informed-consent process and 
application of antiadhesive agents were questioned in addition. 
Results 
The response rate was 34.4%. Two thirds of all respondents (67.7%) agreed that adhesions 
exert a clinically relevant, negative effect. A negative perception of adhesions correlated with 
a positive attitude regarding adhesion prevention (p = 0.182, p < 0.001). However, 
underestimation of the extent and impact of adhesions resulted in low knowledge scores 
(mean test score 37.6%). Lower scores correlated with more uncertainty about indications for 
antiadhesive agents which, in turn, correlated with never having used any of these agents (p = 
0.140, p = 0.002; p = 0.095, p = 0.035; respectively). Four in 10 respondents (40.9%) 
indicated that they never inform patients on adhesions and only 9.8% informed patients 
routinely. A majority of surgeons (55.9%) used antiadhesive agents in the past, but only a 
minority (13.4%) did in the previous year. Of trainees, 82.1% foresaw an increase in the use 
of antiadhesive agents compared to 64.5% of surgeons (p < 0.001). 
Conclusions 
The magnitude of the problem of postoperative adhesions is underestimated and informed 
consent is provided inadequately by Dutch surgeons. Exerting adhesion prevention is related 
to the perception of and knowledge about adhesions. 
 
  
44 
 
Introduction 
Postoperative adhesions occur in about 90% of all patients undergoing abdominal surgery 
and lead to at least one readmission for a third of these patients in the following 10 years (1; 
2). Adhesions become clinically apparent in the form of chronic abdominal pain, female 
infertility, and small-bowel obstruction (3; 4). Furthermore, adhesions can seriously 
complicate subsequent surgery (5; 6). Therefore, postoperative adhesions should not merely 
be regarded as a side effect of abdominal surgery but as the most common complication 
caused by abdominal surgery. 
Regardless of an open or a laparoscopic approach, the surgical treatment of adhesions 
induces the reformation as well as new formation of adhesions (7; 8). Hence, adhesion 
prevention is of key importance. For obvious reasons, reducing surgical trauma by meticulous 
surgical technique is the primary step that needs to be exerted at all times. However, 
performing surgery implies surgical trauma to some extent but it can be further reduced by 
other means, e.g., using powder-free gloves, wetting tissues, and reducing operative time (9). 
The use of adhesion barriers seems inevitable to obtain further adhesion prevention. A local 
barrier composed of hyaluronic acid and carboxymethylcellulose (Seprafilm®, Genzyme, 
Cambridge, MA, USA) has proven effective in reducing adhesions in various open general 
surgery studies (10). Previous reviews have also shown significant benefit with the use of 
Interceed® membrane (Ethicon 360, Johnson & Johnson, New Brunswick, NJ, USA), 
composed of oxidized regenerated cellulose, in open gynaecologic surgery (11). 
Administration of an icodextrin solution (Adept®, Baxter Healthcare Corp., Deerfield, IL, 
USA) that spreads throughout the peritoneal cavity has shown adhesion reductive capacity in 
benign laparoscopic gynaecologic surgery (12). 
In contrast to most surgical complications, the risk of adhesion-related morbidity remains 
for many years and complications are often not followed up by the primary surgeon. In 
addition, symptoms of adhesion-related complications vary and a fully effective remedy has 
not yet been discovered. All these factors have probably resulted in an undervaluation of 
postoperative adhesions by surgeons. This in turn explains why adhesions are mentioned only 
sporadically during the informed-consent process (13; 14). Nevertheless, failure to do so can 
be regarded as an omission of the doctor’s duty of care and has already resulted in successful 
negligence claims (15). 
In spite of the extent and impact of postoperative adhesions, we are under the impression 
that surgeons lack sufficient awareness about this most common complication. Moreover, 
they seem to provide inadequate informed consent on and take insufficient preventive actions 
against adhesions. However, until now, no data has been available to substantiate these 
assumptions. Therefore, we conducted a nationwide survey assessing the awareness of and 
behaviour toward adhesions among Dutch surgeons and surgical trainees. 
 
Materials and methods 
Design of the survey 
A steering group of 11 general and gynaecologic surgeons with a special interest in 
adhesions and its associated morbidity (Dutch Adhesion Group) conceived a first set of 
survey questions. These questions were edited by two independent researchers, both experts 
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in survey and multiple-choice test construction. Subsequently, five surgeons and three 
surgical trainees tested the survey for indistinctness and leading questions. After making 
adjustments, the survey was reviewed again and consecutively approved by the steering 
group, the independent researchers, and the test group of surgeons and trainees. The survey 
consisted of 55 multiple-choice questions, four open-ended questions, and four optional 
questions with a total word count of 716. In its final layout, both an electronic online version 
(six web pages) and a printed version (three pages) were available in Dutch (see Appendix for 
a translated version). 
 
Knowledge test 
Eight multiple-choice questions concerning the prevalence and morbidity of adhesions 
were formulated based on up-to-date and best-available evidence. The following statements 
were considered correct: 
 
Approximately 70% of small-bowel obstructions are due to postoperative adhesions (16–18). 
The 5-year readmission rate after operative procedures of the colon or rectum directly related 
to postoperative adhesions is approximately 5% (19–21). 
The 10-year readmission rate after any abdominal surgery probably or directly related to 
postoperative adhesions is approximately 30% (1; 2). 
Inadvertent enterotomy during adhesiolysis occurs in 20% of patients with a history of 
abdominal surgery (5; 6). 
A total colonic resection has the highest risk of adhesion-related morbidity compared with a 
partial small-bowel resection, an appendectomy, or a resection of the rectum (2; 21). 
Age above 60 years is associated with fewer adhesions, a history of abdominal surgery with 
more adhesions, and a history of Crohn’s disease with no difference in adhesion formation (2; 
21). 
 
Survey distribution 
We aimed to distribute the survey among all officially registered Dutch surgeons and 
trainees (n = 1 282 and 432, respectively). Contact details were retrieved from the 2008 
annual report of the Dutch Association for Surgery from the section of regular members (n = 
1 009) and members of the association of surgical trainees (n = 446). We approached the 
surgeons and trainees by electronic mail (e-mail) or by postal mail when no or no valid e-mail 
address was available. A personalized mail was sent on Tuesday (at 6:00 a.m. in case of e-
mail) and a reminder sent the next Tuesday (at 7:00 p.m. in case of e-mail) when no response 
was recorded yet. As an incentive, five portable audio players and 40 pens with inbuilt laser 
pointer and USB stick were raffled among all respondents. The survey closed 3 weeks after 
the first mailing. 
 
Data analysis 
Only surveys more than 80% complete, excluding optional questions, were included. We 
defined subgroups of respondents as trainees, general surgeons, gastrointestinal surgeons, or 
other surgeons. Proportions were compared using χ2 tests. Comparisons between groups were 
performed using the Mann–Whitney U test, the Wilcoxon signed-rank test, or the Kruskal–
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Wallis test with post-hoc Bonferroni correction. Knowledge test scores were compared with 
Student’s t tests and ANOVA with post-hoc Bonferroni correction. Correlations were 
calculated using Spearman’s rank correlation and a p < 0.050 was considered significant. 
Statistics were performed using SPSS® version 15.0 (SPSS, Inc., Chicago, IL, USA). 
 
Results 
A total of 1 455 surgeons and trainees were contacted by e-mail (83.8%) or postal mail 
(16.2%). Twenty-three physicians indicated not to participate. After 1 week, 352 surveys were 
collected, and there were 523 surveys at close of the survey. Of these, 22 incomplete surveys 
(4.2%) were rejected, resulting in a response rate of 34.4% (501 surveys, 98% complete) 
representing 90.7% of all Dutch surgical departments (98.3% of all teaching and 81.3% of all 
nonteaching departments). Response rates were comparable for e-mail and postal mail (35.3 
vs. 29.8%, respectively, p = 0.102), but higher for surgeons than for trainees (Table 1). The 
survey was completed by a comparable number of trainees (n = 131), general surgeons (n = 
130), gastrointestinal surgeons (n = 116), and other surgeons (n = 124) (p = 0.767). 
  
Table 1 Respondents (n = 501) 
 Trainees Surgeons p Value 
Response rate (%) (n) 29.4% (131 of 446) 36.7% (370 of 1 009) 0.007 
Experience, mean (SD) (years) 4.3 (1.6) 13.2 (9.6) n.a. 
Full-time employment (%) (n) 89.9% (116) 88.8% (316) 0.718 
Academic hospital employment (%) (n) 33.6% (44) 25.8%(95) 0.088 
SD standard deviation; n.a. not applicable 
All χ2 tests 
 
Opinion on adhesions 
About two thirds (67.7%) of all respondents agreed that adhesions exert a clinically 
relevant and predominantly negative effect. The proportion was significantly higher for 
trainees than for surgeons (75.6 vs. 64.9%, respectively, p = 0.025). A small group (6.0%) 
indicated that adhesions exert a clinically relevant and predominantly positive effect. Half of 
all respondents (50.6%) considered adhesiolysis for treating pain not effective, whereas 
26.2% considered it effective. 
 
Awareness of adhesions and their associated morbidity 
Respondents scored a mean of 37.6% correct answers on the knowledge test, with trainees 
scoring slightly but significantly higher than general surgeons (39.9 vs. 34.6%, p = 0.032). 
Only 6.9% of respondents reported a correct 10-year readmission rate after abdominal surgery 
probably or directly related to adhesions (30%), whereas 69.0% thought it was 10% or lower. 
Also, 62.9% underestimated the percentage of small-bowel obstructions caused by adhesions, 
reporting a percentage of 50% or lower. On the other hand, a vast majority of respondents 
(87.6%) correctly indicated that a history of abdominal operations is associated with increased 
adhesion-related morbidity. The knowledge test score did not correlate with respondents’ 
opinion on adhesions (p = 0.010, p = 0.830). 
47 
 
 
Informed consent 
One in 10 respondents (9.8%) reported that they routinely include adhesions or related 
morbidity in the informed consent information for both laparotomies and laparoscopies. Yet, 
40.9% of all respondents reported that they never mention it at all (Fig. 1). No correlation was 
observed with opinion on adhesions or knowledge test score (p = 0.031, p = 0.497; p = 0.016, 
p = 0.730; respectively). Trainees and nonacademic surgeons provided adhesion information 
during informed consent less often than surgeons and academic surgeons, respectively (both p 
= 0.002). Furthermore, providing information on adhesions before a laparoscopic procedure 
was done less often in comparison with laparotomy (p < 0.001). Informing fewer patients 
before a laparoscopy correlated with a greater belief that laparoscopy is a means to limit 
adhesion formation (p = 0.186, p < 0.001). 
 
Figure 1 Informed consent 
 
Adhesion prevention 
Four in 10 respondents (39.1%) expressed a positive opinion on adhesion prevention, 
22.4% expressed a negative one. In addition, a positive opinion correlated with a negative 
view of adhesions (p = 0.182, p < 0.001). All respondents, except gastrointestinal surgeons, 
believed more strongly in adhesion prevention for specific indications than for all abdominal 
surgery (p < 0.001). Significantly more surgeons than trainees believed that a meticulous 
surgical technique minimizes adhesions (83.5 vs. 65.6%, p < 0.001). Similarly, significantly 
more gastrointestinal than nongastrointestinal surgeons believed that laparoscopy reduces 
adhesion formation (90.5 vs. 72.0%, p < 0.001) (Fig. 2). 
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Figure 2 Techniques to minimize adhesions 
 
Antiadhesive agents 
Of all respondents, 26.5% expressed a positive attitude toward antiadhesive agents and 
29.1% expressed a negative one (Fig. 3). Although a majority of surgeons (55.9%) had used at 
least one of these agents, only a minority did in the previous year (13.4%). Significantly 
higher proportions of gastrointestinal and academic surgeons used an antiadhesive agent in 
the previous year compared to general and nonacademic surgeons, respectively (23.0 vs. 
9.0%, p = 0.001; 23.9 vs. 10.5%, p < 0.0001; respectively). Not using antiadhesive agents any 
longer showed no significant associations with knowledge test score, opinion on adhesions, 
adhesion prevention, or antiadhesive agents (p = 0.622, p = 0.431, p = 0.283, p = 0.209, 
respectively). Most surgeons used Adept® (8.9% ever, 8.5% last year) and Seprafilm® 
(33.7% ever, 5.4% last year). In the group of surgeons who used antiadhesive agents, 78.8% 
did so in adhesion-related laparotomies, 29.2% in abdominal wall surgery, and 21.8% in 
(sub)total colectomies. In general, use of products for high-risk operations regarding adhesion 
formation was higher than for low-risk operations (p < 0.001). Uncertainty about when to use 
these products correlated with never having used any products (p = 0.095, p = 0.035) and 
lower knowledge test scores (p = 0.140, p = 0.002). 
 
 
Figure 3 Opinion on antiadhesive agents 
 
Of all trainees, 82.1% predicted that the use of antiadhesive agents will increase compared 
with 64.5% of all surgeons (p < 0.001). Such opinion correlated with a negative view of 
adhesions (p = 0.141, p = 0.002) and with a more positive view in terms of cost–benefits (p = 
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0.148, p = 0.001). Most respondents anticipated that new antiadhesive agents would come to 
the market and that the evidence either for or against adhesion prevention would increase. 
 
Discussion 
Adhesions and related complications lead to substantial morbidity and mortality, with 
increased medical costs (22; 23). This nationwide survey shows that two of three Dutch 
surgeons recognize adhesions as a clinically relevant and negative entity. However, 
readmission rates and small-bowel obstructions caused by adhesions are heavily 
underestimated. Moreover, the informed-consent process and application of antiadhesive 
agents are not in line with the extent and impact of postoperative adhesions. Therefore, it can 
be concluded that the knowledge and awareness of and the behaviour toward adhesions is 
limited among Dutch surgeons and surgical trainees. 
At least 40% of respondents did not inform any patients about postoperative adhesions or 
related morbidity and only very few informed patients routinely. This corresponds with the 
recent finding that more than 90% of consent forms lack this information (13). In contrast, the 
risks for hemorrhage and infection after abdominal surgery are almost invariably discussed 
during the informed-consent process. Adhesion-related complications share nearly all features 
of these complications, including the risk of death, but may occur many years after the 
operation. Thus, it is essential to discuss adhesions as a possible complication during the 
informed-consent process. In addition, in case of any reoperation, a high risk of inadvertent 
organ damage exists and should be discussed prior to surgery as well. These 
recommendations apply also for laparoscopic procedures since laparoscopy has not been 
proven to reduce adhesion-related morbidity compared with laparotomy, though definite 
studies are lacking (24). 
Current surgical trainees consider adhesions a negative drawback of surgery more often, 
have a slightly better understanding of the extent of the problem, rely less on surgical 
technique to reduce adhesions, and have a higher belief in an increasing use of antiadhesive 
agents, compared to surgeons. In contrast, they seem to inform fewer patients about adhesions 
or adhesion-related morbidity compared to current surgeons. The reason for this is unclear, 
but this behaviour may change when they have more responsibilities and follow-up their own 
patients more closely. The finding is of interest for the future and might mandate 
(educational) interventions with this group of young surgeons before they face legal claims. 
The significantly lower response rate of surgical trainees compared to surgeons can be 
explained by the higher number of trainees’ contact details than the number of officially 
registered trainees for general surgery. This is probably due to the fact that plastic and 
orthopedic surgery trainees share the first 2 years of training. 
The current study is the first to evaluate awareness and behaviour of surgeons regarding 
adhesions. Recently, two similar studies reported on adhesion awareness among gynecologic 
surgeons in the United Kingdom and Germany (14; 25). Little over half of those respondents 
agreed that adhesions are the most common complication after abdominal surgery. This is in 
line with our finding that the impact of adhesions is underestimated. Yet, around three in four 
gynecologic surgeons indicated that they inform patients routinely about adhesions and about 
half of the respondents stated that they use antiadhesive agents regularly. This clearly 
surpasses the current behaviour of Dutch surgeons and reflects a higher awareness of 
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adhesions among gynecologic surgeons. Nevertheless, the 8.8% response rate of the British 
gynecologists and the 33.5% response rate of German gynecologic departments might reflect 
a selection bias. 
Approximately 80% of respondents agreed that an extraperitoneal mesh, meticulous 
surgical technique, and laparoscopy reduce adhesions. Only a quarter of surgeons expressed a 
positive opinion toward antiadhesive agents. In addition, only one in 10 surgeons used an 
agent in the past year, with Adept® taking a small lead over Seprafilm®. Adept® is a liquid 
acting throughout the whole abdomen; Seprafilm® is a site-specific barrier film. The efficacy 
of Seprafilm® has already been evidenced in general surgery, whereas for Adept® efficacy 
has been shown in laparoscopic gynecologic surgery and results in general surgery are 
awaited (10; 12). Both agents have been shown to be safe in general abdominal surgery, 
though application of Seprafilm® on bowel anastomoses should be avoided (10; 26; 27). 
Although current agents do not provide complete prevention of postoperative adhesions, it is 
worth considering their use in high-risk surgery such as colorectal procedures. Even a relative 
decrease in adhesions might entail benefits for the patient and the surgeon. Interestingly, 
uncertainty about indications for antiadhesive agents was correlated with never having used 
any agents and with lower knowledge scores. 
This study demonstrates that a change in behaviour is needed among surgeons and trainees. 
Patients have to be informed of the risks of adhesions routinely and the application of 
clinically available antiadhesive agents should at least be considered in specific abdominal 
surgery (28). However, to obtain changes in behaviour, both knowledge and attitudes have to 
be addressed (29). Barriers for improving knowledge include accessibility and volume of 
information; attitudes can be affected by a lack of agreement or poor methodology in 
evidence, but also by personal beliefs and experiences. Therefore, attempts to obtain 
sustainable changes in behaviour have to target multiple aspects. Moreover, breakthrough 
results from basic research should be translated to clinically applicable agents (30). 
Some limitations of this study should be noted. First of all, the 34.4% response rate might 
reflect a selection bias, possibly providing more positive results. Furthermore, no elaborate 
nonresponse analysis could be performed due to the lack of any central database comprising 
detailed information on Dutch surgeons. On the other hand, responses were recorded from 
90.7% of all Dutch surgical departments. In addition, response rates were markedly higher 
than in the recent survey among gynecologic surgeons in the UK and a survey in the USA on 
work, stress, and research among academic surgeons (8.8 and 22.7%, respectively) (14; 31). 
Our relatively high response rate might be due to the raffle, which is known to increase 
response rates without affecting response quality (32; 33). 
The knowledge test was based on up-to-date and best-available evidence selected by the 
steering group of general and gynecologic surgeons. Several rounds of pilot testing were 
conducted to ensure comprehensibility and face and content validity of the survey. However, 
although most of the knowledge questions were based on very large cohort studies, some still 
consider the consistently found high morbidity controversial. Yet, even if the true morbidity 
would be lower, many of the respondents would still underestimate the magnitude of the 
problem. 
Finally, this study surveyed only Dutch surgeons and surgical trainees, but results are 
likely to be generalizable to surgeons worldwide; adhesions are encountered after all 
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abdominal surgeries and the associated morbidity, mortality, and costs are comparably high in 
different countries (23; 34; 35). 
As for the future, action must be taken to improve knowledge, attitude, and behaviour 
concerning adhesions among Dutch surgeons and surgical trainees. Specialty courses could be 
developed and rewarded credits; compulsory classes on adhesions and antiadhesive agents 
should be embedded in the surgical training program. Nonetheless, surgeons represent only 
one of the many parties involved in adhesion awareness. Attention must also be given to the 
other specialists operating in the abdominal cavity, patients, hospitals, antiadhesive agents 
manufacturers, and health insurance companies in order to improve awareness of and 
behaviour toward adhesions. In order to follow-up on the actions, the results of this survey 
can serve as a benchmark for later research. 
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Abstract 
Background 
The operative report contains critical information for patient care, serves an educational 
purpose and is an important source for surgical research. Recent studies demonstrate that 
operative reports are unstructured and lack vital components. The accuracy of the operative 
notes has never been assessed. The aim of this study was to analyse the accuracy of operative 
reports by comparing notes with intraoperative observer-derived findings regarding adhesions 
and adhesiolysis-related complications. 
Methods 
The incidence of adhesions and adhesiolysis-induced injury were scored from the reports by a 
researcher blinded to operative findings obtained prospectively by direct observation. In 
addition, factors influencing correct reporting were analysed, including sex, surgical 
experience, delay in dictation, and the gradual introduction of a new report template with a 
focus on describing operative findings rather than actions taken. 
Results 
A total of 755 consecutive operative reports were analysed. Sensitivity and specificity for the 
incidence of adhesions was 85.1 and 72.4 per cent respectively. Six of 43 inadvertent 
enterotomies, and 17 of 48 other organ injuries, had not been reported. All missed bowel 
injuries were found in reports written in the old template. A median delay in dictating of 
3(range 1–226) working days was found for 56 reports (7.4 per cent). Documentation of 
inadvertent enterotomies was missing more often in delayed reports (2 of 3 versus 4 of 40 in 
reports dictated with no delay; P=0.022). 
Conclusion  
The sensitivity and specificity of operative reports noting adhesions and adhesiolysis were 
low. One in seven enterotomies was not reported. Effort should be put into teaching timely, 
meaningful, structured and accurate reporting of surgical procedures. 
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Introduction 
An operative report is the official medical documentation of an operation. A high accuracy 
in the report is mandatory as it contains crucial information for lifelong safe patient care. 
Reports need to be accurate for proper billing and to provide valuable information during 
medicolegal procedures. In addition, an operative report is an important tool for education and 
a source for clinical research.(1-3) 
Recent studies have raised serious questions about the completeness of an operative 
report.(1-5) In one study, a fundamental element such as the name and signature of the 
surgeon was either not stated or was unclear in 15 per cent of reports.(2) Another study found 
that basic postoperative instructions concerning antibiotics and thrombosis prophylaxis were 
lacking in 85 and 86 per cent of reports respectively.(1) The reports improved after the 
introduction of a standard operative report sheet.(1) Reports on cholecystectomies often lack 
description of the key procedural steps taken during the operation, such as the critical view of 
safety.(3;5;6) 
Little is known about the accuracy of the information written in operative reports.(7) For 
laparoscopic procedures, videotaping of the procedure can support a written report and 
increase accuracy. The videotape may even replace the report, although viewing the video is 
more time consuming than reading a report.(8) For open procedures, video recording is much 
more complicated and often not complete. To date, no comparison between operative report 
notes and the actual findings and actions taken during open surgery has been performed. 
The aim of this study was to assess the accuracy of information recorded in operative 
reports. Adhesiolysis-induced injuries noted in the operative report were chosen for 
comparison because of their clinical relevance.(9) 
 
Methods 
Between June 2008 and June 2010, a researcher observed closely all elective abdominal 
operations at Radboud University Nijmegen Medical Centre; the researcher was present in the 
operating room but did not take part in the operation. Detailed information on adhesiolysis 
and iatrogenic organ injury was noted as part of a study investigating the impact of adhesions 
on operative outcome. 
The reports of 755 consecutive operations included in the LAParotomoy or LAParoscopy 
and ADhesiolysis (LAPAD) study (clinicaltrials.gov registration number NCT01236625) 
were the basis for this study. The LAPAD study was designed to assess the incidence of 
adhesions and impact of adhesiolysis on operative and postoperative complications, quality of 
life and socioeconomic costs. Details of the LAPAD study have been described 
elsewhere.(10) 
During surgery, detailed information concerning adhesions, adhesiolysis and inadvertent 
organ damage was collected through direct observation by a trained researcher. Surgeons 
performing the operations were aware of the study details and that operative data were 
collected. Data from operative reports were extracted by a trained researcher, who was 
blinded for the results of the LAPAD study and was not involved in patient care during the 
study period. 
 
Variables 
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The sensitivity and specificity of operative reports regarding the incidence of adhesions 
were calculated. For this purpose, operative reports with explicit documentation of adhesions, 
or synonyms thereof, or notes probably indicating the presence of adhesions were scored as 
positive. Examples of terms probably indicating adhesions were: ‘grown together’ or ‘frozen 
together’, in addition to reports of the dissection of structures that are normally not attached to 
one another. Operative reports explicitly stating that the abdomen was free from adhesions, or 
that did not note any adhesions, were scored as negative. With regard to the incidence of 
adhesiolysis, the sensitivity and specificity of an operative report for dissecting adhesions 
were determined. 
 Classification of enterotomies 
Where an enterotomy had occurred during adhesiolysis, an analysis was made of cases 
where an enterotomy was noted explicitly in the operative report, phrases that possibly 
indicated an enterotomy (for example, ‘a bowel hole was sutured’) or where there was no 
mention of any enterotomy. Over-reporting of organ injury was not analysed to determine an 
incorrect notation, because this possibility had been taken into account within the definition of 
inadvertent enterotomy. In the LAPAD database, only enterotomies that were made 
accidentally were registered as inadvertent enterotomies. Documentation of an enterotomy 
when dissecting a bowel loop with a pre-existing fistula, and enterotomies necessary to obtain 
an oncological resection, were not registered as an enterotomy in the LAPAD database. Notes 
on seromuscular and other organ injuries were also compared with real-time observations. 
Surgeon characteristics and the report template 
In a second analysis, surgeon and surgery-related characteristics that might impact on the 
correct reporting of adhesions and adhesiolysis were evaluated. Surgeon characteristics were: 
sex, surgical experience (consultant or resident), report template (old or new) and delay before 
dictating the report. For residents, their year of training, initial teaching hospital, and duration 
of training at the authors’ academic centre and previously in a teaching hospital were also 
analysed. Interactions between surgeon characteristics were explored and statistically 
significant interactions reported. 
During the study period, a new operative report template was gradually implemented that 
emphasized the operative findings while limiting the reporting of the actions taken. The old 
report template included text fields for patient and surgeon data, operative codes, a summary 
text field and a free text field with the subheading ‘operative procedure’. The new report 
template included all fields from the old template, and the subheadings ‘preparation’ and 
‘operative findings’ were added to the free text field. As a rule, operative reports in the 
authors’ institution are dictated immediately after surgery. Later dictations were regarded as 
delayed. Surgery characteristics were previous abdominal surgery, enterotomies and 
adhesiolysis time. Factors included in a final analysis that potentially could affect correct 
reporting of enterotomies were the report template, delayed dictation, surgeon’s sex and 
surgical experience. 
Statistical analysis 
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Comparison between groups were conducted using an unpaired t test for normal distributed 
continuous data, ANOVA in not normal distributed continuous data and the χ2 test for 
dichotomous data. SPSS® for Windows® version 16.0 software (IBM, Armonk, New York, 
USA) was used for statistical analysis, with P<0.050 considered significant. 
 
Results 
All 755 operative reports were retrieved. The new report template was used in 128 reports 
(17.0 per cent). Fifty-six reports (7.4 per cent) were dictated at a later time, with a median 
delay 3 (range 1–226) working days. Some 690 (91.4 per cent) of the reports were written by 
male surgeons. Consultants wrote 415 (55.0 per cent) of the reports, and residents wrote 340 
(45.0 per cent). Inadvertent enterotomy occurred in 43 operations (5.7 per cent). Seromuscular 
and other organ injuries occurred in 142 (18.8 per cent) and 48 (6.4 per cent) operations 
respectively. 
Incidence of adhesions 
Absence of adhesions was reported explicitly in only nine reports; two of these patients 
actually had adhesions. In 284 reports (37.6 per cent) no notation had been made for the 
presence or absence of adhesions. The presence of adhesions was reported explicitly in 450 
reports (59.6 per cent) and probably in 12 (1.6 per cent). Thus, 293 (38.8 per cent) were 
scored as negative for adhesions and 462 (61.2 per cent) as positive. The incidence of 
adhesions found by the observer was 497 (65.8 per cent) of 755. The sensitivity and 
specificity for the incidence of adhesions were 85.1 and 72.4 per cent respectively. Operative 
reports were correct regarding the incidence of adhesions in 79.2 per cent of cases. 
Performance of adhesiolysis 
Thirty-nine reports (5.2 per cent) explicitly stated that no adhesiolysis had been performed; 
in seven of these cases, adhesions had been cut according to the observer notes. No 
documentation of adhesiolysis was found in 325 reports (43.0 per cent); in 112 (34.5 per cent) 
of these adhesiolysis had been performed. Performance of adhesiolysis was reported explicitly 
in 376 reports (49.8 per cent) and probably in 15 (2.0 per cent). The incidence of adhesiolysis 
by direct observation was 475 (62.9 per cent) of 755. The operative report was correct 
concerning adhesiolysis in 79.6 per cent, with a sensitivity of 74.9 per cent and a specificity of 
87.5 per cent. 
Iatrogenic injury during adhesiolysis 
Enterotomies were noted explicitly in 37 reports, and possibly in 11. In nine of the 
explicitly and two of the possibly reported enterotomies, the bowel injury did not result from 
adhesiolysis according to the definition used in the LAPAD study. In six cases enterotomy 
occurred during dissection of fistulas, and in three as part of an oncological resection. In the 
remaining two cases there was no explanation for the discrepancy between the report and the 
observer notes. 
Of 43 inadvertent enterotomies resulting from adhesiolysis, only 28 were reported 
explicitly, nine possibly, and no report of enterotomy was made in six cases. Seromuscular 
injury of the bowel was missing in the operative report for 54 (38.0 per cent) of 142 
procedures. In 17 of 48 operations with iatrogenic injury to other organs, the following 
injuries were missing in the notes: liver injury (7), major vascular injury (3) and splenic injury 
(2). 
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Impact of surgeon and surgery characteristics on correct reporting 
There was a significant interaction between surgical experience and surgeon’s sex; thus sex 
was further analysed according to surgical experience. Most surgeon characteristics had no 
influence on the correct reporting of the incidence of adhesions, performance of adhesiolysis 
or inadvertent organ injury (Table 1). Of 340 reports written by residents, 38 (11.2 per cent) 
were by women. Female residents significantly underreported adhesiolysis compared with 
male residents (P=0.046). Residents initially trained in teaching hospital B produced incorrect 
reports more frequently for incidence of adhesiolysis than residents from the other teaching 
hospitals (P=0.019). 
Table 1 Impact of surgeon characteristics on the correct reporting of adhesions and adhesiolysis 
 Incidence of adhesions Adhesiolysis 
Correct 
(%) 
Incorrect(%) P-
value 
Correct (%) Incorrect(%) P-value 
Report template 
• Old 
• New 
 
492 (79) 
106 (83) 
 
135 (22) 
22 (17) 
 
 
.270 
 
499 (79.6) 
102 (79.7) 
 
128 (20.4) 
26 (20.3) 
 
 
.979 
Delay in dictation 
• Undelayed 
• ≥ 2working days 
 
554 (79) 
44 (79) 
 
145 (21) 
12 (21) 
 
 
.903 
 
547 (78.3%) 
43 (76.8%) 
 
141(21.7%) 
43 (23.2%) 
 
 
.587 
Surgical experience 
• Consultant 
• Resident 
 
328 (79) 
270 (79) 
 
87 (21) 
70 (21) 
 
 
.899 
 
325 (78.3) 
276 (81.2) 
 
90 (21.7) 
64 (18.8) 
 
 
.331 
Sex of consultant 
• Male 
• Female 
 
302 (78) 
26 (96) 
 
86 (22) 
1 (4) 
 
 
0.023 
 
300 (77.3) 
25 (92.6) 
 
88 (22.7) 
2 (7.4) 
 
 
.088 
Sex of resident 
• Male 
• Female 
 
244 (81) 
26 (68) 
 
58 (19) 
12 (32) 
 
 
0.075 
 
250 (82.8) 
26 (68.4) 
 
52 (17.2) 
12 (31.6) 
 
 
.046 
Length of training (years) 
• 1 
• 2 
• 3 
• 4 
• 5 
• 6 
• Fellow 
 
1 (50) 
5 (83) 
19 (66) 
75 (80) 
99 (83) 
41 (86) 
30 (71) 
 
1 (50) 
1 (17) 
10 (35) 
19 (20) 
20 (17) 
7 (15) 
12 (29) 
 
 
 
 
 
 
 
.220 
 
2 (100.0) 
4 (66.7) 
21 (72.4) 
78 (83.0) 
96 (80.7) 
42 (87.5) 
33 (78.6) 
 
0 (0.0) 
2 (33.3) 
8 (27.6) 
16 (17.0) 
23 (19.3) 
6 (12.5) 
9 (21.4) 
 
 
 
 
 
 
 
.621 
Residents, duration of training 
in academic centre (months)*† 
 
12 (1 - 32) 
 
12 (1 - 32) 
 
.361 
 
12 (1 - 32) 
 
10 (1 - 32) 
 
.331 ¶ 
Residents, initial teaching 
hospital†‡ 
• None 
• A 
• B 
• C 
• D 
 
 
8 (67) 
60 (85) 
69 (76) 
36 (90) 
67 (80) 
 
 
4 (33) 
11 (16) 
22 (24) 
4 (10) 
17 (20) 
 
 
.215 
.333 
.173 
.104 
.832 
 
 
10 (83.5) 
64 (90.1) 
67 (73.6) 
34 (85.0) 
68 (81.0) 
 
 
2 (16.7) 
7 (9.9) 
24 (26.3) 
6 (15.0) 
16 (19.0) 
 
 
.870 
.032 
.019 
.545 
.869 
Values in parentheses are percentages unless indicated otherwise; *values are median (range). †Data from 298 
operative reports made by residents (excluding fellows). ‡As well as an overall P value, results for residents in 
each centre were compared with those for all residents in the other centres. §χ2 test, except ¶ANOVA. 
 
The reported incidence of adhesions and adhesiolysis was correct significantly more often 
when an enterotomy had been made or when the duration of adhesiolysis was long (P= 0.021 
and P<0.001) (Table 2). Documentation of enterotomy was missing more often in reports 
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dictated following a delay and in those by female surgeons (Fig. 1). In the new report 
template, all enterotomies were noted. 
Table 2 Impact of surgery characteristics on the correct reporting of adhesions and 
adhesiolysis 
 Incidence of adhesions Adhesiolysis 
Correct (%) Incorrect(%) P-value Correct (%) Incorrect(%) P-value 
Abdominal surgery in history 
- No 
- Yes 
 
202 (79.8) 
396 (78.9) 
 
51 (20.2) 
106 (21.1) 
 
 
.759 
 
201 (77.9) 
400 (80.5) 
 
57 (22.1) 
97 (19.5) 
 
 
.405 
Enterotomy made 
- No 
- Yes 
 
558 (78.4) 
40 (93.0) 
 
154 (21.6) 
3 (7.0) 
 
 
.021 
 
561 (78.8) 
40 (93.0) 
 
151 (21.2) 
3 (7.0) 
 
 
.025 
Adhesiolysis time (minutes)* † 
- Adhesions/ Adhesiolysis not 
reported  
- Adhesions/ Adhesiolysis 
reported 
 
 
0 (0 - 0) 
 
25 (0 - 177)  
 
 
5 (0 - 75) 
 
0 (0 - 0) 
 
 
<.001 
 
<.001 
 
 
0 (0 - 0) 
 
26 (1 - 177) 
 
 
5 (1 - 75)  
 
0 (0-0)  
 
 
<.001 
 
<.001 
Values in parentheses are percentages unless indicated otherwise; *values are median (range). †Data from 471 
operations with adhesiolysis and known duration of adhesiolysis (duration missing in 4 patients). ‡χ2 test, except 
§ANOVA. 
 
 
Figure 1 Impact of surgeon characteristics on the correct reporting of 43 inadvertent 
enterotomies. Comparisons were made with the χ2 test 
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Discussion 
Comparison of the data from operative notes with the findings of a prospective 
observational study allowed the accuracy of information written in operation reports to be 
assessed. The present study showed significant inaccuracies in operative reports. Most 
worrisome is the underreporting of major adverse operative events such as an enterotomy and 
other iatrogenic organ injuries, with potential risk of misinterpreting the postoperative course, 
such as anastomotic leakage from an enterotomy repair.(9;11;12) Inaccurate reporting was not 
dependent on surgical experience. The present findings support the concern regarding the 
quality of operative reports raised in recent publications.(1-3) 
The accuracy of operative reports on the presence of adhesions was poor, with a sensitivity 
and specificity of 85.1 and 72.4 per cent respectively. Accuracy on the performance of 
adhesiolysis was comparable, with a sensitivity and specificity of 74.9 and 87.5 per cent 
respectively. As many as one in seven enterotomies and one in three other organ injuries were 
not reported. Delayed dictating of operative reports was associated with more missed 
enterotomies. Female residents were more likely to underreport that adhesiolysis had been 
performed. However, these results should be interpreted carefully as only a small proportion 
of reports were written by a minority of women, so that individual results could have a 
relatively large impact on the results. Residents from training hospital B also underreported 
the performance of adhesiolysis significantly more often; the difference could not be 
attributed to an interaction with resident sex or delay in dictating. 
One in seven enterotomies was missed and one in five was not reported explicitly. This 
corresponds with the finding that only 20 per cent of gallbladder perforations with bile 
spillage during laparoscopic cholecystectomy were reported.(5) It might be argued that failing 
to report a gallbladder perforation is less serious because the course following laparoscopic 
cholecystectomy is usually uneventful and does not create postoperative diagnostic dilemmas, 
in contrast to major abdominal procedures complicated by an inadvertent enterotomy. 
Unnoted operative events can delay the diagnosis of postoperative complications.(13;14) In 
the present cohort, eight of the 15 patients with no explicit mention of an enterotomy suffered 
from major complications related to surgery, such as pneumonia, intra-abdominal abscess and 
prolonged postoperative ileus. Diagnosis of abscess, in particular, might have been delayed in 
the present series, but a relationship with unnoted enterotomies was difﬁcult to conﬁrm. 
An important question is how to improve the accuracy and completeness of operative 
reports. Delayed dictating of operative reports was a risk factor for unnoted enterotomies. The 
Dutch College of Surgeons recommends that operative reports be composed and made 
available within one working day.(15) Immediate dictation after the operation has become a 
quality indicator in the authors’ department, and at present delay in writing an operative report 
is rare. The authors prefer immediate dictation after finishing an operation, as there is some 
evidence that dictating multiple reports at the end of the day might reduce accuracy.(5;7;16) 
Standard or computer-generated operative reports seem to improve reporting8,17. A major 
drawback of standard operative reports is that they can lead to loss of comprehensiveness and 
that they apply only to commonly performed operations. During the study period a new 
standard operative report was introduced that focused on describing intraoperative findings. 
Although numbers were too small for statistical comparison, no enterotomies and only a few 
minor organ injuries were missing in the new reports. The sensitivity and specificity for 
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describing the occurrence of adhesions and adhesiolysis did not improve with the new report 
template. As an increasing number of procedures are performed laparoscopically, the role of 
videotaping might become more important. Videotaping showed more of the procedural steps 
with greater accuracy than written reports in a previous study.(5) A drawback of videotaping 
is that viewing the videos can be time consuming. 
Another study demonstrated that formal teaching of dictating can also improve the 
reliability of operative reports.(18) The differences found in the accuracy of reporting 
between residents from different teaching hospitals may be due to lack of interest or formal 
teaching in some hospitals. A recent review of the operative notes made by Harvey Cushing 
revealed that his openness towards reporting of surgical mishaps helped to improve the 
quality of care4. Increasing the awareness of the negative impact of adhesions on the operative 
course might also diminish the proportion of unnoted adhesions, adhesiolysis and inadvertent 
organ injury. The awareness remains rather low in various countries, and among 
gynaecologists and surgeons.(19;20) The present authors reported recently on the substantial 
morbidity and mortality associated with adhesiolysis and inadvertent enterotomies in elective 
abdominal surgery; they recommended that patients be properly informed regarding adhesion-
related complications during consent for an operative procedure, with the expectation that this 
will also increase awareness of these complications among physicians.(10) 
The present study analysed only the accuracy of reports on operative findings related to 
adhesions. The accuracy of other important aspects of reporting might also be at stake. In a 
recent Dutch study, postoperative instructions were missing in 78 per cent of reports.(6) In 
some billing systems, inaccuracy of the operative report can also result in income 
deprivation.(7) 
The study has shown major deficits in the reporting of adhesion-related findings. Clear and 
concise reporting is crucial for improved postoperative care, in medicolegal cases, and for use 
in medical research. Efforts need to be made to teach timely, meaningful, structured and 
accurate reporting of surgical procedures. 
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Abstract 
Objective 
To determine the incidence of bowel injury in operations requiring adhesiolysis and to assess 
the impact of adhesiolysis on the incidence of surgical complications, postoperative 
morbidity, and costs. 
Background 
Morbidity of adhesiolysis during abdominal surgery seems an important health care problem, 
but the direct impact of adhesiolysis on inadvertent organ damage, morbidity, and costs is 
unknown. 
Methods 
In a prospective cohort study, detailed data on adhesiolysis were gathered by direct 
observation during elective abdominal surgery. Comparison was made between surgical 
procedures with and without adhesiolysis on the incidence of inadvertent bowel defects. 
Secondary outcomes were the effect of adhesiolysis and bowel injury on surgical 
complications, other morbidity, and costs. 
Results 
A total of 755 (out of 844) surgeries in 715 patients were included. Adhesiolysis was required 
in 475 (62.9%) of operations. Median adhesiolysis time was 20 minutes (range: 1–177). Fifty 
patients (10.5%) undergoing adhesiolysis inadvertently incurred bowel defect, compared with 
0 (0%) without adhesiolysis (P < 0.001). In univariate and multivariate analyses, adhesiolysis 
was associated with an increase of sepsis incidence [odds ratio (OR): 5.12; 95% confidence 
interval (CI): 1.06–24.71], intra-abdominal complications (OR: 3.46; 95% CI: 1.49–8.05) and 
wound infection (OR: 2.45; 95% CI: 1.01–5.94), longer hospital stay (2.06 ± 1.06 days), and 
higher hospital costs [$18,579 (15,204–21,954) vs $14,063 (12,471–15,655)]. Mortality after 
adhesiolysis complicated by a bowel defect was 4 out of 50 (8%), compared with 7 out of 425 
(1.6%) after uncomplicated adhesiolysis (OR: 5.19; 95% CI: 1.47–18.41). 
Conclusions 
Adhesiolysis and inadvertent bowel injury have a large negative effect on the convalescence 
after abdominal surgery. The awareness of adhesion-related morbidity during reoperation and 
the prevention of postsurgical adhesion deserve priority in research and clinical practice. 
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Introduction 
 Peritoneal adhesions develop after more than 90% of operations in the abdominal 
cavity, procedures frequently performed by general, vascular, and gynaecological surgeons 
and urologists.(1–3) 
 Intestinal obstruction, female infertility, and abdominal pain are well-known adhesion-
related complications that negatively impact millions of lives worldwide.(1;2;4–7) 
Surprisingly, adhesion-related complications receive little attention in clinical practice.(8–11) 
Complications that occur after adhesiolysis during repeat surgery might even form a larger 
burden of morbidity.8 In a retrospective cohort, the risk of inadvertent bowel defects was as 
high as 19%.(12) The risk of needing repeat abdominal surgery is relatively high and is 
expected to increase in the western world with the increase of life expectancy and 
developments in surgical technology.(13–17) 
Little is known of the impact of adhesiolysis and related organ injury on morbidity and 
socioeconomic costs in comparison with other adhesion-related complications. Knowledge of 
the morbidity related to adhesiolysis is needed to properly inform patients before surgery to 
take adhesiolysis risks into account in the operative decision-making, and to improve 
diagnosis of postoperative complications. In addition, proper data on adhesiolysis time and 
the socioeconomic burden of adhesions are helpful for operative room management and 
health care insurance. 
In this prospective study, we did a detailed assessment and analysis of adhesiolysis, 
(post)operative complications, and socioeconomic factors in a large cohort of elective 
abdominal operations (clinicaltrials.gov registration number: NCT01236625). 
 
Methods 
Study Design and Patients 
This was a prospective observational study as part of the LAPAD (LAParotomy or 
LAParoscopy and ADhesiolysis) study. The LAPAD study was designed to assess the 
incidence and impact of adhesiolysis on preoperative and postoperative complications, quality 
of life, and socioeconomic costs. All adult patients planned for elective abdominal surgery at 
the Department of Surgery of the Radboud University Nijmegen Medical Center between 
June 2008 and June 2010 were screened for inclusion. Patients planned for admission to the 
surgical day-care unit were excluded because the short hospital stay did not allow for 
adequate follow-up. 
 Inclusion criterion was an elective laparotomy or laparoscopy. Exclusion criteria were age 
under 18 years and mental disorder. Patients were included after giving oral and written 
informed consent. 
Relevant patient, surgical, and medical data were prospectively assessed before, during, 
and after hospital stay and at the outpatient clinic until 6 months after discharge. At surgery, 
detailed information of adhesions, adhesiolysis, and inadvertent organ damage was collected 
through direct observation by a trained researcher (R.B., C.S., or Y.I.) who did not take part in 
the operation. Evaluation of adhesions was comprised of a description of the location, for 
example, ventral abdominal wall, operative area, and other parts of the abdomen, grading of 
adhesions at these 3 locations according to the Zühlke classification, and timing the duration 
of adhesiolysis by stopwatch.(18) Findings were recorded into the real-time database by the 
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researcher present in the operating theatre. Operative and treatment decisions were made 
according to department guidelines or at the discretion of the surgical staff. As a rule in our 
institution, adhesiolysis was done by sharp dissection and not by electrocautery or ultrasonic 
dissection. The study was approved by the local medical ethical committee and conducted 
according to the revised version of the Declaration of Helsinki (October 2008, Seoul). 
 Variables 
 Primary outcomes were the incidence of adhesions, adhesiolysis time, the incidence of 
bowel defects, seromuscular injury, injuries to other organs and structures, and the incidence 
of major surgery-related complications. 
 A detailed description of any adhesion present was obtained by direct observation. 
Adhesiolysis time was measured in minutes from the start of adhesiolysis until the operative 
area was cleared of adhesions. 
 Bowel defects were classified as inadvertent enterotomy or delayed diagnosed perforation. 
Inadvertent enterotomy was defined as any iatrogenic, unintended full thickness bowel defect 
detected during operation. Preexisting fistulas or defects created while dissecting the bowel 
loop that harboured the fistula were not scored as inadvertent enterotomy. Delayed diagnosed 
perforation was defined as a bowel defect with spill of gastrointestinal content that was 
diagnosed postoperatively by imaging, at reoperation, or at autopsy, and that could not be 
explained by anastomotic leakage, bowel ischemia, or any other obvious causes of leakage 
unrelated to adhesiolysis. 
 Seromuscular injury was defined as injury to the serosal and muscular layers of the bowel, 
without visualization of the bowel lumen or spillage of bowel content. Other intraoperative 
injuries were comprised of any injury to the spleen, liver, pancreas, urogenital structures, 
lung, vascular structures, or nerves. 
 Postoperative complications noted as major surgery-related complications were death, 
wound infection (categorized as superficial or deep), anastomotic leak, fistula and abscess, 
pneumonia, sepsis, haemorrhage, and urinary tract infection. Major surgery-related 
complications were defined according to the criteria of the International Classification of 
Diseases, Tenth Revision, the National Nosocomial Infections Surveillance System, the 
Centre for Disease Control and Prevention, or according to the decision of the senior medical 
staff of the department. 
Secondary outcomes were other morbidity and socioeconomic costs including total 
operative time, blood loss, recovery unit stay, hospital stay, unplanned or prolonged intensive 
care unit admission, intensive care unit stay, parental feeding, tube feeding, incidence of 
emergency reoperations, and incidence of readmission to the hospital within 30 days after 
discharge. 
Cost analysis was performed in United States dollars (unit of analysis) and included only 
the direct hospital costs: operation costs, ward stay, intensive care unit stay, extra charges for 
parental and tube feeding, postoperative diagnostics, reoperation costs, and blood products. 
Cost calculations were performed using the guidelines for cost analysis of the Dutch College 
of Health Insurance Companies using a top-down approach.(19) Operation costs were 
calculated based on total anaesthesia time using operating room costs of $1390 per hour, 
including personnel, material, and overhead costs. Total costs for the surgical ward and 
intensive care unit were $661 and $2289 per day, respectively, and included basic nutritional 
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costs. More than basic parental and tube feedings were considered as extra nutritional costs. 
Diagnostic and reoperation costs were calculated using the 2004 price lists for medical 
procedures by the Dutch College of Health Insurance Companies. Medication costs and blood 
products costs were calculated according to the standardized price list of the Dutch College of 
Health Insurance Companies updated for June 2008.(20) 
Baseline demographics included sex, age, body mass index, Alcohol Use Disorders 
Identification Test alcohol abuse index,(21) history of abdominal operations, number of 
laparotomies in history, number of laparoscopies in history, history of generalized peritonitis, 
American Society of Anaesthesiologists classification, P-Possum score, Revised Cardiac Risk 
Index, diabetes mellitus, extent of surgery, surgical approach (open or laparoscopic), 
anatomical site of operation [upper gastro-intestinal, lower gastro-intestinal, hepatobiliary–
pancreatic, abdominal wall, or other], and level of surgical experience (surgeon or resident). 
 Statistical Methods 
Univariate comparisons were performed using linear regression for continuous and logistic 
regression for dichotomous data. Effect size was expressed as mean difference with standard 
deviation for continuous data and odds ratios (ORs) for dichotomous data. Despite the large 
number of patients, differences in baseline factors between the groups were expected because 
adhesions are mostly due to prior surgery. To avoid potential bias by an unequal distribution 
of risk factors, we calculated an adjusted effect size using multivariate linear and logistic 
regression for continuous and dichotomous data, respectively. All factors with unequal 
distribution at baseline with P < 0.010 were included in the multivariate model, except a 
history of peritoneal surgery and generalized peritonitis, and peritoneal surgery and previous 
peritonitis were considered pathogenic for adhesion formation and were not expected to have 
further independent adverse effects on treatment outcomes. In composite outcomes, statistical 
results were presented for both the composite outcome and the individual components of the 
composite. Costs are presented as mean cost with a 95% confidence interval (CI). Statistical 
comparison of costs was performed by multivariate regression on the logistically transformed 
values of the costs to reduce the impact of outliers. All outcomes were assessed per operation 
and analysed according to an intention-to-treat, unless otherwise stated. 
 In the subgroup of operations with adhesiolysis, we compared major surgery-related 
complications, other morbidities, and costs between adhesiolysis complicated by bowel 
defects and uncomplicated adhesiolysis. 
 In an additional analysis, we calculated the risk for enterotomy, seromuscular injury, and 
other organ injury by categorizing adhesiolysis time (none, 1–15, 16–30, 31–60, and >60 
min). 
 There was only minimal missing data; thus, we excluded per analysis those cases with 
missing data. We used SPSS for Windows version 16.0 software (SPSS, Chicago, IL) for 
statistical analysis. Values of P < 0.05 were considered significant. 
Results 
Cohort and Baseline Comparison 
A total of 844 consecutive elective surgeries were screened for eligibility; 89 operations 
were excluded. Main reasons for exclusion were cancellation of the operation (N = 38), 
refusal to participate (n = 11), and mental incompetence of the patient (N = 8). A total of 755 
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operations carried out in 715 patients were included in the study (Fig. 1). Adhesiolysis time 
was missing in 4 operations (0.5%). There were no further missing data. 
The incidences of adhesions and adhesiolysis were 497 out of 755 (65.8%) and 475 out of 
755 (62.9%), respectively. Most common etiologies for the presence of adhesions were 
previous intra-abdominal surgery and peritonitis (Table 1); mean adhesiolysis time was 20 
minutes (range: 1–177). Adhesions to the incision scar of a previous operation were found in 
399 (80.3%) of operations with adhesions, whereas in 416 operations (83.7%), adhesions 
were present in the operative area and in 329 operations (63.6%), adhesions were found in 
other parts of the abdomen. Median Zühlke score was 2 (range: 1–5) at all 3 locations. Severe 
adhesions (Zühlke score: 3 or 4) were found under a previous scar in 233 operations (46.9%) 
with adhesions, at the operative area in 235 operations (47.3%), and in other parts of the 
abdomen in 160 operations (32.2%). Patients who had adhesions and no prior surgery or 
general peritonitis in their history usually only had a few low-grade adhesions with a median 
adhesiolysis time of 5 minutes (range: 1–93). Those adhesions were mostly located adjacent 
to a local inflammatory process or tumour. 
Table 1 shows the baseline data for the 2 groups. There were significant differences in the 
anatomical location of the operation (P < 0.001), operative severity (P < 0.001), surgical 
approach (P = 0.01), and body mass index (P = 0.003). 
Impact of Adhesiolysis on Peroperative Complications 
The incidence of full thickness bowel defects was 10.5% in the adhesiolysis group and 0% 
in the nonadhesiolysis group (P < 0.001). During 43 operations, there was a median of 1 
(range: 1–9) inadvertent enterotomy. Bowel resection and anastomosis were required in 24 
operations (55.8%) with 1 or more enterotomies, and in the remaining operations, 
enterotomies were repaired by primary suturing. Injury to the seromuscular layer occurred in 
131 procedures (27.6%) with adhesiolysis compared with 11 (3.9%) without adhesiolysis (P < 
0.001). As a rule, seromuscular injuries were repaired by suturing. 
Delayed diagnosed perforation occurred after 10 surgeries. A delayed diagnosed 
perforation occurred after 8 out of 142 seromuscular injuries (5.6%) and 3 out of 43 
enterotomies (7.0%). The 3 patients with a delayed diagnosed perforation after an enterotomy 
also had seromuscular injuries. In 2 patients with delayed diagnosed perforation (20.0%), no 
seromuscular injury or enterotomy occurred during initial operation 
Injury to other organs was 8.6% in the adhesiolysis group compared with 2.5% in the 
nonadhesiolysis group (P = 0.001). Most common injuries in the adhesiolysis group were to 
the liver (n = 14), vascular structures (n = 11), urogenital structures (n = 8), spleen (n = 4), 
and bile ducts (n = 3). Injuries in the nonadhesiolysis group were comprised of vascular 
structures (n = 4), spleen (n = 2), and bile duct (n = 1). 
After adjustment for anatomical location, operative severity, surgical approach, and body 
mass index, the difference in incidence of seromuscular injury and other organ injuries 
remained significant (Fig. 2A). Multivariate analysis could not be conducted for bowel 
defects as none occurred in the nonadhesiolysis group. 
The 43 inadvertent enterotomies occurred exclusively in patients who underwent open 
surgery. One patient (2.9%) who underwent laparoscopy had a delayed diagnosed perforation 
compared with 9 (2.0%) who underwent open surgery (P = 0.75). 
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Figure 1. Flow diagram of the included operations. 
Assessed for eligibility (n= 844 ) 
Excluded  (n= 89 ) 
♦ Operation cancelled (n= 38  )
♦ Declined to participate (n= 11 )
♦ Mental incompetence (n= 8)
♦ Miscellaneous (n= 32 )
Data available for analysis  
♦ Operative organ injury (n= 475)
♦ Postoperative complications (n= 475)
♦ Socioeconomic parameters (n= 475)
♦ Adhesiolysis time (n= 471)
Lost to follow-up (give reasons) (n= 0 ) 
Operations with adhesiolysis (n= 475 ) 
Lost to follow-up (give reasons) (n= 0 ) 
Operations without adhesiolysis (n= 280  ) 
Data available for analysis  
♦ Operative organ injury (n= 280)
♦ Postoperative complications (n= 280)
♦ Socioeconomic parameters (n= 280)
♦ Adhesiolysis time (n= 280)
73 
Table 1 Baseline Comparison Between Operations With and Without Adhesiolysis 
Adhesiolysis group 
(n=475) 
No adhesiolysis 
group (n=280) P- value 
Demographics 
Sex 
  Male 264 (55.6%) 116 (59.3%) 
  Female 211 (44.4%) 114 (40.7%) .32 
Age* 58.1 ± 13.8 59.4 ± 14.1 .23 
BMI* 26.0 ± 4.8 25.1 ± 3.8 .003 
Smoking status 
  Non Smoker 163 (34.3%) 104 (37.3%) 
  Ex- Smoker 210 (44.2%) 130 (46.6%) .20 
  Smoker 102 (21.5%) 45 (16.1%) 
Alcohol abuse 
  Low Risk 450 (94.9%) 261 (93.5%) 
  Moderate Risk 18 (3.8%) 12 (4.3%) .60 
  High Risk 6 (1.3%) 6 (2.2%) 
Peritoneal Surgery in History 
  Yes 412 (86.7%) 90 (32.1%) 
  No 63 (13.3%) 190 (67.9%) <.001 
Laparotomies in History† 2 (0-56) 0 (0-3) <.001 
Laparoscopies in History† 0 (0-2) 0 (0-1) <.001 
Generalized Peritonitis in History 
  Yes 66 (13.9%) 1 (0.4%) 
  No 409 (86.1%) 279 (99.6%) <.001 
Preoperative risk assessement 
ASA Slassification 
  I 77 (16.2%) 46 (16.4%) 
  II 284 (59.8%) 172 (61.4%) 
  III 113 (23.8%) 62 (22.1%) .83 
  IV 1 (0.2%) 0 (0.0%) 
P- Possum Score* 6.2 ± 9.8 6.0 ± 8.7 .79 
Revised Cardiac Risk Index 
  2 396 (83.4%) 222 (79.3%) 
  3 66 (13.9%) 45 (16.1%) .25 
  4 13 (2.7%) 13 (4.6%) 
Diabetes Mellitus in History 
  Yes 43 (9.1%) 29 (10.4%) 
  No 432 (90.9%) 251 (89.6%) .56 
Operative Severity 
  Minor 0  (0.0%) 2 (0.7%) 
  Moderate 22 (4.6%) 14 (5.0%) 
  Large 311 (65.5%) 134 (47.9%) <.001 
  Major 142 (29.9%) 130 (46.4%) 
Characteristics of planned operation 
Open surgery/Laparoscopy 
  Open surgery 440 (92.6%) 244 (87.1%) 
  Laparoscopy 35 (7.4%) 36 (12.9%) .01 
Anatomical site of primary intervention 
  Upper GI- tract 25 (5.3%) 58 (20.7%) 
  Lower GI- tract 219 (46.1%) 122 (43.6%) 
  HPB 82 (17.3%) 61 (21.8%) 
  Abdominal wall 115 (24.2%) 9 (3.2%) <.001 
  Other 34 (7.2%) 30 (10.7%) 
Surgical Experience 
  Surgeon 330 (69.5%) 194 (69.3%) 
  Resident 145 (30.5%) 86 (30.7%) .96 
*= mean ± standard deviation ; †= medain (range) 
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The incidence of enterotomy was 0.0% in virgin abdomens, 2.5% after 1, 8.7% after 2, and 
15.5% after 3 or more prior abdominal operations. A high Zühlke score correlated with an 
increased incidence of enterotomy. Incidence of enterotomy was 0% in grade 1, 0.7% in grade 
2, 8.9% in grade 3, and 36.4% in operations with grade 4 adhesions in the operative area. 
Enterotomies were found in 2 operations (0.6%) without adhesions to a previous scar, 0% 
with grade 1, 2.2% with grade 2, 12.0% with grade 3, and 26.9% with grade 4 adhesions to a 
previous scar. The correlation between adhesion grade and enterotomies was less strong for 
adhesions in other parts of the abdomen with an incidence of 0.5% without adhesions, 2.9% 
with grade 1, 7.4% with grade 2, 19.5% with grade 3, and 18.9% with grade 4 adhesions. The 
incidence of enterotomy, seromuscular injury, and other organ injury significantly increased 
with longer adhesiolysis time (Figs. 2A–C). 
DISCUSSION 
In this study, adhesiolysis-induced morbidity was high: a median of 20 minutes increase of 
operative time, a 1 in 10 risk of inadvertent bowel defects, a sevenfold increase in 
seromuscular injury, and a threefold to fourfold increase in other organ injury. Adhesiolysis, 
particularly with the resulting bowel defects, led to more postoperative sepsis, intra-
abdominal complications including surgical site infections, a longer hospital stay, more 
readmissions, and increased costs. 
Adhesiolysis at repeat surgery has received less attention than bowel obstruction and 
infertility in reports assessing the clinical and socioeconomical burden of postoperative 
adhesions. Underestimation of the related morbidity and the passiveness of many physicians, 
who consider adhesiolysis an annoying but unavoidable part of redo surgery, account for the 
paucity of reports on the consequences of adhesiolysis. The available literature is limited to 
small series in specific surgical areas or retrospective series in which previous surgeries or 
rehospitalisation are taken as the measure of adhesiolysis.(2;12;22;23) We designed a large 
prospective study to provide accurate incidences of adhesiolysis-related morbidity and 
socioeconomical costs. This study provided for continuous observation of the surgical 
procedures in the operating theatre by a trained researcher who did not take part in the 
surgery. This enabled the collection of reliable data that most probably could not have been 
retrieved from other sources such as operative reports.(24–26) 
The long total adhesiolysis time reflected the high complexity of these operations: when 
the adhesiolysis was longer than 1 hour, 40% of the operations resulted in bowel defects. 
Previous studies have used adhesion scores and entry times as the parameter for 
complexity.(18;23) However, an adhesion score is subjective and loses merit when adhesions 
are present in different parts of the abdominal cavity. Entry time is only a useful parameter 
when opening a previous abdominal incision and reflects a minor part of total adhesiolysis 
time and adhesiolysis-related complications.(12;23) We also had difficulty in distinguishing 
between adhesiolysis required just to enter the abdomen and adhesiolysis required to free the 
operative area in cases with massive adhesion formation to the ventral and lateral abdominal 
walls. 
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 FIGURE 2. A, Crude and adjusted ORs with 95% CI for (post)operative complications 
compared between surgery with and without adhesiolysis. B, ORs with 95% CI of 
postoperative complications after surgery with adhesiolysis compared between surgery with 
or without inadvertent bowel defect.  
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FIGURE 3. Risk of inadvertent organ injury with 95% CI stratified by adhesiolysis time: A, 
Enterotomy. B, Seromuscular injury. C, Other organ injury. 
A 
 
B 
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The incidence of inadvertent enterotomy in this study was lower than the 19% previously 
reported by our group.(12) The increased awareness of the impact of adhesiolysis and the 
modification in our department's protocol for cutting adhesions may have contributed to the 
decrease in bowel defects. Another explanation could be the strict definition of iatrogenic 
bowel defects, which no longer included enterotomies in the proximity of a pre-existing 
bowel fistula. The presence of an observer might also have raised the surgeon's vigilance to 
avoid injury. We noted, however, that the operating teams rapidly became accustomed to 
having an observer in the operating theatre. 
The need for adhesiolysis in 60% of the surgical procedures and the low number of 
laparoscopies could limit the generalizability of the study results. However, these percentages 
have been consistent in our academic department during the past decade, and they compare 
with those in a large multicentre series of patients who underwent elective colorectal surgery 
for a benign disease.(27;28) The percentage also results from the exclusion of short-stay 
surgery, which is predominantly minimally invasive surgery in virgin abdomens and 
emergency abdominal surgeries. 
Our article is the first showing adhesiolysis as a risk factor for postoperative surgical 
complications, longer hospital stays, more readmissions, and increased costs. Inadvertent 
bowel defects increased even more morbidity and costs and they also caused significant 
mortality, which agrees with the results from our retrospectively collected data.(12;22) 
Incisional wound infection was the most prominent complication reflecting the longer 
adhesiolysis-related operating times and increased blood loss, events that are used to estimate 
the risk of surgical site infection.(29) The high morbidity, long hospital stay, and high costs of 
a surgical site infection are well known from other reports.(30;31) The portion of patients 
with surgical site infection after previous surgery could not be identified from the patients’ 
medical charts. A history of peritonitis could be reliably obtained and was not a significant 
risk factor for surgical site infection. 
The economical burden of adhesive bowel obstruction in the United States is at least 2 
billion dollars annually.(32) The cost of adhesive small bowel obstruction per patient is 
estimated at $9700 for operatively treated patients and at $4000 for conservatively treated 
patients.(33;34) The cost data from this prospective study permitted an accurate calculation of 
the in-hospital costs related to adhesiolysis. These costs were $4500. Taking into account that 
adhesiolysis was required in 60% of the patients and that only about 2% to 4% of the patients 
acquire an adhesive small bowel obstruction after abdominal surgery, the economical burden 
of adhesiolysis is likely to exceed that of adhesive small bowel obstruction.(2;35) These cost 
calculations can be used for reimbursement purposes and to re-evaluate decisions concerning 
the use of barriers to prevent adhesion formation in elective abdominal surgery. Current cost-
effectiveness analyses have focused on prevention of adhesive small bowel obstruction and, in 
many countries, have not lead to the routine use of anti-adhesive barriers.(33) With the 
projected increase in more repeat abdominal surgeries because of a longer life expectancy and 
newer technologies, prevention of adhesiolysis-related morbidity might be even more cost-
effective. 
The huge burden of adhesiolysis-related morbidity in elective abdominal surgery has 
consequences for the daily practice of physicians with regard to counselling patients. Less 
than 10% of surgeons inform their patients about the risk of adhesions.(9) The high risk of 
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 adhesiolysis complicating the immediate postoperative course warrants routine informed 
consent.(11) In an analysis of medicolegal claims for complications after adhesiolysis, 
inadvertent bowel injury accounted for a considerable portion of both submitted and granted 
complaints.(36;37) 
This study has demonstrated the substantial clinical and socioeconomical burden of 
adhesiolysis, particularly when a bowel defect occurs. All physicians treating patients with 
disorders of the abdominal cavity that might require surgery should be aware of the adverse 
effects of adhesiolysis. Our data can be of help when counselling patients before surgery, 
when physicians and health care providers make decisions on implementing anti-adhesive 
strategies, and for the reimbursement policy of insurance companies. 
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Abstract 
Objectives  
To establish the incidence and predictive factors of enterotomy made during adhesiolysis in 
abdominal wall repair and to assess the impact of enterotomies and long-lasting adhesiolysis 
on postoperative morbidity such as sepsis, wound infection, abdominal complications and 
pneumonia, and socioeconomic costs. 
Background 
Adhesions frequently complicate surgical repair of abdominal wall hernia. Enterotomies made 
during adhesiolysis specifically have a large impact on morbidity of patients, especially 
surgical site infections. Little is known on the incidence and burden of enterotomies and long-
lasting adhesiolysis in abdominal wall repair. 
Methods 
Between June 2008 and June 2010 demographics, disease characteristics and perioperative 
data of all patients undergoing elective abdominal wall repair were included in a prospective 
cohort study that was focused on adhesiolysis-related problems. A trained researcher observed 
all surgeries and collected data on adhesion location, tenacity, adhesiolysis time, and 
inadvertent organ damage such as enterotomies. Primary outcome was the incidence of 
enterotomy, and predictive factors for enterotomy were assessed through univariate and 
multivariate analyses. In addition, we evaluated the impact of adhesiolysis and enterotomy on 
morbidity. 
Results 
A cohort of 133 abdominal wall repairs was analyzed. Adhesiolysis was required in 124 
(93.2%), with a mean adhesiolysis time of 35.7 ± 29.8 minutes. Thirty-three enterotomies 
were made in 17 patients (12.8%). Two patients had a delayed diagnosed bowel perforation. 
Adhesiolysis time, hernia size greater than 10 cm, and fistula were significant predictive 
factors in univariate analysis. In multivariate analysis, only adhesiolysis time was a significant 
and independent predictive factor for enterotomy (P = 0.004). Trends toward an increased risk 
were seen for patients with mesh in situ and hernia size greater than 10 cm. Patients with 
enterotomy had significantly more urgent reoperations (P=0.029), and they more often 
required parenteral feeding (P=0.037).Moreover, patients with extensive adhesiolysis 
(adhesiolysis time, >30 minutes) more often suffered from wound infection (9/63 vs 2/70; P = 
0.025), abdominal complications (5/63 vs 0/70; P = 0.022), and sepsis (4/63 vs 0/70; P = 
0.048). 
Conclusions  
One in 8 patients undergoing abdominal wall repair suffer inadvertent enterotomy following 
adhesiolysis. Adhesiolysis time predicts enterotomy. Morbidity in patients with extensive 
adhesiolysis and adhesiolysis complicated by enterotomy is high, inducing longer hospital 
stay and increased health care utilization. 
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Introduction 
Abdominal wall defect is a common indication for surgery and poses a significant health 
problem. Incisional ventral hernia is the most frequent abdominal wall defect and occurs in 
about 10% to 20% of patients undergoing open surgery.(1;2) The incidence might even by 
higher in obese patients and after recurrent abdominal surgeries.(1–3) Symptoms of incisional 
ventral hernia include pain and discomfort at the hernia site, limitations in daily activities, and 
intestinal obstruction. A complex incisional ventral wall hernia may present with 
enterocutaneous fistula–associated problems such as skin infection, wound care difficulties, 
and malnutrition.(4) 
About one third of patients with ventral hernia undergo surgical repair by synthetic mesh, 
autologous tissue repair, or a combination of both.(5–7) Short-term complications of repairs 
are frequent and include postoperative haemorrhage, seroma formation, surgical site infection, 
and mesh infection.(7–11) 
A largely neglected intraoperative complication of both open and laparoscopic abdominal 
wall repair is an inadvertent enterotomy following adhesiolysis.(12) Enterotomy increases the 
risk for unplanned enterectomy, wound infection, reoperations, and fistula formation and 
jeopardizes reconstruction with mesh. In a retrospective study of repeat laparotomy after all 
types of abdominal surgery, inadvertent enterotomy was correlated with a high number of 
complications, urgent reoperations, intensive care unit (ICU) admissions, and need for 
parenteral feeding.(13) The mortality rate of patients with inadvertent enterotomies varies 
between 8% and 50%, depending on whether the enterotomy is recognized immediately 
during surgery or with delay in the postoperative phase.(8) 
With a reported incidence of 90% adhesions after intraperitoneal surgery, adhesiolysis is 
an expected part of incisional ventral hernia repair.(14;15) The close proximity of the scarred 
skin, peritoneum, and bowel in patients with ventral hernia poses the bowel at risk to be 
injured at open abdominal entry or trocar insertion for laparoscopic repair. Inadvertent 
enterotomy has been reported in about 2% to 7% of patients with elective hernia repair, but in 
case of recurrent and complicated hernia surgery, this percentage seemed even higher. 
(8;9;16;17) 
Little is known about the clinical and socioeconomic burden of adhesiolysis and 
inadvertent enterotomy in ventral hernia repair. One review reported the combined incidence 
of enterotomies from a multitude of mostly smaller series of ventral hernia repair.(8) Two 
studies specifically reviewed the incidence in larger cohorts of patients on the basis of 
operation codes and notes of mortality and morbidity rounds.(9;18) However, bias due to self-
reporting and the retrospective nature of these studies might have led to an underestimation of 
the problem. 
Knowing the impact of adhesiolysis and the incidence and morbidity of inadvertent 
enterotomy is important to make decisions in abdominal wall repair and to increase the 
awareness of adhesions, inducing complications during peritoneal surgery. In addition, the 
patient consent process requires surgeons to adequately inform patients undergoing incisional 
ventral hernia repair of risks associated with adhesiolysis. 
We aimed to prospectively assess the incidence of inadvertent enterotomy in a large group 
of consecutive patients undergoing abdominal wall repair and to identify possible predictive 
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factors. We analyzed the impact of adhesiolysis and inadvertent enterotomy on morbidity and 
mortality, and health care utilization. 
 
Methods and Materials 
Study Design 
This was a prospective observational study as part of the LAParotomy or LAParoscopy 
and ADhesions (LAPAD) study (clinicaltrials.gov registration number NCT01236625). The 
LAPAD study was designed to assess the incidence and impact of adhesiolysis on operative 
and postoperative complications, quality of life, and socioeconomic costs. All adult competent 
patients undergoing elective laparotomy or laparoscopy admitted to the surgical ward between 
June 1, 2008, and June 2, 2010, at the Department of Surgery of the Radboud University 
Nijmegen Medical Center, Nijmegen, the Netherlands, were eligible for participation in the 
LAPAD study. Surgical patients treated in daycare were not screened for eligibility because 
early postoperative follow-up for complications was not adequate. During the operation, 
detailed information of adhesions, adhesiolysis, and inadvertent organ damage was collected 
through direct observation by a trained researcher (R.B.) not taking part in the surgery. 
Relevant data related to patients and to surgical and medical procedures were prospectively 
assessed during hospital stay and at the outpatient clinic until 6 months after discharge. 
Operative and treatment decisions were taken according to department guidelines or at the 
discretion of the surgical staff. In all cases, both sharp dissection and electrocautery were used 
for adhesiolysis. As a rule, however, electrocautery was avoided in dense adhesions (Zühlke 
score 3 and 4) to prevent bowel injury from thermal injury and necrosis.(19,20) The study was 
approved by the local medical ethical committee and conducted according to the revised 
version of the Declaration of Helsinki (October 2008, Seoul). 
Cohort Selection 
For each patient participating in the LAPAD study, the planned and actual operative 
procedures were noted using the hospitals operation coding system. The indications for the 
procedure were defined following the International Statistical Classification of Diseases and 
Related Health Problems, version 10 (ICD-10). The current study group was selected by 
actual operative procedure codes related to the ventral abdominal wall. Consecutive patients 
with the diagnosis ventral hernia or abdominal wall defect, who consented, were included. 
The last repair in patients who underwent more than 1 ventral abdominal wall repair in the 
study period was analyzed and the other repairs were regarded previous operations. 
Our department is a tertiary referral center for patients with abdominal wall defects 
complicated by infection, enterocutaneous fistula, loss of domain, and severe comorbidity. 
Therefore, overall results might overestimate those obtained in an average population of 
ventral hernia repair. To address this potential bias, we separately analyzed all primary and 
secondary outcomes in a subgroup of patients who underwent repair of an uncomplicated 
midline incisional hernia. Uncomplicated was defined as no wound infection, no 
enterocutaneous fistula, and no further surgical procedure at repair. 
Outcome Measures 
Primary outcome was the incidence of inadvertent enterotomy. Inadvertent enterotomy was 
defined as every iatrogenic unintended full-thickness bowel defect detected during operation. 
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Bowel defects from preexisting fistulas or created while dissecting the bowel loop that 
harbored the fistula were not scored as inadvertent enterotomy. 
Secondary outcomes were a delayed diagnosed perforation (DDP), the occurrence of 
serious adverse events (SAEs), and health care utilization. DDP was defined as a bowel defect 
with spill of gastrointestinal content that was diagnosed postoperatively by imaging, at 
reoperation or at autopsy, and which was not explained by anastomotic leakage or bowel 
ischemia. 
SAEs were scored for their presence and number. Postoperative complications scored as a 
SAE were death, wound infection, urinary tract infection, pneumonia, sepsis, anastomotic 
leakage, bleeding, fistula, and abscess. SAEs were diagnosed according to the criteria of the 
ICD-10, the National Nosocomial Infections Surveillance System, the Center for Disease 
Control and Prevention, or according to the opinion of the senior medical staff of the 
department. 
Health care utilization data included the number of patients requiring urgent surgical 
reintervention, parental feeding and admission to the ICU, total hospital stay, and ICU stay. 
Medication costs were calculated according to the standardized price list by the Dutch College 
of Health Insurance Companies updated for June 2008. Health care utilization outcomes were 
analyzed for the subgroups of patients with and without enterotomy and patients with an 
adhesiolysis time shorter or longer than 30 minutes. 
Possible Risk Variables 
Demographic characteristics were gender (male, female), age (years), body mass index 
(BMI, kg/m2), smoking habit (smoker, ex-smoker, nonsmoker), and the Physiologic and 
Operative Severity Score for the enumeration of Mortality and Morbidity (P-POSSUM) (0%–
100%). 
Preoperative variables included use of corticosteroids, a history of peritonitis, presence of 
intestinal fistula, the number of previous abdominal operations, and the anatomical site of the 
last operation before the first hernia repair (lower abdominal, upper abdominal, 
gynecological, urological, and none) according to the classification used by the Surgical and 
Clinical Adhesions Research group.(16;21) Hernia characteristics were obtained from the 
patient records and operation notes and the patient history including the number of previous 
repairs, the type of hernia (midline, not midline), the largest diameter of the hernia (<=10 cm 
or >10 cm), and the type (coated, noncoated) and location (intraperitoneal, extraperitoneal) of 
mesh used in previous repairs. Intraoperative variables included adhesiolysis time and 
adhesion score according to Zühlke et al: 0, no adhesions; 1, filmy adhesions; 2, stronger 
adhesions requiring some sharp dissection; 3, dense vascularized adhesions requiring sharp 
dissection; 4, extreme dense adhesions with high risk for organ damage during dissection.(22) 
Patients with a Zühlke score of 3 and 4 were compared with those with a score of 0, 1, or 2. 
Statistical Analysis 
Univariate and multivariate regression analyses were performed to identify risk factors for 
all patients suffering from one or more inadvertent enterotomies and separately for the 
subgroup of patients with an uncomplicated midline incisional hernia. Risk factors with P <= 
0.30 in univariate were selected as candidate risk factors for multivariate analysis. In 
multivariate analysis, a stepwise forward selection procedure was used with a P-entry <= 0.30 
and P-stay <= 0.10. Discriminative value of the regression model was assessed by 
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determining receiver operative characteristic (ROC) curve. We calculated the incidence of 
enterotomies per total adhesiolysis time, expressed as the time needed to harm. Characteristics 
of a continuous nature were reduced to a dichotomous nature with the median as cutoff. 
Health care utilization and SAE data were analyzed with Kruskal-Wallis and Fisher exact 
tests for continuous and dichotomous characteristics, respectively. SAEs and health care data 
were compared between patients with and without an enterotomy and between patients with 
and without extensive adhesiolysis. Extensive adhesiolysis was defined by adhesiolysis time, 
using the methods to determine the optimal cut point for research purposes described by 
Magder et al.(23) This method was applied on the odds ratio (OR) for incidence of SAE with 
cut points rounded at 5 minutes. We used SPSS for Windows version 17.0 software (SPSS, 
Chicago, IL) for statistical analysis. P < 0.05 was considered significant. 
 
Results 
Patient Characteristics 
A total of 844 planned operations were eligible for inclusion in the LAPAD study. One 
hundred forty-three operations met the inclusion criteria repair of ventral hernia or abdominal 
wall defect. Eight patients were excluded because informed consent could not be obtained. 
Two patients had incisional hernia repair twice in the study period, resulting in 133 patients 
for analysis. 
Five experienced surgeons performed all abdominal wall repairs either as primary surgeon 
or as assisting surgeon supervising a resident. No data were missing. Fourteen (10.5%) 
patients underwent hernia repair by primary closure, 29 (21.8%) by component separation 
technique, 66 (49.6%) by mesh repair, and 24 (18.0%) by a combination of component 
separation technique and mesh repair. Nine patients (6.7%) underwent laparoscopic ventral 
hernia repair. Laparoscopy was converted in 2 (22.2%) patients, for complicated adhesiolysis 
in one and difficulty with fixation of the mesh in the other. 
One hundred twenty-nine patients (97%) had a ventral incisional hernia, in 107 (82.9%) in 
the midline. Three patients (2.3%) had a parastomal hernia and one patient (0.8%) had a 
primary umbilical hernia. In 20 patients (15%), the hernia was complicated by 
enterocutaneous fistula. The hernia was larger than 10 cm in length or width in 69 (51.8%) 
patients. 
Additional surgical procedures were done in 12 (9%) patients, a bowel resection in 3, a 
pancreas resection in 3, a liver resection in 3, an esophageal resection in 1, and a 
cholecystectomy and placement of a feeding jejunostomy each in 1 patient. Seventy-eight 
(58.6%) patients had an uncomplicated incisional midline hernia and formed the subgroup. 
Sixty-six (47.5%) patients underwent repair of a recurrent hernia, 35 patients had one and 
31 patients had multiple previous repairs. Forty-four (66.7%) patients with recurrent hernia 
had a mesh in situ from a previous hernia repair, 18 (40.9%) in an intraperitoneal and 26 
(59.1%) in an extraperitoneal position. Most intraperitoneal meshes contained an absorbable 
(50.0%) or nonabsorbable (27.8%) antiadhesive layer. Fully absorbable mesh and mesh 
without antiadhesive properties were used in 11.1% of intraperitoneal mesh repair. 
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Table 1 Patients With Enterotomy and Crude ORs From Univariate Logistic Regression of 
Risk Factors for Inadvertent Enterotomy in the Total Group 
Inadvertent Enterotomy Univariate Analysis 
Yes No OR 95% CI P 
Demographics 
Gender 
• Male
• Female
11 (12.8%) 
6 (12.8%) 
11 (87.2%) 
6 (87.2%) 
Ref. 
1.00 0.34-2.90 .998 
Age* (each year increase) 62 ± 11.9 58.5 ± 12.1 1.03 0.98-1.08 .267 
BMI* (kg/m2, each point increase) 25.8 ± 3.3 27.9 ± 5.1 0.90 0.79-1.02 .098 
Smoking 
• Non smoker
• ex-smoker
• smoker
5 (11.1%) 
10 (16.7%) 
2 (7.4%) 
40 (88.9%) 
50 (83.3%) 
25 (92.6%) 
Ref. 
1.60 
0.64 
0.51-5.06 
0.12-3.55 
.424 
.610 
Patient history 
Previous hernia corrections 
• None
• One
• Multiple
8 (11.9%) 
4 (11.4%) 
5 (16.1%) 
59 (88.1%) 
31 (88.6%) 
26 (83.9%) 
Ref. 
0.95 
1.42 
0.27-3.41 
0.42-4.75 
.94 
.57 
Number of previous operations† 
(each number increase) 
4 (2 - 7) 3 (0 - 14) 1.15 0.93-1.41 .193 
Surgical experience 
• Surgeon
• Resident
11 (13.6%) 
6 (11.5%) 
70 (86.4%) 
46 (88.5%) 
Ref. 
0.83 0.29-2.40 .731 
P-Possum score* (% increase) 4.0 ± 5.3 3.4 ± 6.9 1.01 0.95-1.10 .704 
Corticosteroid use  
• No
• Yes
17 (13.4%) 
0 (0%) 
110 (86.6%) 
6 (100%) 
Ref. 
0.00 0.00-NA >.999 
Peritonitis in history 
• No
• Yes
12 (11.7%) 
5 (16.7%) 
91 (88.3%) 
25 (83.3%) 
Ref. 
1.52 0.49-4.71 .471 
Index operation 
Lower abdominal 
• Upper abdominal
• Gynecological
• Urological
• None
10 (13.5%) 
4 (11.1%) 
2 (15.4%) 
1 (11.1%) 
0 (0%) 
64 (86.5%) 
32 (88.9%) 
11 (84.6%) 
8 (88.9%) 
1 (12.8%) 
Ref. 
0.80 
1.16 
0.84 
0.00 
0.23-2.75 
0.22-6.04 
0.09-7.10 
0.00-NA 
.800 
.857 
.800 
>.999 
Operative characteristics 
Type of hernia  
• Other
• Median
2 (6.5%) 
15 (14.7%) 
29 (93.5%) 
87 (85.3%) 
Ref. 
2.50 0.54-11.59 .242 
Adhesiolysis time*  
(each minute increase) 66.9 ± 32.4 31.1 ± 26.6 1.03 1.02-1.05 <.001 
Zühlke score 
• ≤ 2
• > 2 ‡
8 (9.6%) 
9 (18.0%) 
75 (90.4%) 
41 (82.0%) 
Ref. 
2.06 0.73-5.73 .168 
Mesh in situ 
• no
• yes
9 (10.1%) 
8 (18.2%) 
80 (89.9%) 
36 (81.8%) 
Ref. 
1.95 0.70-5.47 .204 
Fistula  
• No
• Yes
10 (8.8%) 
7 (35.0%) 
103 (91.2%) 
13 (65%) 
Ref. 
5.55 1.80-17.08 .003 
Size 
• ≤10cm
• >10cm
2 (3.1%) 
15 (21.7%) 
62 (96.9%) 
54 (78.3%) 
Ref. 
8.61 1.88-39.37 .005 
Values are ∗mean (SD) or †median (range). 
‡Zühlke score > 2 in operative area and under scar. 
Ref indicates reference. 
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The anatomical area of the initial operation was lower abdominal in 74 (55.6%), upper 
abdominal in 36 (27.1%), gynecological in 13 (9.8%), and urological in 9 (6.8%) patients. 
One patient with umbilical hernia (0.8%) had no prior surgery (Table 1). 
Inadvertent Enterotomy, DDP, and Adhesiolysis Time 
A median number of 1 (range 1–9) enterotomies occurred in 17 of 133 patients (12.8%). 
Eleven patients had small bowel enterotomies, 4 had large bowel enterotomies, and 2 patients 
had enterotomies in both small and large bowel. DDP occurred in 2 patients, one in whom 
also an enterotomy was detected during surgery. There were no enterotomies or DDPs in the 
laparoscopic group. 
Surgical history was comparable between patients with and without an enterotomy. Nine 
(52.9%) patients with enterotomy had a previous abdominal wall defect repair compared with 
47 (49.1%) patients without enterotomy; the number of patients with multiple repairs were 5 
and 26, respectively (P = 0.814). 
Enterotomies were made during the opening of the abdominal cavity in 4 patients. Two 
patients suffered enterotomies both during opening of the abdominal cavity and during 
subsequent adhesiolysis deeper in the abdominal cavity or along the peritoneal side walls. The 
remaining 11 patients had enterotomies after opening of the abdominal cavity, in 6 of them 
following resection of a previously placed mesh. 
Adhesiolysis was done in 124 patients (93.2%). Mean (± SD) adhesiolysis time was 66.9 ± 
32.4 minutes in patients with enterotomy versus 31 ± 26.6 minutes in patients without 
enterotomy (P < 0.001). Thirty-three inadvertent enterotomies were caused in 4750 minutes of 
adhesiolysis, corresponding with a cumulative incidence of 1 enterotomy after every 144 
minutes of adhesiolysis. Adhesiolysis times were comparable for patients with intraperitoneal 
mesh, extraperitoneal mesh, or no mesh in situ (35.1 ± 26.8 minutes, 39.4 ± 32.0 minutes, and 
34.8 ± 30 minutes, respectively; P = 0.747). 
Tenacity of adhesions was high with 85 (63.9%) patients having Zühlke scores more than 2 
under the scar and 75 (56.4%) further away. Extreme dense adhesions (Zühlke score 4) were 
found under the scar in 27 (20.3%) patients and at the operative areas in 26 (19.5%) patients. 
Fifty (37.6%) patients had dense adhesions both under the scar and distant of the scar. 
Adhesiolysis time, the presence of a fistula, and hernia size greater than 10 cm were 
significant risk factors in the univariate analysis (Table 1). These and the factors age, BMI, 
the number of previous abdominal operations, a midline hernia, and the presence of mesh, 
with a P < 0.30, were included in the multivariate analysis. Subdivision of the location of the 
mesh (ie, intraperitoneal or extraperitoneal) was not presented in the final multivariate 
analysis because it did not result in any significant changes and did not improve the model 
(intraperitoneal vs extraperitoneal mesh, OR 0.84; 95% CI 0.17-4.0-7; P = 0.828). 
Multivariate stepwise regression analysis revealed adhesiolysis time as independent and 
significant risk factor for incidence of inadvertent enterotomy [OR (95% confidence Interval 
[CI]) 1.03 (1.01–1.05) for each minute increase in adhesiolysis time]. There was a trend 
toward a higher incidence of enterotomy in patients with mesh in situ and a hernia size greater 
than 10 cm. A trend toward a lower incidence was found in patients with higher BMI (Table 
2). The area under the ROC curve of the multivariate model was 0.87 (95% CI 0.79–0.96). 
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Table 2 Adjusted ORs From Stepwise Multivariate Logistic Regression of Risk Factors for 
Inadvertent Enterotomy in the Total Group and Subgroup 
Total group Subgroup 
OR 95% CI P OR 95% CI P 
Demographics 
Age (each year increase) NS NS NS NA NA NA 
BMI (kg/m2, each point increase) 0.86 0.72-1.02 .076 NA NA NA 
Patient history 
Number of previous operations 
(each n increase) 
NS NS NS NS NS NS 
Operative characteristics 
Type of hernia (median vs other) NS NS NS NA NA NA 
Adhesiolysis time  
(each minute increase) 
1.03 1.01-1.05 .004 1.04 1.02-1.07 .002 
Zühlke score (>2 vs ≤2) NS NS NS NS NS NS 
Mesh in situ (yes vs no) 3.28 0.93-11.61 .066 7.371 1.03- 53.0 .047 
Fistula (yes vs no) NS NS NS NA NA NA 
Size (>10cm vs ≤10cm) 5.19 0.97-27.68 .054 NS NS NS 
NS: not selected for model in stepwise multivariate analysis. 
NA: not applicable as candidate risk factor in the subgroup analysis (P > 0.30 in univariate). 
Eight (10.3%) patients had a median of one enterotomy (range 1–9) in the subgroup of 
patients with uncomplicated midline incisional hernia. Again, adhesiolysis time was a 
significant risk factor in univariate analysis with an OR 1.04 (95% CI 1.02–1.07; P = 0.002) 
for each minute increase in adhesiolysis time. There was a trend toward increased enterotomy 
incidence in patients with mesh present [mesh 5/25 (20%) vs no mesh 3/53 (5.7%); OR 4.2; 
95% CI 0.9–19.1; P = 0.066]. In multivariate analysis, adhesiolysis time and mesh presence 
were significant risk factors (OR 1.05; 95% CI 1.02–1.09; P = 0.004 and OR 7.4; 95% CI 
1.0–53.0; P = 0.047, respectively). The area under the ROC curve was 0.90 (95% CI 0.81–
0.98). 
Impact of Enterotomy 
Eight (47.1%) patients with an enterotomy underwent enterectomy. Bowel resection in 
patients without enterotomy was mostly done as part of resection of an enterocutaneous 
fistula. There were no anastomotic leakages related to bowel resection for enterotomy. Two 
patients (1.5%) died during hospital admission; one of these patients had experienced an 
enterotomy and a DDP. Cause of death was hemorrhage after a long and complicated ICU 
stay. The other patient died from pneumonia. 
Patients with an inadvertent enterotomy experienced significantly higher rates of 
complications requiring urgent surgical reintervention and parenteral feeding (38.9% vs 
12.9%; P = 0.029 and 35.6% vs 13.8%; P = 0.037, respectively) than patients without an 
enterotomy (Table 3). Total hospital stay of patients with enterotomy was significantly longer 
(20.8 ± 35.0 vs 8.6 ± 10.6 days, P = 0.002) and costs of in-hospital prescribed medication 
were higher (€1178 ± 3207 vs €250 ± 475, P < 0.001). The increase in medication costs was 
mainly due to increased use of intravenous antibiotics. 
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 Table 3 Impact of Adhesiolysis Complicated by Enterotomy on Clinical Outcomes and Costs. 
 
Outcome  
Enterotomy 
(n=17)  
No enterotomy  
(n=116) 
P   
Patients with     
  SAE (n) 
  Sepsis 
  Wound infection 
  Abscess/ fistula/ leakage 
  Urinary tract infection     
  Pneumonia 
  Hemorrhage 
  Death 
7 (41.2%) 
2 (11.8%) 
2 (11.8%) 
2 (11.8%) 
1 (5,6%) 
3 (17.6%) 
1 (5.9%) 
1 (5.9%) 
32 (27.6%) 
2 (1.7%) 
9 (7.8%) 
3 (2.6%) 
5 (4.3%) 
15 (12.9%) 
10 (8.6%) 
1 (0.9%) 
.264 
.079 
.632 
.122 
.567 
.702 
>.999 
.240  
   ICU admissions (n) 5 (29.4%) 17 (14.7%) .159  
   Reinterventions (n) 6 (35.3%) 15 (12.9%) .029 
   Parenteral feeding (n) 6 (35.3%) 16 (13.8%) .037  
Hospital stay (days) 20.8 ± 35.0*  8.6 ± 10.6* .002  
ICU stay (days) 10.7 ± 36.2* 1.0 ± 4.0* .096  
Medication costs (€) 1178 ± 3207* 250 ± 475* <.001  
*Means ± SD 
 
In 6 (35%) patients with an enterotomy but no gross spillage of intestinal content, an 
extraperitoneal mesh was placed during hernia repair. In one of the patients, the mesh was 
removed 2 days after surgery in an acute setting because of a DDP. In another patient, the 
mesh was removed after 3 months because of fistula formation. One patient presented at the 
emergency department 2 weeks postoperatively with wound infection, but no excision of 
mesh was required. The other 3 patients did not suffer from any complications. 
Optimal cut point for extensive adhesiolysis was 30 minutes. Sixty-three (47.4%) patients 
had an adhesiolysis time longer than 30 minutes, and these patients had significantly more 
complications than those with adhesiolysis time shorter than 30 minutes (38.1% vs 21.4%; P 
= 0.038). Patients with adhesiolysis more than 30 minutes experienced a significantly higher 
rate of sepsis (6.3% vs 0%; P = 0.048), wound infection (14.3% vs 2.9%; P = 0.025), and 
abdominal complications (fistula, abdominal abscess, and anastomotic leakage; 7.9% vs 0%; 
P = 0.022) than those with an adhesiolysis less than 30 minutes (Table 4). Excluding patients 
with an enterotomy or DDP, adhesiolysis of 30 minutes or longer still was associated with a 
higher number of ICU admissions (25.0% vs 7.4%; P = 0.015), a greater need for parenteral 
feeding (29.2% vs 2.9%; P < 0.001), a longer total hospital stay (12.8 ± 14.7 vs 5.6 ± 4.5 
days; P = 0.001) and ICU stay (2.1 ± 5.9 vs 0.2 ± 1.2 days; P = 0.006) and higher costs from 
in-hospital prescribed medication (€421 ± 644 vs €129 ± 248; P < 0.001). 
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Table 4 Impact of Adhesiolysis (≥30 min) on Clinical Outcomes and Costs in the Total Group 
Outcome 
Adhesiolysis 
<30 min 
(n=70) 
Adhesiolysis 
≥30 min 
(n=63) 
P  Adhesiolysis ≥30 min 
No enerotomy, no DDP 
(n=48) 
P 
Patients with  
SAE (n) 
  Sepsis 
  Wound infection 
  Abscess/ fistula/ leakage 
  Urinary tract infection     
  Pneumonia 
  Hemorrhage 
  Death 
15 (21.4%) 
0 (0%) 
2 (2.9%) 
0 (0%) 
1 (1.4%) 
7 (10%) 
6 (8.6%) 
1 (1.4%) 
24 (38.1%) 
4 (6.3%) 
9 (14.3%) 
5 (7.9%) 
5 (7.9%) 
11 (17. 5%) 
5 (7.9%) 
1 (1.6%) 
.038 
.048 
.025 
.022 
.101 
.310 
>.999 
>.999  
17 (35.4%) 
2 (4.2%) 
7 (14.6%) 
3 (6.2%) 
4 (8.3%) 
8 (16.7%) 
4 (8.3%) 
0 (0.0%) 
.141 
.169 
.032 
.068 
.158 
.402 
>.999 
>.999 
  ICU admissions (n) 5 (7.1%) 17 (27.0%) .002 12 (25.0%) .015 
  Reinterventions (n) 5 (7.1%) 16 (25.4%) .004 10 (20.8%) .048 
  Parenteral feeding (n) 2 (2.9%) 20 (31.7%) .001 14 (29.2%) <.001 
Hospital stay (days) 5.6 ± 4.5* 15.2 ± 22.2* <.001 12.8 ± 14.7* <.001 
ICU stay (days) 0.2 ± 1.2* 4.5 ± 22.2* .002 2.1 ± 5.9* .006 
Medication costs (€) 128 ± 244* 636 ± 1754* <.001 421  ± 644* <.001 
*Means ± SD
In the subgroup of 78 patients with an uncomplicated incisional hernia, no significant 
differences in the incidence of SAEs could be found between enterotomy and no enterotomy 
(Table 5). The 8 patients with enterotomy had a longer hospital stay (26.0 ± 51.4 vs 17.4 ± 
10.7 days; P = 0.030) and higher medication costs (€1887 ± 4690 vs €215 ± 395; P = 0.030) 
compared with those without enterotomy. Patients with adhesiolysis time longer than 30 
minutes were admitted more frequently to the ICU (22.9% vs 4.7%; P = 0.037), had longer 
ICU stay (5.8 ± 25.5 vs 0.2 ± 1.1 days; P < 0.001), a longer total hospital stay (14.7 ± 28.0 vs 
4.9 ± 2.9 days; P < 0.001), and higher medication cost (€720 ± 228 vs €114 ± 176; P < 0.001). 
Table 5 Impact of Adhesiolysis Complicated by Enterotomy and of Adhesiolysis (≥30 min) 
on Clinical Outcomes and Costs in the Subgroup 
Outcome 
Adhesiolysis 
<30 min 
(n=43) 
Adhesiolysi
s ≥30 min 
(n=35) 
P  No enterotomy 
(n=70) 
enterotomy 
(n=8) 
P 
Patients with  
SAE (n) 
  Sepsis 
  Wound infection 
  Abscess/ fistula/ leakage 
  Urinary tract infection     
  Pneumonia 
  Hemorrhage 
  Death 
11 (25.6%) 
 0 (0.0%) 
1 (2.3%) 
0 (0.0%) 
1 (2.3%) 
6 (14.0%) 
3 (7.0%) 
1 (2.3%) 
9 (25.7%) 
2 (5.7%) 
2 (5.7%) 
1 (2.9%) 
1 (2.3%) 
 5 (14.3%) 
  2 (5.7%) 
1 (2.9%) 
>.999 
.198 
.585 
.449 
.585 
>.999 
>.999 
>.999 
17 (24.3%) 
1 (1.4%) 
2 (2.9%) 
0 (0%) 
3 (4.3%) 
9 (12.9%) 
4 (5.7%) 
1 (1.4%) 
3 (37.5%) 
1 (12.5%) 
1 (12.5%) 
1 (12.5%) 
0 (0%) 
2 (25.0%) 
1 (12.5%) 
1 (12.5%) 
.416 
.196 
.280 
.103 
>.999 
.314 
.427 
.196 
  ICU admissions (n) 1 (2.3%) 5 (14.3%) .037 8 (11.4%) 2 (25.0%) .271 
  Reinterventions (n) 3 (7.0%) 6 (17.1%) .285 7 (10.0%) 2 (25.0%) .229 
  Parenteral feeding (n) 1 (2.3%) 5 (14.3%) .084 5 (7.1%) 1 (12.5%) .496 
Hospital stay (days) 4.9 ± 2.9* 14.7 ± 
28.0* 
<.001 17.4 ± 10.7* 26.0 ± 51.4* .212 
ICU stay (days) 0.20 ± 1.1* 5.8 ± 25.5* <.001 0.73 ± 3.0* 20.1 ± 52.6* .030 
Medication costs (€) 114 ± 176* 720 ± 228* <.001 215 ± 395* 1887 ± 4690* .030 
*Means ± SD
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 Discussion 
Open abdominal wall hernia repair is associated with extensive adhesiolysis leading to 
inadvertent organ damage in about 1 of 8 patients. Adhesiolysis time, most likely reflecting 
the difficulty of the repair procedure, was a significant and independent risk factor for 
enterotomy both in the whole group and in patients with uncomplicated midline incisional 
hernia. Adhesiolysis complicated by enterotomy and a long during adhesiolysis adversely 
affected important clinical and socioeconomic aspects of patient convalescence. 
The incidence of enterotomy was unexpectedly high. Jenkins et al evaluated laparoscopic 
repairs of 69 recurrent hernias and found only 3% patients with an enterotomy.(24) In a recent 
study, Wara et al found a 4% incidence of enterotomy during laparoscopic repair of 72 
parastomal hernias. (25)  In a large cohort of 114 laparoscopic hernia and 1009 open hernia 
repairs, 8% and 7% enterotomies, respectively, were reported.(9) The higher rate in the 
present study most likely reflects a more difficult patient population as may be concluded 
from the small proportion of laparoscopic repairs and the high proportion of patients with 
complex hernia and comorbidity. One in 6 patients had a fistula at the time of hernia repair 
and almost all surgeries were (clean-) contaminated. More complexity, however, does not 
fully explain the high incidence because uncomplicated midline incisional hernia repair still 
had a 10% enterotomy rate. Perhaps the lower incidence of enterotomies reported in 
laparoscopic hernia repair is an underestimate because delayed bowel perforation was not 
included in those series.(12;20;26) Delayed detection of operative bowel injury seems to 
occur more frequently in laparoscopic than in open repair and is associated with marked 
morbidity and mortality.(12) 
The prospective nature of the study enabled us to accurately evaluate adhesiolysis-related 
factors predicting an enterotomy. Adhesiolysis time was found to be a strong predictor for 
enterotomy in both complicated and uncomplicated hernia repair; a large defect and mesh 
presence were weak predictors. Obviously, adhesiolysis time cannot be accurately predicted 
before operation. The finding of enterotomy associated with adhesiolysis time, however, is of 
value during patient counseling for informed consent. 
Highly dense adhesions are prone for inadvertent injury when lysed. Yet, the impact of 
tenacity on enterotomy risk was not significant in our study. The scoring of adhesion tenacity 
was an estimate because adhesion tenacity varied between adhesions in the abdomen and 
adhesion quantity was not assessed. This likely explains the lack of significance of the single 
variable tenacity. Adhesiolysis time encompasses tenacity and quantity of adhesions and 
better reflects the complexity of adhesiolysis. 
In a previous retrospective study from our group that predominantly included repeat 
colorectal surgeries and revealed a risk for enterotomy of 19%, one third of enterotomies 
occurred at abdominal entry.(13) In that series, lower pelvis adhesiolysis had the highest risk 
for enterotomy, which is an area not commonly dissected in ventral hernia repair. The number 
of previous laparotomies predicted the risk of enterotomy, a finding not reproduced in the 
present series. Most likely, the percentage of multiple recurrent hernia repairs (<25%) was too 
low to allow appropriate analysis. 
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The attendance of an observer in the operating room might have raised vigilance of 
surgeons to meticulously do adhesiolysis and avoid bowel opening. This would imply that the 
enterotomy incidence would be higher when unobserved. We noticed, however, that the 
operating team became rapidly habituated to the presence of an observer during the study 
period of 2 years. So, the observer effect seems limited. 
We introduced the “adhesiolysis time needed to harm” in this analysis. This outcome 
measure does not provide a better understanding of the patient's individual risk but gives a 
qualitative assessment of the difficulty surgeons face while cutting adhesions in a 
homogeneous group of patients. Calculation of the “time needed to harm” might facilitate 
comparison between studies of factors that influence the difficulty of adhesiolysis and has 
value for health economists involved in cost price calculation of surgical interventions. 
Halm et al reported a significant difference in bowel resection between patients with 
intraperitoneal mesh (21%) and those with extraperitoneal mesh (0%) and related this 
observation to bowel injury cutting adhesions between bowel and mesh.(17) We found a 
higher incidence of enterotomy with mesh regardless of intraperitoneal or extraperitoneal 
mesh position. Notably, antiadhesive coatings were used in 4 of 5 patients with intraperitoneal 
mesh in our series, and the majority of meshes in Halm's study were made of nonabsorbable 
polypropylene. One should also be cautious to take bowel resection as a measure of adhesion 
severity and injury after adhesiolysis as Halm et al did. Only half of our patients with 
enterotomy required bowel resection. In a recent large retrospective study of 1444 patients in 
16 Veterans Affairs hospitals examining the effect of repair type and technique on the 
difficulty and complications of subsequent surgery (two-third rerepair of ventral hernia), no 
significant effect of repair type, mesh type, or position on risk of inadvertent enterotomy was 
demonstrated.(27) These results correspond with our findings indicating that extraperitoneal 
mesh position does not prevent adhesiolysis-induced injury. We have regularly encountered a 
peritoneal protrusion of an extraperitoneal mesh with adhesive attachments giving similar 
operative difficulty as an intraperitoneal mesh at rerepair. One might speculate to use 
antiadhesive meshes when placed in the extraperitoneal space after open abdominal wall 
repair on the basis of the assumption that the peritoneal layer takes part in the inflammatory 
response elicited by the surgery and the foreign body implanted and becomes adhesiogenic. 
Placing a mesh in a contaminated environment is known to increase the risk of mesh 
infection and fistula formation.(28) In a retrospective cohort of 42 mesh infections, early 
infection correlated with DDP.(29) Half of the patients in our study who received a mesh after 
an inadvertent enterotomy was repaired suffered from complications, even though there was 
no gross spillage from the enterotomy and meshes were not placed in the intraperitoneal 
cavity. The difficult and long adhesiolysis rather than the enterotomy probably accounts for 
the mesh-related complications. Our limited data of patients with enterotomy and mesh 
placement suggest avoiding mesh repair after long during complicated adhesiolysis. 
Patients with adhesiolysis complicated by enterotomy had a significantly higher incidence 
of unplanned bowel resection, sepsis, urgent reoperation, parenteral feeding, and prolonged 
hospital stay underlining the huge impact of inadvertent enterotomy on postoperative 
complications. The results accord with those of a previous retrospective study of all types of 
reoperations from our department.(13) A new finding is the higher incidence of postoperative 
surgical complications, the longer hospital stay, and increased medication costs after more 
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than half an hour of adhesiolysis. This finding was independent of enterotomy occurrence or 
complexity of the abdominal wall defect. In a large prospective randomized study of 1701 
patients undergoing colorectal resection for benign causes, every 30 minutes of adhesiolysis 
was correlated with an increase of postoperative stay by 1 day.(30) This and our results 
demonstrated the large adverse effect of adhesiolysis time alone on morbidity and health care 
utilization. 
Prolonged adhesiolysis and adhesiolysis complicated by bowel injury introduced high 
direct hospital costs given the twofold increase in hospital stay, the higher number of patients 
needing ICU treatment, the higher number of reoperations, and the almost fivefold increase in 
medication costs. Available literature on the socioeconomic burden of adhesions has focused 
only on direct hospital costs caused by adhesive small bowel obstruction. In a recent study, 
Wilson et al estimated the cumulative costs of readmission for adhesive small bowel 
obstruction after abdominal surgery at €960 per patient.(31) Comparison has not been done, 
but we speculate that the costs of adhesiolysis and subsequent inadvertent organ damage are 
higher than those of adhesive small bowel obstruction. 
Although adhesiolysis-related organ damage is common during repeat surgery and 
accounts for a huge burden of morbidity, it is one of the most neglected and poorly 
investigated complications of abdominal surgery. This is the first large prospective cohort 
study giving detailed information on the morbidity of adhesions in open abdominal wall 
repair. Although our series encompass patients with complex abdominal wall defects, most 
findings were similar for relatively simple midline ventral incisional hernias. Therefore, the 
results are representative for open ventral hernia repair. 
This study provides the first important epidemiological data on incidence, predictive 
factors, and impact of adhesiolysis in surgical repair of abdominal wall defects. The high 
incidence and large impact of adhesions emphasizes the need for adhesion prevention in all 
abdominal surgeries potentially complicated by a hernia. Unfortunately, only a minority of 
surgeons routinely use antiadhesion barrier.(32) Use of antiadhesive coating on meshes is 
recommended when repairing a ventral wall hernia to reduce bowel adherence to the mesh 
with fistula formation and troublesome separation of viscera from the intraperitoneal mesh at 
recurrent hernia repair.(17;33;34) 
Having established in a prospective way the incidence and intra- and postoperative burden 
of adhesions in ventral hernia repair, surgeons can properly inform their patients before 
consent. In addition, hospitals, health care economists, insurances companies, and 
manufacturers of hernia meshes may use these findings for organizational and economic 
purposes and cost–benefit analyses. 
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Abstract 
Background 
Inadvertent bowel injury during adhesiolysis is a major cause of increased morbidity and 
mortality following abdominal surgery. Identification of risk factors predicting this 
complication would guide preoperative counselling and surgical decision-making. The aim of 
this study was to identify predictive preoperative factors for inadvertent bowel injury 
occurring during adhesiolysis. 
Methods 
All patients undergoing elective abdominal surgery between June 2008 and June 2010 were 
evaluated prospectively as part of the LAPAD study. Data on adhesiolysis and inadvertent 
organ injury were gathered by direct observation during operation. Univariable logistic 
regression was used to investigate factors that increased the risk of inadvertent bowel injury. 
Independent predictors of bowel injury were identified using multivariable logistic regression 
and used to create a clinical nomogram. 
Results 
Of 715 patients eligible for analysis, 48 (6.7 per cent) had inadvertent bowel injuries. In 42 
patients the defect was detected during operation and in nine at a later time (3 patients had 
both). Bowel resection was required for almost two-thirds of the enterotomies. The number of 
previous laparotomies, anatomical site of the operation, presence of bowel fistula and 
laparotomy via a pre-existing median scar were independent predictors of bowel injury. A 
clinical scoring system was constructed using a nomogram incorporating these risk factors; 
this had a predictive discrimination, measured as the area under the receiver operating 
characteristic curve, of 0.85.  
Conclusion 
A nomogram based on four independent factors predicted the risk of inadvertent bowel injury. 
Registration number: NCT01236625 (http://www.clinicaltrials.gov). 
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Introduction 
Adhesion formation is the most important long-term complication of abdominal surgery, 
with a lifelong risk of developing a variety of clinical conditions including small bowel 
obstruction, infertility and chronic pain.(1;2) A possibly more important consequence of 
adhesion formation is the difficulty encountered during repeat surgery.(3;4) Adhesiolysis 
increases operating time and has an adverse effect on the patient’s convalescence, especially 
if a bowel injury occurs.(5-7) The incidence of accidental bowel injury is as high as 10–20 per 
cent in patients undergoing adhesiolysis.(4;6) The sequelae of bowel injury include unplanned 
bowel resections, an increase in the incidence of surgical complications, admission to an 
intensive care unit and even an increase in mortality. The mortality rate from bowel injury is 
estimated at between 8 and 50 per cent, depending on whether or not the defect was 
recognized during the operation.(4-6;8;9)
The authors have demonstrated previously that bowel injuries occur more often in patients 
who require extensive adhesiolysis, those with high adhesion scores or a history of multiple 
laparotomies, and patients who have had lower abdominal procedures.(4;6;7) Most of these 
factors are not known before operation, but become apparent during the procedure. Estimating 
the risk of adhesiolysis-related complications, based on preoperative variables, would enable 
the risks and benefits of surgery for the individual patient to be taken into consideration; this 
information could be used during counselling, and to identify those who might benefit from 
the use of adhesion barriers.(10;11) 
The aim of this study was to define preoperative predictors of bowel injury from data 
collected in a large prospective cohort of patients undergoing elective abdominal surgery. The 
authors also investigated whether a meaningful clinical scoring system could be developed to 
predict the risk of bowel injury. 
Methods 
This prospective observational study was carried out as part of the LAParotomy or 
LAParoscopy and Adhesiolysis (LAPAD) study (registration number NCT01236625; 
http://www.clinicaltrials.gov). The manuscript was written in accordance with the 
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) 
statement.(12) Detailed information on the LAPAD methods has been published previously. 
(4;7) The executive board of the institutional review board confirmed that the study was 
exempt from its approval. The LAPAD study was designed to assess the incidence and impact 
of adhesiolysis on perioperative and postoperative complications.  
Patient inclusion and data collection 
All adult patients scheduled for elective abdominal surgery between 1 June 2008 and 2 
June 2010 at the Department of Surgery, Radboud University Nijmegen Medical Centre, were 
screened for inclusion. The inclusion criterion was an elective laparotomy or laparoscopy. 
Exclusion criteria were age under 18 years and mental disorder. Patients were included after 
giving oral and written informed consent.  
Patient, surgical and medical data were assessed prospectively before, during and after 
hospital stay, and from the outpatient clinic for 6 months after discharge. During surgery, 
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detailed information on adhesions, adhesiolysis and inadvertent organ damage were collected 
through direct observation by a trained researcher who did not take part in the operation.   
Variables analysed 
Preoperative data on demographics, patient history, medication, operative risk scores and 
the planned procedure were extracted from the database for analysis. Demographics analysed 
comprised: sex, age, body mass index, smoking habits, and alcohol abuse based on the 
Alcohol Use Disorders Identification Test score.(13) Variables extracted from the patient’s 
history included: laparotomies, laparoscopies, interval since last laparotomy, history of other 
surgery (and, if yes, what type of surgery), exploratory laparotomy, peritonitis, diabetes 
mellitus, inflammatory bowel disease and active malignancy. Medications included: 
corticosteroids, immunosuppressants, non-steroidal anti-inflammatory drugs, opioids  and 
statins. The following operative risk scores were assessed: American Society of 
Anesthesiologists fitness classification, Portsmouth modification of the Physiological and 
Operative Severity Score for the enUmeration of Mortality and morbidity (P-POSSUM) and 
Revised Cardiac Risk Index. Aspects of the planned operation included: anatomical site of 
operation, median incision through a pre-existing scar, previous surgery at the anatomical site 
of the operation, resection of bowel fistula, surgical experience, operative severity, mesh for 
ventral hernia repair in situ and surgical approach. 
To facilitate calculations, the variable anatomical operation site was categorized as lower 
gastrointestinal, abdominal wall or miscellaneous, the latter comprising upper gastrointestinal, 
hepatopancreatobiliary and other abdominal surgery associated with a low incidence of bowel 
injury. 
Assessment of outcome 
Bowel injury was classified as inadvertent enterotomy or a delayed diagnosis of 
perforation. Inadvertent enterotomy was defined as any iatrogenic unintended full-thickness 
bowel defect detected during operation. Pre-existing fistulas or defects created while 
dissecting the bowel loop that harboured the fistula were not scored as an inadvertent 
enterotomy.  
Delayed diagnosis of perforation was defined as a bowel defect with spill of 
gastrointestinal content that was diagnosed after surgery by imaging, at reoperation or at 
autopsy, and which was not explained by anastomotic leakage, bowel ischaemia or any other 
obvious causes of leakage unrelated to adhesiolysis. 
Statistical analysis 
For patients who had undergone several operations during the study interval, the most 
recent procedure was analysed and the others regarded as previous operations to avoid 
duplication of risk factors.  
Univariable logistic regression was used to study the differences in demographics, patient 
history, medication, operative risk scores and the planned procedure between patients with 
and without bowel defects.  The incidence of bowel injuries and crude odds ratios (ORs) with 
95 per cent confidence intervals (c.i.) were calculated. All predictors found to be significant in 
univariable analysis were included in a multivariable analysis. A stepwise, backwards 
selection procedure was used with a P entry ≤ 0.100 and P stay ≤ 0.100. The adjusted OR was 
calculated with 95 per cent c.i. The R2 value was computed to assess the information gained 
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by addition of the co-variable(s) in the logistic regression model in comparison to a model 
without any co-variables. R2 ranges between 0 and 100 per cent, with 0 per cent indicating that 
the prediction model explains none of the variability in the outcome data and 100 per cent 
indicating a perfect fit on the data. 
The area under the receiver operating characteristic (ROC) curve (AUC) was used to 
quantify predictive discrimination. In general, these measures can be expected to be too high 
because the model was developed solely using the study sample, and this model would be 
expected to perform less adequately on a different random sample. Therefore, to evaluate the 
reliability of the created prediction model, an internal cross-validation was performed using 
bootstrap methods. The corrected R2 and corrected AUC were calculated.  
A nomogram was constructed using the multivariable prognostic model using the standard 
methods of the Regression Modelling Strategies package version 4.1-1 for R 2.12.0.(14) Such 
a nomogram can be used to predict bowel injury in an individual patient by filling in the 
values for each independent risk factor. The corresponding number of points can then be read 
from the scale presented. These are then summed to give a total point score, which is 
translated into a risk of enterotomy by using the two scales at the bottom of the nomogram. 
The 95 per cent c.i. of the predicted risk can be read from a 95 per cent c.i. plot of the 
estimated risks. The 95 per cent c.i. values were obtained by simulating 1000 draws for each 
combination of risk factors from the model’s posterior distribution.   
R version 2.12.0 (R Project for Statistical Computing, Vienna, Austria) was used for 
statistical analysis.  P < 0.050 was considered statistically significant in all analyses.  
Results 
Of 844 consecutive elective operations that were eligible for inclusion, 89 were excluded 
for various reasons. Some 755 operations performed in 715 patients were available for 
analysis (Fig. 1).  Most patients (62.9 per cent) were operated by one of 13 senior consultants 
participating in the study, 6.9 per cent by one of three junior consultants and 30.2 per cent by 
one of 31 residents. Bowel injuries occurred in 48 patients (6.7 per cent). In 42 patients a 
median of 1 (range 1–9) enterotomies was detected during the operation. A delayed 
perforation was diagnosed in nine patients. Three patients had both enterotomies detected 
during surgery and a delayed diagnosis of perforation. 
A total of 73 enterotomies were detected in 42 patients. In 23 of these patients at least one 
of the enterotomies was made either under the incision, or during adhesiolysis between bowel 
and the abdominal wall. Eleven patients had an enterotomy in the left lower quadrant. The left 
upper quadrant and true pelvis was the location of an enterotomy in six and four patients 
respectively. Two patients had an enterotomy in the right half of the abdomen. Among the 42 
patients with an enterotomy, the small bowel was lacerated in 28, the large bowel in nine, 
both small and large bowel in four, and one patient had a gastric enterotomy. 
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 Figure 1 Flow chart of patients included in the study 
Impact of bowel injury 
The mortality rate was higher in the bowel injury group than among those without bowel 
injury: 8 per cent (4 of 48) compared with 1.9 per cent (13 of 667) respectively (P = 0.022). 
All four patients who died in the bowel injury group had been diagnosed with a delayed 
perforation, and two also had an enterotomy detected during operation. One patient died after 
4 days from ongoing abdominal sepsis after delayed perforation; the other three died from 
haemorrhage following relaparotomy, pneumosepsis or acute heart failure. 
Enterotomy was followed by bowel resection in 26 of 42 patients, whereas enterotomies in 
the remaining patients were closed primarily. Thirteen of 48 patients with bowel injury 
required admission to an intensive care unit. Twenty-one patients (44 per cent) had one or 
more serious adverse events, which included abdominal sepsis (13 per cent), wound infection 
(17 per cent) and pneumonia (25 per cent). 
Univariable analysis of risk factors for bowel injury 
In  univariable analysis, the number of previous laparotomies, and a history of surgery of 
the lower gastrointestinal tract, abdominal wall and urogenital tract  were significant risk 
factors for bowel injury (Table 1; Table S1, supporting information). Patients who had 
undergone a single laparotomy previously had only a moderately increased risk of bowel 
injury; this increased dramatically with additional laparotomies. The risk of bowel injury was 
also higher when a previous laparotomy had been carried out within the previous 6 months. 
Patients with active malignancy had a lower risk of bowel injuries, but also had undergone 
fewer laparotomies previously.  
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Table 1 Risk factors for bowel injury identified by univariable logistic regression analysis 
No. of patients* Odds ratio† P 
Patient history 
  Laparotomies 
  0 
  1 
  2 or 3 
  ≥ 4 
2 of 263 (0.8) 
5 of 186 (2.7) 
24 of 191 (12.6) 
17 of 75 (23) 
1.00 (reference) 
3.61 (0.69, 18.79) 
18.75 (4.38, 80.39) 
38.25 (8.60, 170.15) 
< 0.001 
0.128 
< 0.001 
< 0.001 
  Lower GI surgery 
  No 
  Yes 
9 of 378 (2.4) 
39 of 337 (11.6) 
1.00 (reference) 
5.37 (2.56, 11.25) < 0.001 
  Abdominal wall surgery 
  No 
  Yes 
31 of 582 (5.3) 
17 of 133 (12.8) 
1.00 (reference) 
2.61 (1.40, 4.86) 0.003 
  Urological surgery 
  No 
  Yes 
36 of 635 (5.7) 
12 of 80 (15) 
1.00 (reference) 
2.94 (1.46, 5.91) 0.003 
  Active malignancy 
  No 
  Yes 
40 of 375 (10.7) 
8 of 340 (2.4) 
1.00 (reference) 
0.20 (0.09, 0.44) < 0.001 
  Peritonitis 
  No 
  Yes 
39 of 653 (6.0) 
9 of 62 (15) 
1.00 (reference) 
2.67 (1.22, 5.82) 0.013 
Aspects of planned operation 
  Anatomical site of operation 
  Miscellaneous 
  Lower GI 
  Abdominal wall 
4 of 270 (1.5) 
28 of 327 (8.6) 
16 of 118 (13.6) 
1.00 (reference) 
6.23 (2.16, 17.99) 
10.43 (3.40, 31.94) 
< 0.001 
0.001 
< 0.001 
  Repeated median laparotomy 
  No 
  Yes 
11 of 462 (2.4) 
37 of 253 (14.6) 
1.00 (reference) 
7.02 (3.51, 14.04) < 0.001 
  Previous surgery at anatomical site 
  No 
  Yes 
12 of 448 (2.7) 
36 of 267 (13.5) 
1.00 (reference) 
5.66 (2.89, 11.09) < 0.001 
  Resection of fistula 
  No 
  Yes 
39 of 683 (5.7) 
9 of 32 (28) 
1.00 (reference) 
6.46 (2.80, 14.90) < 0.001 
  Mesh in situ 
  No 
  Yes 
40 of 672 (6.0) 
8 of 43 (19) 
1.00 (reference) 
3.61 (1.57, 8.30) 0.002 
Values in parentheses are *percentages and †95 per cent confidence intervals. GI, gastrointestinal. A 
full list of variables evaluated in the univariable analysis can be found Table S1 (supporting 
information). 
A previous laparoscopy had no significant effect on the risk of bowel injury. The risk of 
enterotomy was highest in patients scheduled for surgery of the abdominal wall and lower 
gastrointestinal tract. The risk also increased when surgery was planned using a median 
incision through a pre-existing scar, was at the same anatomical location as previous 
operations, required fistula resection, or a mesh was in situ from a previous ventral hernia 
repair. None of the demographic variables, medications or operative risk scores had a 
significant effect on the risk of bowel injury (Table S1, supporting information).  
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Multivariable analysis of risk factors for bowel injury 
In the multivariable analysis, four predictors were included in the final model (Table 2). A 
history of laparotomies was the strongest predictor of bowel injury, the risk increasing with 
each additional laparotomy. The anatomical site of planned surgery also had an independent 
impact on the risk of bowel injury. Other variables included in the multivariable model were 
fistula resection and a median incision through a pre-existing scar. 
The AUC as a measurement of the predictive discrimination of the model was 0.85 and the 
R2 value was 25.8 per cent. After internal validation using bootstrapping, the AUC was 0.82 
and R2 was 20.7 per cent.   
A nomogram was constructed to calculate the risk of bowel injury (Fig. 2) and 95 per cent 
c.i. of the predicted risk calculated (Fig. 3). Several clinical examples of how the model can 
be applied are provided in Table S3 (supporting information). 
 
Table 2 Adjusted risk of bowel injury in multivariable logistic regression analysis  
 Adjusted odds ratio P 
History of laparotomies  
   0 
   1 
   2 or 3 
   ≥ 4 
 
1.00 (reference) 
2.27 (0.40, 12.97) 
10.03 (2.04, 49.24) 
15.79 (2.97, 83.91) 
 
< 0.001 
0.355 
0.005 
0.001 
Anatomical site of operation 
   Miscellaneous 
   Lower GI 
   Abdominal wall 
 
1.00 (reference) 
3.81 (1.26, 11.55) 
2.57 (0.78, 8.44) 
 
0.050 
0.018 
0.120 
Fistula surgery 
   No 
   Yes 
 
1.00 (reference) 
2.34 (0.95, 5.74) 
 
 
0.064 
Repeat median laparotomy 
   No 
   Yes 
 
1.00 (reference) 
1.99 (0.89, 4.44) 
 
 
0.094 
Values in parentheses are 95 per cent confidence intervals. GI, gastrointestinal. 
 
Discussion 
This study identified four predictors of adhesiolysis-related bowel injury. Using the 
nomogram built on this prediction model, the risk of inadvertent bowel injury can be 
estimated for an individual patient. The risk estimate can be used to inform the patient about 
their risk of bowel injury during adhesiolysis when obtaining informed consent. In addition, 
the surgeon can use the information to weigh up the benefits and risks of surgery. The 
prediction model demonstrated good internal validation, with comparable AUC and R2 values 
after bootstrapping. The predicted risks of bowel injury ranged from 0 to 50 per cent.  
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Figure 2 Nomogram to calculate the risk of enterotomy. 
Draw a vertical line for each variable to the ‘points’ axis at the top. Sum the points for the four variables and locate this total 
score on the ‘total points’ axis. Draw a vertical line from this through the bottom two scales to determine the linear predictor 
and the predicted risk of enterotomy. GI, gastrointestinal 
Figure 3 The predicted risk of enterotomy and 95 per cent confidence interval obtained by 
simulation  
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This large prospective cohort study was designed specifically to assess complications of 
adhesiolysis by direct observation, thereby guaranteeing data accuracy, which enabled the 
search for risk factors related to adhesiolysis injury. Previous studies had to rely on medical 
records, which are often inaccurate when reporting adhesive complications.(15-17) The 
present results were obtained using robust statistical methods and were validated internally 
using bootstrapping. 
Although this prediction model shows a good fit, it only identifies groups with low and 
moderate risk of bowel injury, with predicted risks ranging between 0 and 50 per cent. The 
inability to predict incidences above 50 per cent is most likely due to the many operative 
aspects that can result in bowel injury, the absence from the present data of other potentially 
relevant risk factors, and unknown risk factors such as the variation among humans in the 
extent and severity of adhesion formation after a similar insult. It is questionable whether 
prediction of complications after surgery could ever reach 100 per cent considering the 
interaction of multiple patient, surgeon and local environmental factors. Recently a prediction 
model for development of surgical-site infection found an incidence ranging from 15.6 to 36.1 
per cent; a model predicting the need for blood transfusion in head and neck surgery yielded 
rates ranging from 0.5 to 62 per cent.(18;19) The present model identified predictive factors 
that are easily assessed from the history of all elective surgical patients. This enables the 
prediction model to be validated in external populations. 
In this study, previous laparoscopic surgery was not identified as a risk factor for bowel 
injury. This finding should be interpreted with caution because of the low incidence of major 
previous laparoscopic procedures in this series. There are limited data showing less adhesion 
formation and better adhesion-related clinical outcome with gynaecological laparoscopy and 
other minor general surgical procedures.(20) Evidence regarding laparoscopic colorectal 
surgery is not convincing, particularly because adhesion formation was assessed post hoc or 
as a secondary outcome in colorectal studies.(21;22)  
Other potential preoperative factors for prediction of adhesion-related complications are 
the use of adhesion barriers, and mapping of adhesions to the abdominal wall and between 
viscera.(11) Adhesion barriers were barely used in any of the previous operations in the 
present cohort, consistent with the low use of barriers reported in surveys.(10;23) Adhesion 
mapping was not included as a variable here because such diagnostic tools are still 
experimental.(24-26) No routine diagnostic tool exists that can reliably assess adhesions 
before surgery, especially those between viscera. 
Two previous retrospective studies provided evidence that the number of previous 
laparotomies increases the risk of bowel injury at adhesiolysis.(6;17) In these studies age was 
also a risk factor, which could not be confirmed in the present cohort. Other risk factors 
identified in the present study had either not been analysed previously or did not show a 
significant effect. (6;16;27) 
Some variables identified as potential risk factors in univariable analysis were not 
significant in the final multivariable risk model, including history of peritonitis, mesh in situ 
and time since last laparotomy, which have been associated with more dense and extensive 
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adhesions in other studies.(7;28-31) Numbers in these subgroups might have been too small to 
demonstrate significance. 
There was no difference in the risk of bowel injury between senior and junior consultants, 
and residents. However, high-risk patients were often scheduled for surgery by a consultant 
(or at least with a consultant available to assist), which might have obscured the impact of 
surgical experience in this observational study. 
Although the statistical background of the risk model presented is complex, patients at risk 
of bowel injury are easily identified using the nomogram based on the four predictive factors 
from the multivariable model. Fewer than 10 per cent of surgeons inform their patients about 
the risks of adhesions.(10) Given the high risk of morbidity and increased perioperative 
mortality associated with bowel injuries, not informing patients about these risks could be 
deemed negligent.(32) The present results may be used to weigh up the risks and benefits of 
surgery for the individual patient. Most patients undergoing abdominal surgery have a vital 
(oncological) indication for surgery. However, many others with benign conditions undergo 
abdominal surgery to improve quality of life (ventral hernia with mainly cosmetic 
complaints). In these patients, the potential benefits of the operation and the risk of reducing 
quality of life owing to bowel injury can now be discussed more appropriately. Having 
identified a high-risk patient, precautions can be taken, such as scheduling extra operating 
theatre time, and recruiting a dedicated consultant and operating room team.  
 Future studies are needed to evaluate whether reduction of adhesion formation by the use 
of adhesion barriers can decrease the risk of bowel injury during reoperations.(11;33) 
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Abstract 
Introduction 
Adhesion formation is the most common complication following peritoneal surgery and the 
leading cause of small bowel obstruction, acquired infertility and inadvertent organ injury at 
reoperation. Using a ‘good surgical technique’ is advocated as first step in preventing of 
adhesions. However, the evidence for different  surgical techniques to reduce adhesion 
formation needs confirmation. 
Materials and methods 
Pubmed, Embase and CENTRAL were searched to identify randomized controlled trials that 
investigated the effect of various aspects of surgical technique on adhesion-related outcomes. 
Clinical outcomes and incidence of adhesions were the primary endpoints. Identification of 
papers and data extraction was performed by two independent researchers.  
Results 
28 papers from 27 studies included for a systematic review. Of these, 17 studies were eligible 
for meta-analysis, and 11 for qualitative assessment only. None of the techniques that were 
compared significantly reduced the incidence of adhesive small bowel obstruction. In a small 
low quality trial, the pregnancy rate increased after subserous fixation of suture knots. 
However, the incidence of adhesions was lower after laparoscopic compared to open surgery 
[relative risk (RR) 0.14; 95% confidence interval (CI): 0.03-0.61] and when the peritoneum 
was not closed (RR 0.36; 95% CI 0.21-0.63).  
Conclusion 
None of the different techniques that were compared reduced the two main adhesion-related 
clinical outcomes, small bowel obstruction and infertility. The meta-analysis provides little 
evidence to the surgical principle that less invasive techniques, introducing less foreign bodies 
or causing less ischemia reduces the extend and severity of adhesions. 
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Introduction 
Post-operative adhesions form as a result of peritoneal injury in abdominal and pelvic 
surgery, abdominal inflammatory diseases and infection.(1-4) Adhesions may cause a wide 
variety of morbidities, including adhesive small bowel obstruction (ASBO), acquired female 
infertility, chronic abdominal pain and inadvertent organ injury during repeat surgery.(5-10) 
The risk for adhesion-related complication is highest following colorectal surgery and surgery 
of the ovaries, with a 10-year risk of readmission directly related to adhesions as high as 8.8 
and 7.5%, respectively.(11-13) 
Prevention of post-surgical adhesion formation is the only way to combat adhesion-related 
morbidity because proper medical treatment does not exist and surgical adhesiolysis has the 
drawback of adhesion reformation. The first step in preventing post-operative adhesions is 
applying a so-called ‘good surgical technique’ minimizing injury to serosal surfaces and the 
parietal peritoneum. The significance of minimizing peritoneal injury had been emphasized in 
numerous reports, however, without substantiating on what constitutes good surgical 
technique from a number of anti-adhesion measures and agents. 
Aspects of surgical technique often mentioned in literature to be associated with (reduction 
of) adhesion formation are laparoscopy, closure of the parietal peritoneum, foreign bodies 
(e.g. glove powder, sutures and meshes), electrocautery, infection (prevention) and peritoneal 
lavage. Some studies show conflicting results. Recent clinical observational studies 
demonstrated a lower incidence of adhesions following laparoscopy in comparison with open 
surgery.(14-17) However, laparoscopy did not significantly reduce adhesion related morbidity 
in a large population-based study.(4) Animal experiments demonstrated an unfavourable 
effect of CO2 pneumoperitoneum at laparoscopy on peritoneal perfusion, reactive oxygen 
species formation and desiccation of the peritoneum, all of which are factors known to induce 
adhesion formation.(18) Peritoneal closure in order to reduce adhesion formation is much 
debated, especially following a Caesarean section.(19-21) Animal studies have demonstrated 
that the choice of suture material influences adhesion formation by its effect on the 
inflammatory response and that unipolar electrocautery causes more thermal injury to the 
peritoneum than ultrasonic dissection in a rat model of direct peritoneal injury.(22;23)  
A recent questionnaire among Dutch surgeons indicated that many questions exist 
regarding the influence of surgical technique on adhesion formation and there seems to be a 
need for clear recommendations and guidelines in order to adhere to the best surgical 
technique based on the best available clinical evidence.(24) 
A few randomized clinical studies have been published investigating certain aspects of 
surgical technique with regard to peritoneal adhesion formation. The endpoints of these 
studies vary from direct observation of the incidence of adhesions during second-look surgery 
to assessment of the fibrinolytic response to peritoneal injury as an indirect measure of 
adhesion formation. Although these studies indicate a pivotal role for fibrinolysis in adhesion 
formation, fibrinolytic activity has never been validated as a surrogate outcome for the 
incidence of adhesions or related morbidity.(25) 
This study aimed to systematically review all randomized clinical trials (RCTs) comparing 
surgical techniques in patients undergoing abdominal or pelvic surgery with direct endpoints 
of adhesion formation to obtain evidence of good surgical techniques that reduce adhesion 
formation. 
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Materials and methods 
Search 
A comprehensive literature search was carried out in Pubmed, Embase and CENTRAL. A 
list of predefined search terms was combined with the Cochrane Highly Sensitive Strategy for 
Pubmed (Table 1). Similar keywords were used for searching Embase and CENTRAL. The 
EMBASE search was combined with the sensitivity maximizing search strategy described by 
Wong et al.(26) No language or date restrictions were applied. The latest search was carried 
out on 1 October, 2011. A manual search of the bibliographies of relevant papers was carried 
out to identify additional studies for possible inclusion. 
Paper selection  
Identified articles were screened for the following inclusion criteria in title and abstract: 
patients undergoing intra-peritoneal surgery; comparison of different surgical techniques; at 
least one of the outcome measures as defined below and randomized trials. If in doubt, full 
text of articles was retrieved. Multiple publications of one original RCT were excluded when 
the papers did not add new information for quality assessment of the predefined outcomes. 
Outcomes 
Primary outcomes were the incidence of ASBO, pregnancy rate and incidence of adhesions 
at second-look surgery.(27) ASBO was regarded as a valid outcome only if the diagnostic 
criteria for ASBO were clearly described. Pregnancy rate was regarded as a valid measure of 
clinical success only in those studies where included patients underwent gynaecologic surgery 
and had clear pregnancy desire. Both the total number of clinical pregnancies and live births 
were analysed. Secondary endpoints were the site-specific incidence of adhesions and the 
standardized mean difference (SMD) in adhesion score.  
Data and statistical analysis 
Identification of papers and extraction of data were performed by two independent 
researchers (R.P.G.B. and N.K.-K.) and discrepancies were resolved through discussion under 
supervision of a third author (H.G.). We described outcomes and risk of bias of all articles, 
using the Cochrane Collaboration’s tool for assessing risk of bias. Studies were eligible for 
meta-analysis if the methods of follow-up were adequate for the outcome and necessary 
statistics could be retrieved. Follow-up was considered adequate if the length of follow-up 
was sufficient for the outcome to occur, data were obtained from a prospective source and 
,20% of patients were lost to follow-up. If statistics for meta-analysis were not provided or 
inconsistent in the full text of articles, email contact or, if necessary, telephone contact with 
the primary author was made to obtain the missing data. If the author could not provide these 
data, the main findings were only described and the study was excluded from meta-analysis. 
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Table 1: Predefined search terms used in Pubmed 
PATIENTS 
1. abdo*[Title/Abstract] 
2. intraabdominal[Title/Abstract]
3. peritoneal[Title/Abstract]
4. intraperitoneal[Title/Abstract]
5. laparoscop*[Title/Abstract]
6. laparotom*[Title/Abstract] 
7. myomect*[Title/Abstract]
8. gyne*[Title/Abstract] 
9. surgi*[Title/Abstract] 
10. surge*[Title/Abstract] 
11. leostom*[Title/Abstract]
12. colon*[Title/Abstract] 
13. color*[Title/Abstract] 
14. pelv*[Title/Abstract]
15. cesarean section [Title/Abstract] 
16. caesarean section [Title/Abstract] 
17. COMBINE 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16
INTERVENTIONS 
18. electrocoag*[Title/Abstract]
19. electrotherm*[Title/Abstract]
20. ultrason*[Title/Abstract]
21. harmonic scalpel[Title/Abstract]
22. ultracision[Title/Abstract]
23. periotneal[Title/Abstract] 
24. peritoneum[Title/Abstract] 
25. lavage[Title/Abstract] 
26. sutur*[Title/Abstract] 
27. closure[Title/Abstract]
28. powder[Title/Abstract]
29. foreign*[Title/Abstract] 
30. laparoscop[Title/Abstract]
31. laparotom*[Title/Abstract] 
32. hydra[Title/Abstract]
33. conditioning[Title/Abstract]
34. antibio*[Title/Abstract] 
35. laser[Title/Abstract] 
36. COMBINE 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR
33 OR 34 OR 35 
CONTROL 
- 
OUTCOME 
37. adhesi*[Title/Abstract]
38. tissue adhesions[MeSH Terms]
39. COMBINE 37 OR 38
TOTAL 
40. COMBINE 17 AND 36 AND 39
Similar keywords were used for searching Embase 
Data extraction and meta-analysis were performed following the recommendations of the 
Cochrane Handbook and QUOROM statement. Studies designed to assess an adhesion end-
point, with low risk of bias on at least three domains, ,10% of patients lost to follow-up and 
no important flaws in design were considered high-quality RCTs. When appropriate, a 
separate analysis was made for high-quality and low-quality studies in addition to the pooled 
analysis. The Mantel–Haenszel method was applied for pooling of dichotomous data and 
presented as relative risk (RR) with 95% confidence interval (CI). The inverse variance 
method was used for pooling continuous data and this was presented as SMD and 95% CI. A 
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fixed-effects model was applied for meta-analysis. In the presence of significant 
heterogeneity, a random effects model was applied. Heterogeneity was tested with x2 and I2 
test. An I2 value ≥50% or a P-value ,0.05 was considered significant. Data were analysed 
using Review Manager 5.0 (The Cochrane Collaboration, Copenhagen, Denmark). 
A summary of the results from the meta-analysis was presented in a figure showing the 
number of studies, number of participants and relative risk with 95% CIs for all primary 
outcomes per comparison of techniques. 
 
Results 
Description and quality of included studies 
Searches identified 3912 publications. After removal of duplicates, abstracts and titles of 
2854 publications were assessed. There were 59 potentially relevant papers were identified 
from title and abstract, and 31 papers were excluded. One paper was written in Romanian 
language and full text could not be retrieved. The other 30 papers were excluded from 
analysis after reading the full text. There were 25 papers excluded because they did not 
compare different surgical techniques or did not report an adhesion-related outcome. Four 
papers encompassed studies already included and provided no additional information on 
outcomes or methodology. Only one paper described a study protocol (Fig 1). 
Finally, 28 papers from 27 studies were included. Two papers of Lundorf et al. reported 
results on different outcomes of the same trial.(28;29) The methodological quality of most 
studies was poor, the median number of domains with low risk of bias was 2 (range 0–5; 
Table 2). The low-quality resulted from inadequate description of randomization methods, 
lack of observer blinding and lack of power analysis. Ten studies had high rates of 
withdrawals and dropouts or gave no explanation for loss to followup. Eight of these had rates 
of patients lost to follow-up varying between 31.1 and 81.9%; five of these studies addressed 
Caesarean section. Two further confounders were detected that might have influenced the 
validity of the outcome parameters. In five studies, second look was performed by a repeat 
Caesarean section. This might have introduced a selection bias at the second-look operation, 
because patients who develop periadnexal adhesions have more difficulty conceiving a second 
time. Three studies with pregnancy as an outcome parameter described no or incomplete 
fertility assessment of patient and partner. 
Of the 28 papers, 17 were included in the meta-analysis (see Table 3 for characteristics). 
The remaining 11 papers were excluded from meta-analysis because of inconsistency in data 
or inadequate follow-up. Two papers had inconsistencies in the presented data, which could 
not be resolved via email contact with the authors.30;31 In two papers, the incidence of small 
bowel obstruction was established using retrospective data from operative notes.32;33. In the 
remaining papers more than 20% of patients did not return for the second-look operation 
(Table 4). 
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Figure 1 Quorom flow chart illustrating the selection procedure of relevant articles. RCT, 
randomized clinical trial 
All 27 studies were published between 1986 and 2010 and addressed different topics of 
surgical technique. There were 23 studies performed in patients undergoing gynaecological 
surgery and four studies in patients undergoing general abdominal surgery. Five topics of 
surgical technique were studied in more than one study; closure of the parietal peritoneum 
(seven papers), laparoscopy or laparotomy (six papers), use of laser during surgery (two 
papers) and suturing following salpingotomy (two papers). Two studies in women with 
acquired infertility compared fertility rates after singlestage fertility surgery versus fertility 
surgery with a second-look laparoscopy. Other topics were the technique used for Caesarean 
section, the use of sutures in comparison to electrocautery to achieve haemostasis, two 
suturing techniques in laparoscopic myomectomy, two suturing methods following 
salpingotomy, the type of incision in the operative treatment of bowel perforation and a 
variety of techniques for laparoscopic ovarian drilling in patients with polycystic ovarian 
syndrome. Median sample size was 75 (range: 17–794). 
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Outcomes 
Results from the meta-analysis are summarized in Fig 2. Results per comparison and the 
results from qualitative assessment of the 11 papers not suitable for meta-analysis are 
described in detail below. 
Laparoscopy versus Laparotomy 
Six papers were published comparing adhesion formation between laparoscopy and 
laparotomy. Four studies of patients undergoing bowel resection reported on ASBO as 
secondary end-point and thus were not powered for ASBO. Two trials assessing incidence of 
ASBO were suitable for meta-analysis.(34;35) 
The incidence of ASBO confirmed by surgery was not significantly different between 
patients undergoing laparoscopy or laparotomy (RR 0.14; 0.02–1.12; P = 0.06).Ng et al. 
additionally reported the incidence of clinical suspicion of ASBO, which was lower in 
patients undergoing laparoscopy (RR 0.14; 95% CI: 0.03– 0.61; P = 0.008).(35)  
Two trials compared pregnancy rate following laparoscopic or open surgery.(29;36) The 
results were highly heterogeneous (I2= 72%). Using a random effects model, there was no 
significant difference in clinical pregnancy rate (RR 1.28; 95% CI: 0.94–1.74; P = 0.12). 
There was also no significant difference in live births in one study (RR 0.88; 95% CI: 0.40–
1.90).(37) Adhesions at second look were found in 1/39 patients (2.6%) after laparoscopy, 
compared with 30/37 patients (81.1%) after open gynaecological surgery (RR 0.03; 95% CI: 
0.00–0.22;P < 0.001) in one trial.(36) 
Two studies analysed the incidence of ASBO retrospectively in cohorts previously 
randomized between laparoscopic or open colorectal surgery. Taylor et al. found no 
significant difference in the incidence of ASBO between patients operated laparoscopically or 
by open surgery (7/280; 2.5% vs. 4/131;  3.1%; P=0.749).(33) In the study of Stocchi et al. 
2/27 patients in the laparoscopic group versus 0/29 patients in the open group required 
reoperation for ASBO (P=0.23).(32) 
The study of Lundorff et al. was excluded for meta- analysis on the outcome incidence of 
adhesions because 27.8% of randomized patients did not return for a second look 
laparoscopy.(28) In this study, the incidence of adhesions was 18/31 (58.1%) following 
laparoscopic and 33/42 (78.6%) following open surgery, but this difference was not 
significant  (P=0.08).  
Peritoneal closure 
Seven of the included studies compared adhesion formation after peritoneal closure or non-
closure of the peritoneum. Three trials were eligible for meta-analysis.(21;38;39) One high-
quality trial studied the incidence of ASBO following hysterectomy and pelvic node 
dissection in 120 patients. Only one patient in the non-closure group was reoperated 
for ASBO, with the adhesive band found at the plane of the pelvic node dissection. The 
difference was not significant (2.95; 95% CI:0.12–73.9; P = 0.51).(38) The incidence of 
adhesions was significantly lower when the peritoneum was left open in one trial (RR 0.36; 
95% CI: 0.21–0.63; P < 0.001).(39) The adhesion score was significantly lower in a high-
quality trial in patients with ovarian cancer, when the peritoneum was not closed 9.1+2.8 
versus 6.1+2.4; SMD -1.14 (95% CI: -1.56, -0.72; P < 0.001).(21)  
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Figure 2 Summary of meta-analysis presenting relative ratio with CI for primary outcomes 
per comparison of techniques. 
Four studies investigating adhesion formation after closure or nonclosure of the 
peritoneum in Caesarean section were excluded from meta-analysis because only a small 
portion of patients returned for a second operation with evaluation of adhesion formation.(40-
43) The results from these studies were highly heterogeneous (I2= 67%) and a mean of 77.1%
of patients were lost to follow-up. No conclusions could be drawn from these studies on the 
incidence of adhesions after closure or non-closure of the peritoneum (RR 1.02; 95% CI: 
0.43–2.40; P = 0.97). 
Two Techniques of Caesarean Section 
The study of Nabhan et al. on Caesarean section was separately analyzed because operative 
technique between the experimental and control group differed on more aspects than 
peritoneal closure alone. This study was not suitable for meta-analysis because 79.3% of 
patients was lost to follow-up.(44) In the standard technique control group, Caesarean section 
was performed using the traditional Pfannenstiel-Kerr technique, making a bladder flap and 
closing the peritoneum. In the modified technique group, the Joel-Cohen-Stark technique 
(based on the Misgav Ladach technique) was used, without making a bladder flap and without 
closing the peritoneum. The incidence of adhesion was significantly lower in the modified 
technique group (11.3% vs. 35.5%; P=0.003).(44) Obviously, this reduction cannot solely be 
attributed to peritoneal non-closure. 
Hemostasis 
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Two trials compared pregnancy rate between patients treated with laser and patients treated 
with unipolar electrocautery.(45;46) Gürgan et al. randomized between electrocautery and 
ND:YAG laser in 17 patients and Tulandi et al. randomized 63 patients between CO2- laser 
and electrocautery. There were no differences in pregnancy rate using laser devices compared 
with electrocautery (RR 0.93; 95% CI: 0.62- 2.21.371; P=0.70). No information could be 
obtained on the number of live births following conception. All patients who conceived in the 
trial of Gürgan et al. had intrauterine pregnancies.(45) Three of the pregnancies in the trial of 
Tulandi et al. were ectopic, two in the electrocautery group and one in the laser group; this 
difference was not significant.(46) Gürgan et al. additionally found no difference in incidence 
of adhesions during a second look laparoscopy (RR 0.93; 95% CI: 0.62 – 1.44; P=0.75).(45) 
Pellicano et al. randomized 32 women undergoing surgery for ovarian endometrioma.(47) 
Haemostasis was achieved by intra-ovarian suturing with only light additional coagulation if 
necessary or  by using bipolar coagulation only. The adhesion score, expressed by the 
American Society for Reproductive Medicine score, was significantly lower in the suturing 
group at a second look, 5.4 ± 2.1 versus 10.3± 2.9 (SMD-1.87; 95% CI:  -2.79, -0.94; 
P<.001). Incidence of adhesions was not significantly different (RR 0.54; 95% CI: 0.21-1.37; 
P=0.19).(47) 
Second look fertility surgery 
Two trials in fertility surgery compared pregnancy rates between patient undergoing 
single-stage fertility surgery and patients who had second-look laparoscopy.(48;49) There 
were 129 patients randomized and there was no loss to follow-up. The pregnancy rate was 
22/65 (33.8%) in patient with second-look surgery compared to 30/64 (46.9%) after single-
stage surgery (RR 0.73; 95% CI: 0.48- 1.11; P=0.14). In the trial of Alborzi et al. the number 
of live births was 11/46 (23.9%) in the second-look group, compared with 15/44 (34.1%) in 
the single-stage surgery group (RR 0.55; 95% CI: 0.30- 1.03; P=0.06).(49)  
Suturing in Salpingotomy 
Two studies analysing pregnancy rates after suturing or no suturing following 
salpingotomy were included in the qualitative assessment. Fujishita et al. analysed the 
pregnancy rate in 32 patients with a pregnancy desire. In the group without suturing, 15/19 
(78.9%) conceived, compared with 12/13 (92.3%) in the group with suturing after the 
salpingotomy. The difference was not significant (P=0.27).(50) The number of live births was 
not reported. 
Tulandi et al. reported the intrauterine pregnancy rate after randomizing 34 patients to 
salpingotomy with or without suturing. The reported 2-year pregnancy rate was 45% in the 
nonsuturing group and 47% in the suturing group.(30) 
Laparoscopic ovarian drilling 
Three trials addressed distinct aspects of laparoscopic ovarian drilling in patients with 
polycystic ovarian syndrome. The clinical pregnancy rate was comparable in one study 
randomizing 44 patients between unilateral compared and bilateral treatment (RR 1.00; 0.52, 
1.91; P=1.00), in both groups 10/22 patients became pregnant. The number of live births was 
8/22 in the unilateral group and 9/22 in the bilateral group (RR 0.89; 95% CI: 0.42-1.88; 
P=0.74).(51) Sharma et al. studied the pregnancy rate following laparoscopic ovarian drilling 
after randomizing between bipolar or unipolar electrocautery in 20 patients. In the bipolar 
group 7/10 (70%) patients conceived, compared with 5/10(50%) in the unipolar group (RR 
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1.40; 95% CI: 0.67, 2.94; P=0.37). The number of live births was four in the unipolar group 
and was not reported for the bipolar group, thus comparison was not possible.(52) Mercorio et 
al. randomized the right and left ovary to 6 or 12 puncture holes in 90 women undergoing 
bilateral ovarian drilling using a unipolar electrocautery technique. The site specific incidence 
of adhesions was 41/90 or 42/90, respectively, after 6 or 12 punctures (RR 0.98; 95% CI: 
0.71- 1.34; P= 0.88).(53)  
Miscellaneous 
Pellicano et al. compared two techniques of suturing in patient undergoing laparoscopic 
myomectomy. Subserous suturing was done with a first deep uterine crossing of the suture 
and a second subserous transfixation of the knot. This was compared with deep figure of eight 
suturing as the standard treatment.(54) Both suturing methods where tested among two 
groups, one with and one without additional use of an anti-adhesive hyaluronic acid gel. A 
trend towards a higher pregnancy rate was demonstrated for the subserous sutures in both the 
anti-adhesive gel group and the group without adhesion barrier. Clinical pregnancy rate was 
significantly higher when comparing subserous sutures (14/18; 77.8%) to standard sutures 
(7/18; 38.9%) when analysing the adhesion barrier and non-barrier groups together (RR 2.56; 
95% CI: 1.11, 5.87; P = 0.03). The number of live births was not reported. 
Talwar et al. analysed the incidence of ASBO in 56 patients with small bowel perforation 
in enteric fever, comparing a right paramedian incision to a Rutherford–Morrison 
incision.(55) The Rutherford– Morrison incision is a right iliac incision similar to the muscle 
splitting incision used for appendectomy except that all muscle fibres are cut in the same line. 
In both groups, one patient required reoperation for ASBO (RR 1.07; 95% CI: 0.7–16.33; P = 
0.96). Clinically suspected ASBO could not be analysed because the methods of follow-up 
and criteria for clinical diagnosis of ASBO were not reported. 
 
Discussion 
Summary of evidence 
Surgical techniques aiming to reduce adhesion formation included a large variety of 
technical aspects. None of the different techniques or approaches evidently showed a 
reduction of the main adhesion-related complications ASBO and infertility. The incidence of 
ASBO, established by reoperation, was not significantly different in any comparison. The 
clinical suspicion of ASBO was lower following laparoscopy compared with open surgery in 
one study. The incidence of adhesions was lower following laparoscopy than laparotomy and 
when the peritoneum was left open compared with peritoneal closure. However, the evidence 
for a lower incidence of adhesions was limited to a single small RCT and conflicting results 
were found in the qualitative assessment of lower quality studies. The pregnancy rate was 
significantly higher in one study after subserous fixation of sutures compared with standard 
sutures in a small low-quality RCT. 
Strengths and limitations of the review 
The present study is the first systematic review and meta-analysis of the impact of different 
surgical techniques on adhesion formation. The available evidence is predominantly from 
surgery of gynaecologic origin, particularly fertility surgery.(56;57) This type of surgery is 
often chosen in adhesion prevention research, because of the historical awareness of the 
adhesion problem within the European and the American fertility societies, and because the 
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surgery includes a second-look procedure and prevention of local adhesion (re)formation 
corresponds with clinical success.(58-61) 
The failure to demonstrate an effect on a relevant clinical end-point such as ASBO and 
pregnancy in this meta-analysis has several causes. Most studies were designed to detect a 
difference in adhesion incidence or score. Studies with an end-point ASBO or pregnancy 
included a too small numbers of patients to draw meaningful conclusions. Particularly in 
gynaecological studies, a substantial portion of patients were lost to follow-up decreasing the 
number of evaluable patients. The feasibility of showing a difference in ASBO and pregnancy 
rates in adhesions prevention studies is a subject of debate because of the multifactorial 
genesis of these end-points.(27) There is a doubt about the possibility, even in studies 
investigating anti-adhesive agents, of including sufficient numbers of patients in a short 
period of time and with long enough follow-up to show a significant effect on these clinical 
end-points. Taking into account the small contribution of some technical aspects to the total 
adhesion formation following intraperitoneal surgery, it is not expected that one element of 
surgery will influence the incidence of ASBO and pregnancy rates. One single adhesive band 
may still cause a bowel obstruction. 
There is some evidence from adhesion barrier studies, that reducing the incidence of 
adhesions results in a lower incidence of adhesion- related complications.(62;63) The 
outcome extent and severity of adhesions is more difficult to interpret because, unlike a 
reduction of incidence, reduction of extent and severity does not eliminate the risk of 
adhesion-related infertility or ASBO. However, patients undergoing repeated abdominal 
surgery might benefit from a reduction of extent and severity. High tenacity is traditionally 
recognized as a risk factor for organ damage during adhesiolysis.(64) In a recent prospective 
cohort of ventral hernia repairs, adhesiolysis time as an indicator of adhesion extent and 
tenacity was a strong predictor for the risk of enterotomy and complex adhesiolysis had a 
significant effect on morbidity and medication costs.(65) Unpublished data from a large RCT 
revealed that every 30 minutes of adhesiolysis was correlated to an increase in hospital stay 
with one day.(62) Thus, although considered secondary end-points in this review, the 
reduction of extent and tenacity of adhesions can be of importance especially in repeated 
abdominal surgery. 
A large number of studies had difficulty in achieving a complete follow-up. As many as 
nine studies were excluded from meta-analysis because of an inadequate follow-up. 
Especially, the repeat Caesarean section model seems prone to high numbers of patients lost 
to follow-up.40-44. Further, the choice of a repeat Caesarean section as a second-look 
procedure to study peritoneal closure bears the risk of selection bias towards patients with 
fewer adhesions because they have a higher chance of becoming pregnant again. Such study 
design also leads to a large variation in follow-up period, as the timing of a next pregnancy 
and the need for another Caesarean section are unpredictable.  
Two trials reported inconsistent statistics. These were conducted many years ago and an 
attempt to obtain raw data by email and telephone contacts unfortunately failed .(30;31)  
Comparison with previous research 
The reduction in adhesion extent and severity by limited electrocoagulation, subserous 
suture fixation and non- closure of the peritoneum emphasizes the importance of limiting 
peritoneal ischemia and foreign body material in surgery.(21;47;66) These findings concord 
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with histology results of peritoneal biopsies showing foreign body and ischemia induce 
adhesion formation in animal and human studies.(67-69) We recently demonstrated a larger 
peritoneal ischemic response following electrocautery in comparison to ultrasonic dissection, 
illustrating the adhesiogenic potential of heat application.(23) Taking down adhesions using 
electrocautery caused more bowel injury than with the harmonic scalpel in humans.(10) 
Non- closure of the peritoneum reduced adhesion formation in this meta-analysis 
confirming consistent findings of animal experiments.(70-72) In the qualitative assessment of 
lower quality studies, adhesion reduction was not evident when the peritoneal layer was not 
sutured separately.(40-43;70;71) The substantial loss of follow-up, the significant 
heterogeneity and the predominance of repeat Caesarean sections in the low quality studies, 
may have contributed to the discrepancies in study outcomes.  
Traditionally, closure of the peritoneum has been considered the technique of choice to 
reduce short-term complications and to minimize adhesion formation.(73) Contrastingly, 
current guidelines suggest that non-closure might be more favourable in terms of short-term 
complications, recovery and adhesion formation.(74;75) A Cochrane review studying short-
term complications and recovery after Caesarean section found no difference between closure 
and non- closure of the peritoneum.(76) A recent large RCT of Caesarean sections also 
demonstrated no difference in short-term complications. Long-term follow-up results are still 
awaited.(77;78) Six RCTs addressing peritoneal closure in general surgery and following 
hysterectomy have demonstrated a similar incidence of incisional hernia after closure or non- 
closure of the peritoneum.(79-84) Summarizing the results of suturing or not suturing the 
peritoneum in Caesarean section, both techniques seem acceptable considering short-term 
complications but non-closure might decrease incidence of adhesions. 
Laparoscopy was found to be favourable in randomized trials on the outcomes, incidence 
of adhesions and pregnancy rate. However, the studies in the qualitative assessment showed 
conflicting results.(28;29;36) In a large pivotal demographic study, laparoscopy failed to 
demonstrate a beneficial effect on morbidity related to adhesions in gynaecological 
patients.(4) Also no beneficial effect was found in a 3-year follow-up study in patients who 
were randomized to laparoscopic or open colorectal surgery.(33) In contrast, most animal data 
show a decrease in adhesion formation after laparoscopic compared with open surgery and 
observational human studies also demonstrate lower adhesiogenicity following 
laparoscopy.(14-17,85-88) The question is why are adhesions not more effectively prevented 
despite the strong concept of minimal invasive surgery inducing less tissue damage and thus a 
lower risk of adhesion formation. A number of factors might explain the lack of difference 
between laparoscopic and open surgery. First, an abdominal incision is often needed after a 
laparoscopic procedure to extract the specimen by an open approach. Secondly, the extent of 
serosal wound surfaces is comparable between open and laparoscopic procedures. Thirdly, the 
CO2 pneumoperitoneum, the higher intra-abdominal pressure and the light of the laparoscope 
being associated with peritoneal ischaemia, decreased fibrinolysis and increased adhesion 
formation.(18;89) Fourth, the pneumoperitoneum potentially injures the whole peritoneal 
surface inducing adhesion formation at remote areas. More meticulous dissection and 
haemostasis, no retraction of the abdominal wall and no use of gauzes in the peritoneal cavity 
in laparoscopic surgery counterbalance the drawbacks mentioned. The net effect on adhesion 
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 formation and related morbidity is unknown and may only become apparent from a well-
designed prospective RCT with adhesion formation as a primary outcome. 
Implications for future research 
The poor quality of RCT’s and the limited number of eligible patients illustrate the main 
difficulty in clinical adhesion research, e.g. the execution of a planned second-look operation, 
which is the gold standard for assessment of the incidence and severity of adhesions. The 
number of planned second procedures has declined over recent years in both female patients 
who undergo planned second-look laparoscopy following fertility surgery and patients who 
are scheduled for a two-stage colorectal surgery with planned enterostomy take down. 
Second-look laparoscopy itself has no beneficial effect on fertility outcome, as confirmed in 
this meta-analysis, and in vitro fertilization is more widely available as an alternative 
treatment.(48;49;90) Improved medical treatment for Crohns disease and ulcerative colitis has 
significantly reduced the number of surgeries and thereby the number of planned enterostomy 
take downs during which adhesions can be scored.(91)  
The declining number of planned second procedures is a challenge for future research in 
adhesion prevention. Visceral slide and cine-MRI are non-invasive adhesion detection 
techniques that have the potential to replace a second-look operation.(92) Cine-MRI 
especially holds promise identifying both adhesions to the abdominal wall and between 
abdominal viscera.(93;94)  
Implications for clinical practice 
None of the different techniques had a major impact on adhesionrelated complications. 
This meta-analysis provides little evidence that less invasive techniques, less foreign body 
material and less ischaemic injury reduce the extent and severity of adhesions in humans. The 
total prevention of adhesion formation is the only means to prevent an adhesion-related 
complication. It is not expected that optimal surgical technique alone will achieve this goal, 
based on the inevitable peritoneal injury inflicted by any type of surgery. As a consequence, 
there continues to be a need for anti-adhesion barriers and agents in open and laparoscopic 
surgery.56;62;95;96 
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Abstract 
Background 
Minimizing peritoneal tissue injury during abdominal surgery has the benefit of reducing 
postoperative inflammatory response, pain, and adhesion formation. Ultrasonic dissection 
seems to reduce tissue damage. This study aimed to compare electrocautery and ultrasonic 
dissection in terms of peritoneal tissue ischemia measured by microdialysis. 
Methods 
In this study, 18 Wistar rats underwent a median laparotomy and had a peritoneal 
microdialysis catheter implanted in the left lateral sidewall. The animals were randomly 
assigned to receive two standard peritoneal incisions parallel to the catheter by either 
ultrasonic dissection or electrocautery. After the operation, samples of microdialysis dialysate 
were taken every 2 h until 72 h postoperatively for measurements of pyruvate, lactate, 
glucose, and glycerol, and ratios were calculated. 
Results 
The mean lactate–pyruvate ratio (LPR), lactate–glucose ratio (LGR), and glycerol 
concentration were significantly higher in the electrocautery group than in the ultrasonic 
dissection group until respectively 34, 48, and 48 h after surgery. The mean areas under the 
curve (AUC) of LPR, LGR, and glycerol concentration also were higher in the electrocautery 
group than in the ultrasonic dissection group (4,387 vs. 1,639, P = 0.011; 59 vs. 21, P = 0.008; 
7,438 vs. 4,169, P = 0.008, respectively). 
Conclusion 
Electrosurgery causes more ischemic peritoneal tissue damage than ultrasonic dissection. 
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Introduction 
Peritoneal tissue ischemia resulting from dissection, electrocautery, sutures, carbon dioxide 
(CO2) insufflation (in laparoscopy), and retraction by instruments seems unavoidable in 
abdominal surgery. Ischemia induces an inflammatory response of the peritoneum, which is 
associated with postoperative pain, abdominal distension, and adhesion formation (1). 
A good surgical technique is advocated to minimize tissue damage and peritoneal ischemia. 
The type of dissection device used during surgery may have an impact on the degree of 
ischemic damage. Recent reports suggest that ultrasonic dissection is superior to 
electrocautery (e.g., causing less deep tissue injury and less profound ischemia). The data in 
these reports are derived predominantly from vascular and thoracic surgery studies showing 
less endothelial injury and vasospasm (2; 3). Despite the wide usage of electrocautery and 
ultrasonic dissection in laparoscopic and open abdominal surgery, little is known about their 
impact on peritoneal ischemia or about related early and long-term postoperative outcomes 
(4). 
Microdialysis is capable of continuously monitoring extracellular space chemistry, avoiding 
serial tissue sampling. In the past, it was predominantly used in neurointensive care 
monitoring of cerebral ischemia and in metabolic control. Currently, microdialysis is more 
widely applied to include early detection of visceral ischemia after abdominal surgery (5). It 
proves to be a simple and reliable technique for continuous monitoring of tissue responses to 
injury. 
The current study aimed to assess the extent of ischemic peritoneal damage as determined 
by microdialysis in animals undergoing surgery with either electrocautery or ultrasonic 
dissection. 
Materials and Methods 
Animals 
This study used 18 male Wistar rats weighing 250 to 300 g (Harlan BV, Horst, The 
Netherlands). The animals were acclimated to laboratory conditions with day–night cycles of 
12 h for 1 week before commencement of experiments. The rats were housed under standard 
conditions in filter-topped cages, 2 rats per cage before surgery and 1 rat per cage after 
surgery, with free access to animal chow (Hope Farms, Woerden, The Netherlands) and 
water. 
The study was approved by and conducted in accordance with the guidelines of the Animal 
Ethics Review Committee of the Faculty of Medicine, Radboud University Nijmegen, The 
Netherlands. 
Study Design 
The 18 rats were randomly assigned to a group undergoing either peritoneal tissue incision 
with ultrasonic dissection (UD group, n = 9) or electrocautery (EC group, n = 9). Peritoneal 
microdialysis was performed for 72 h after surgery, and 2-h samples were obtained to 
determine metabolic and ischemic parameters. The rats were killed 3 days after surgery to 
check the position of the catheters. 
Surgical Procedure 
The animals were fasted overnight and anesthetized using isofluorane, nitrous oxide, and 
oxygen. Procedures were performed under sterile conditions. After shaving and disinfection 
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with 70% ethanol, the rats underwent a median laparotomy incision with a total length of 4 
cm (Fig 1A). A microdialysis catheter was implanted in the left lateral parietal peritoneum 
between the peritoneum and the abdominal muscle and fixed with nonresorbable 5/0 
polypropylene. The connecting tubes were tunnelled subcutaneously to the top of the animal’s 
head. 
Figure 1 Surgical procedure and microdialysis system A Median laparotomy. B Two parallel 
incisions in the parietal peritoneum on both sides of the microdialysis catheter at a distance of 
5 mm from the probe. The catheter is connected to a pump and automatic sampler. 
Two parallel incisions in the parietal peritoneum with a length of 2 cm were made, both 5 
mm from the catheter. (Fig 1B) The incisions were made using an ultrasonic “coagulation” 
blade (Harmonic Scalpel; Johnson and Johnson, Amersfoort, the Netherlands) in the UD 
group and using an electrocautery blade (Valleylab, Boulder, CO, USA) in the EC group. The 
ultrasonic coagulation was fixed at level 3 (the coagulation level normally used in humans). In 
the EC group, the lesions were made with a fixed rate of energy (blend 1/30 W). The contact 
time with the tissue was exactly 3 s for both methods of injury. The abdominal wall was 
closed with 3/0 polyglactin and the skin with agraves. 
At the end of surgery, all the animals received buprenorphine hydrochloride 0.1 mg/kg 
intramuscularly and 10 ml of 0.9% NaCl subcutaneously. The animals were killed 3 days after 
surgery by O2/CO2 asphyxiation. The abdomen was reopened, and the catheter was inspected 
for location and removed. 
Microdialysis 
The ClinicalMicrodialysisAnalyzer/20 (CMA microdialysis, Stockholm, Sweden) was used 
for microdialysis. The CMA/20 microdialysis probe had a concentric construction of a soft 
flexible inner and outer plastic tube covered at the tip by a membrane. The probe had an outer 
diameter of 0.5 mm and was fitted with 200-mm-long inlet and outlet tubings. The membrane 
had a length of 10 mm and a cutoff of 100,000 daltons. The maximal flow rate was 10 μl/min. 
After the microdialysis catheter had been inserted into the tissue, it was connected to a 
microdialysis pump (CMA 102; CMA, Stockholm, Sweden) and perfused at a flow rate of 0.3 
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μl/min. The perfusate consisted of a buffer solution (NaCl 147 mmol/l, KCl 2.8 mmol/l, 
CaCl2 3.4 mmol/l, K2HPO4 0.6 mmol/l, MgCl2 1.2 mmol/l, ascorbate adjusted to pH 6.9) 
and 40 mg/ml of Dextran 70 (Amersham Pharmacia Biotech AB, Uppsala, Sweden) 
administered with a 2.5-ml glass syringe (CMA, Stockholm, Sweden). 
Sampling and biochemical analysis 
The first sample was collected 2 h after laparotomy by a synchronized sampler (CMA/140, 
CMA microdialysis; CMA, Stockholm, Sweden), and automatic sampling was continued 
every 2 h for a total duration of 3 days. The samples were stored at –20°C. 
The concentrations of peritoneal extracellular pyruvate, lactate, glucose, and glycerol were 
measured immediately after the whole experiment using ordinary enzymatic methods with a 
microdialysis-analyzer (CMA 600; CMA). 
Statistical analysis 
Lactate–pyruvate and lactate–glucose ratios were calculated. Data of continuous variables 
are expressed as means and 95% confidence intervals (CI). A two-sided t-test was calculated 
to evaluate any differences between two categorical variables. The area under the curve 
(AUC) was calculated by GraphPad, and data are expressed as mean and range. The 
Wilcoxon test was performed to evaluate any differences between continuous variables at 
different intervals. Statistical analysis was performed using SPSS 14.0 (SPSS, Chicago, IL) 
and GraphPad (GraphPad Prism 4.00; GraphPad Software, San Diego, CA). A P value less 
than 0.05 was considered significant. 
Results 
All the animals survived the experimental period, and a 100% sampling was obtained. All 
the catheters remained in position during the study period. 
The unrefined data of the separate animals showed the same tendency over time within one 
treatment group (Fig 2). The means and 95% confidence intervals of metabolite 
concentrations at the time points are shown in Figure 3. Figure 3 shows the AUC, which 
represents the total concentration of variables in the 72-h period. 
Glucose 
The immediate postoperative mean glucose concentration was significantly lower in the EC 
group (4.7 mmol/l) than in the UD group (5.4 mmol/l; P < 0.01). In the animals treated with 
electrocautery, the mean glucose concentration decreased in the first 12 h, reaching the lowest 
value of 3.0 mmol/l, then increased again. The UD group showed an almost straight curve, 
with values of 4.9 to 5.7 mmol/l. 
The mean values in the EC group were significantly lower than in the UD group for the first 
36 h after surgery. The total glucose concentration, represented by the AUC, was lower in the 
EC group (316 mmol/l h) than in the UD group (380 mmol/l h; P = 0.008). 
Lactate 
In the immediate postoperative period, the mean lactate concentration was significantly 
higher after electrocautery (3.4 mmol/l) than after ultrasonic dissection (2.0 mmol/l; P < 
0.01). Within the first 9 h postoperatively, a peak of 6 mmol/l was reached in the EC group, 
followed by a decline to baseline. In contrast, the UD group did not reach a peak and 
remained at levels 1.4 and 2.1 mmol/l. The mean lactate values were significantly higher in 
the EC group than in the UD group until 48 h postoperatively. The total lactate concentration 
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was significantly higher in the EC group (AUC, 233 mmol/l h) than in the UD group (AUC, 
112 mmol/l h; P = 0.008). 
Glycerol 
From the beginning, the mean glycerol concentration (a direct parameter for tissue ischemia) 
was significantly higher in the EC group (210 μmol/l) than in the UD group (104 μmol/l; P < 
0.01). The EC group showed a gradual decline until 50 h after surgery. The animals treated 
with ultrasonic dissection showed a similar tendency, but the concentrations were lower and 
declined only from 104 to 47 μmol/l. The total glycerol concentration in the EC group (mean 
AUC, 7,438 μmol/l h) was almost two times higher than in the UD group (mean AUC, 4,169 
μmol/l h; P = 0.008). 
Lactate–pyruvate ratio 
The mean calculated lactate–pyruvate ratio immediately after surgery was significantly 
higher in the EC group than in the UD group (105 vs. 30; P < 0.01). The EC group reached 
ratios comparable with those of the UD group at 50 h after surgery. The animals treated with 
ultrasonic dissection showed an almost straight curve, with ratios between 14 and 30. The 
mean values were significantly higher in the EC group than in the UD group until 34 h after 
surgery. The mean AUC of the lactate–pyruvate ratio was higher in the EC group than in the 
UD group (4,387 vs. 1,639; P = 0.011). 
Lactate–glucose ratio 
The mean calculated lactate–glucose ratio was significantly higher in the EC group than in 
the UD group (0.74 vs. 0.37; P < 0.01). A peak was reached 22 h after surgery, with a ratio of 
1.8. Thereafter, it declined to values between 0.2 and 0.4. The animals treated with ultrasonic 
dissection had ratios between 0.2 and 0.4. The mean values were significantly higher in the 
EC group until 48 h after surgery. The mean AUC of the lactate–glucose ratio was 
significantly higher in the EC group than in the UD group. (59 vs. 21; P = 0.008; Table 1). 
Discussion 
The current study demonstrates that electrocautery causes more ischemic peritoneal tissue 
damage than ultrasonic dissection. Ultrasonic surgery had no effect or only a transient 
ischemic effect on peritoneal tissue and therefore fits well into the principia of “good surgical 
technique.” 
Microdialysis was proved useful in continuously measuring peritoneal extracellular 
chemistry. The inserted semipermeable membrane allowed a continuous diffusion of 
molecules out of the peritoneal interstitional space fluid into the perfusate medium for the 
whole study period without any failure. 
Extracellular concentrations of glucose, pyruvate, lactate, and glycerol are broadly used as 
indicators of tissue hypoxia (5–14). During ischemia, impaired blood flow decreases the 
delivery of glucose and oxygen to the tissue, forcing it to switch from aerobic to anaerobic 
metabolism (15; 16). The result is an increase in lactate, and if the glucose supply is 
inadequate, also a decrease in pyruvate level. 
The rise in interstitional glycerol level is related to membrane phospholipid degradation, 
indicating tissue damage (7). Although hyperlactataemia frequently is used as an indicator of 
anaerobic metabolism (6), its accumulation also can be caused by other conditions such as 
hypermetabolism, alkalosis, hepatic failure, toxins, and sepsis (6; 17; 18). Therefore, the 
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 lactate–pyruvate ratio is a more reliable tissue-specific indicator of visceral ischemia (6; 8–11; 
14;18). It correlates with the redox potential (6) and is less susceptible to artefacts caused by 
alterations in the dialysate recovery rate (8). The immediate rise in the lactate–pyruvate ratio, 
reflecting sudden ischemia and inducing tissue necrosis, accords with the pathology of the 
coagulation injury. 
The immediate rise in glycerol, another sensitive cell membrane marker for ischemia, further 
supports early cell damage. The lactate–glucose ratio provides an understanding of the 
qualitative relation between the ischemic glycolysis substrate and the end product and 
therefore is elevated in tissue ischemia (12). This elevation starts later than that of the lactate–
pyruvate ratio, reaching a peak after 24 h, making the lactate–glucose ratio a less reliable 
parameter measuring early ischemia in this model. Within 48 to 72 h postoperatively, no 
difference was seen any longer between the two treatment groups, suggesting a rapidly 
developing but short-lasting ischemia and a rapid peritoneal healing response. 
 
 
Table 1 Area under curve (AUC) 
DIALYSATE UD 
(N=9) 
 EC 
(n=9) 
 P 
 
Glucose (mmol.hr/L)                  
                                Mean 
 
 
380.3 
  
 
316.1 
  
 
0.008 
                                Range 357.1-395.6  282.2-354.3   
                                SD 11.57  22.43   
 
Lactate (mmol.hr/L)                    
                                Mean 
 
 
112.3 
  
 
232.7 
  
 
0.008          
                                Range  96.5-155.0  185.8-276.0   
                                SD 22.2  36.9   
 
Glycerol (µmol.hr/L)                  
                               Mean 
 
 
4169.4 
  
 
7437.6 
  
 
0.008 
                               Range 3162-4751  4778-8872   
                               SD 602.1  1210.1   
 
Lactate/Pyruvate Ratio  
                               Mean                                 
 
 
1639.2
  
 
4387.0 
  
 
0.011 
                               Range 839.2-3307.0  2563-6734   
                               SD 768.9  1513.9   
 
Lactate/Glucose Ratio  
                                Mean            
 
 
20.8 
  
 
59.1 
  
 
0.008 
                                Range  17.3-29.2  44.1-70.5   
                                SD 4.2  8   
      
P values are for the differences between UD and EC 
UD ultrasonic dissection, EC electrocautery, SD standard deviation 
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Figure 2 Unrefined data. Microdialysis parameters in animals that had surgery with ultrasonic 
dissection (UD) (n = 9) or electrocautery (EC) (n = 9). 
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Figure 3 Microdialysis parameters in animals that had surgery with ultrasonic dissection 
(UD) (n = 9) or electrocautery (EC) (n = 9). Values are expressed as means and 95% 
confidence intervals. *P < 0.01. 
 
Ultrasonic dissection caused almost no tissue damage in the current study. In an animal 
study of peritonitis, control subjects undergoing a sham operation (laparotomy and peritoneal 
insertion of a microdialysis catheter) showed patterns of ischemic indices corresponding with 
those of the ultrasonic group (19). Less injury by using ultrasonic dissection rather than 
electrocautery also was demonstrated in histologic biopsies of vascular endothelium, 
abdominal fascia, and bile duct (3; 20; 21). This accords with various clinical studies showing 
fewer gallbladder perforations during laparoscopic cholecystectomy, fewer symptomatic 
lymphoceles after paraaortic lymphadenectomy, less necrosis after flap reconstruction, and 
less postoperative pain after gynaecologic surgery and tonsillectomies, all explained by less 
tissue necrosis and inflammation (22–27). 
Others have reported less favourable results with use of the ultrasonically activated scalpel 
related to high heat production, activation longer than 10 s, and slow cooldown after the 
instrument is turned off (4; 28). The use of a scalpel versus a hook, the duration of instrument 
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activation, the different tissues examined (well- vs. poor- vascularised tissue), and the tissue 
contact after application explain the differences in findings between studies. The short 
duration of peritoneal contact with a hook probably explains the more favourable outcome in 
our study than in the study of Kim et al (4). Lateral thermal injury also was less in pig 
intestine and abdominal wall when energy was applied with pauses in contrast to the 
continuous activation of the Harmonic Scalpel (29). 
Placement of the catheter itself did not seem to influence the current data, as deduced from 
the minimal changes in the UD group. Because of catheter placement, we did not control for 
peritoneal tissue responses through measurements, for example, in the subcutaneous tissue, as 
many studies do. A previous study demonstrated the same pattern recorded over time for 
catheters placed intraperitoneally and subcutaneously (17). 
In daily practice, electrocautery is more frequently used than ultrasonic dissection despite 
multiple clinical studies indicating a superiority of the latter in causing less tissue damage, as 
evidenced by a decrease in gallbladder and intestine perforations during surgery and a 
reduction in complication rates for various abdominal, vascular, cardiac, and plastic surgeries 
(15; 22–25; 30–38). The results of our study support a more frequent use of ultrasonic 
dissection in abdominal and pelvic surgery. 
A favourable consequence of less tissue ischemia is the reduction in adhesion formation. 
Notably, the use of sutures was associated with a lower adhesion score compared with 
electrocautery in a small randomized controlled trial (39). Adhesion formation was not a 
primary end point in the current study because 3 days of microdialysis was too short for 
accurate scoring of adhesions. A longer duration of microdialysis was deemed hazardous 
because of an increased risk of catheter blocking and foreign body reaction, which would 
introduce adhesions. 
 
It is concluded that the metabolic profiles in the current study resemble tissue ischemia with 
the use of ultrasonic surgery compared with electrocautery. In terms of optimal surgical 
technique, therefore, ultrasonic dissection is the preferred over electrocautery. 
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Abstract 
Background  
Formation of adhesions after peritoneal surgery results in high morbidity. Barriers to prevent 
adhesion are seldom applied, despite their ability to reduce the severity of adhesion formation. 
We evaluated the benefits and harms of four adhesion barriers that have been approved for 
clinical use. 
Methods  
In this systematic review and meta-analysis, we searched PubMed, CENTRAL, and Embase 
for randomised clinical trials assessing use of oxidised regenerated cellulose, hyaluronate 
carboxy methylcellulose, icodextrin, or polyethylene glycol in abdominal surgery. Two 
researchers independently identified reports and extracted data. We compared use of a barrier 
with no barrier for nine predefined outcomes, graded for clinical relevance. The primary 
outcome was reoperation for adhesive small bowel obstruction. We assessed systematic error, 
random error, and design error with the error matrix approach. This study is registered with 
PROSPERO, number CRD42012003321. 
Findings  
Our search returned 1840 results, from which 28 trials (5191 patients) were included in our 
meta-analysis. The risks of systematic and random errors were low. No trials reported data for 
the effect of oxidised regenerated cellulose or polyethylene glycol on reoperations for 
adhesive small bowel obstruction. Oxidised regenerated cellulose reduced the incidence of 
adhesions (relative risk [RR] 0.51, 95% CI 0.31–0.86). Some evidence suggests that 
hyaluronate carboxymethylcellulose reduces the incidence of reoperations for adhesive small 
bowel obstruction (RR 0.49, 95% CI 0.28–0.88). For icodextrin, reoperation for adhesive 
small bowel obstruction did not differ significantly between groups (RR 0.33, 95% CI 0.03–
3.11). No barriers were associated with an increase in serious adverse events. 
Interpretation  
Oxidised regenerated cellulose and hyaluronate carboxymethylcellulose can safely reduce 
clinically relevant consequences of adhesions. 
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Introduction 
Adhesions are the most common cause of long-term complications from abdominal 
surgery. They can cause small bowel obstruction, injury at reoperations, female infertility, and 
chronic pain.(1- 5) Adhesions can affect the quality of life of millions of patients, jeopardise 
life expectancy, and result in more than US$2 billion dollars of health-care costs in the USA 
yearly.(2;6;7) 
Steps are rarely taken to prevent adhesion despite evidence that adhesion barriers reduce 
their formation.(1;8-11) Underestimating the burden of adhesions seems to be an important 
explanation for the lack of use of adhesion barriers.(12) Unlike other postsurgery 
complications, the consequences of adhesion formation include various clinical entities that 
are often dealt with by specialists other than the surgeon who did the initial operation.(4; 5;7) 
Additionally, many questions exist about the indications for adhesion barriers, cost-
effectiveness, and which barrier to use.(12;13) 
Cochrane reviews have not answered the questions of efficacy and safety of barriers.(14-
16) More than 20 different membranes and liquids have been investigated in clinical studies
for use as adhesion barriers. Many were either unsuccessful in reducing the formation of 
adhesions or were only assessed using outcomes of little clinical importance.(17;18) Some 
were even associated with detrimental effects.(19) Results were dispersed over three reviews 
and only trials in gynaecological or colorectal surgery were included. Thus, appraising the 
available evidence about the use of adhesion barriers remains difficult. 
The error matrix approach has been specifically developed for such situations, in which the 
possible benefits and harms of an intervention are difficult to summarise.(20) This approach 
consists of assessment of the three dimensions of systematic error, random error, and design 
error. The three dimensions of error can be presented in a three dimensional plot so that the 
relevance and strength of evidence for different benefits and harms can be judged at a single 
glance. 
We assessed the benefits and harms of use of adhesion barriers for all types of abdominal 
surgery by such an approach. 
Methods 
Study design and systematic review 
We assessed the results of our systematic review and meta-analyses by the error matrix 
approach. The error matrix approach has been validated in systematic reviews of 
cholecystectomy and inguinal hernia repair.(21;22) We included randomised trials evaluating 
the four adhesion barriers that have been approved for clinical use by legislative authorities in 
Europe and the USA: hyaluronate carboxymethylcellulose (Seprafilm®, Sanofi, Paris, 
France), oxidised regenerated cellulose (Interceed®, Johnson & Johnson, New Brunswick, 
NJ, USA), icodextrin 4% solution (Adept®, Baxter, Deerfield, IL, USA), and polyethylene 
glycol (Spraygel®, Sprayshield®, Confluent Surgical, Waltham, MA, USA). 
We searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials 
with Mesh descriptors including: “carboxymethylcellulose”, “hyaluronic acid”, “icodextrin”, 
“polyethylene glycols”, “tissue adhesions”, “intestinal obstruction”, “infertility, female”, 
“abdominal pain”, “pelvic pain”, and “intestinal disease/surgery”. The appendix shows the 
full search strategy. We did not apply any language restrictions and included all relevant 
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articles up to Feb 2, 2013. Only randomised trials were included. We also searched the 
reference lists of identified trials, for further references, including those published in grey 
literature. We did additional searches to find relevant grey literature and unpublished trials 
(appendix). 
RPGtB and MWJS identified eligible reports; discrepancies were resolved through 
discussion. We applied the following inclusion criteria to the titles and abstracts of the search 
results: patients undergoing intraperitoneal surgery, application of one of the four adhesion 
barriers, and report of adhesion-related outcomes. Results of some trials were reported in 
more than one report. Information from the different reports was linked and analysed as a 
single trial. 
We assessed all trials for the risk of bias (measured by the level of evidence), the risk of 
random error, and the design error.(20) We present data in a three-dimensional Manhattan 
plot. We assessed the risk of systematic error with the Cochrane Collaboration's instrument 
for bias risk assessment.(23) Six components associated with the risk of bias were assessed: 
generation of the allocation sequence, allocation concealment, masking of outcome assessors, 
selective outcome reporting, incomplete follow-up, and other potential sources of bias. Trials 
with a low risk for all six components were defined as having an overall low risk of bias. 
Trials in which one or more of the six bias components were unclear or had high risk of bias 
were defined to be at high risk of bias. Because masking the surgeon to allocation is 
impossible, trials in which patients and outcome assessors were masked were deemed to have 
a low risk of bias for masking. Additionally, we recorded data about funding sources. 
The risk of random error is the risk of drawing a false conclusion based on sparse data. 
This risk is quantified as the p value. However, because random low (and random high) p 
values might occur during accumulation of data and sequential testing, they do not 
sufficiently represent the risk of random error between different studies.(24) The standard 
error (SE) measures the amount of variability in the sample mean; it indicates how closely the 
population mean is likely to be estimated by the sample mean. We therefore used SE to 
evaluate the risk of random error, using the algorithms suggested by the Cochrane 
collaboration.(23) We defined small risk of random error as an SE of less than 0.20 and 
moderate risk as an SE of less than 1.00. Studies with higher risk of random error (≥1.00) fell 
outside the range of the plot. 
We assessed design error (external validity) by classifying the clinically relevant outcome 
measures according to the Grading of Recommendations Assessment, Development and 
Evaluation approach.(25) We assessed publication bias with funnel plots. Raw data from 
unpublished studies and studies using adhesion-related outcomes other than those predefined 
were reported separately. 
We compared use of a barrier with no barrier for nine predefined outcomes. The primary 
outcome was reoperation for adhesive small bowel obstruction. We also assessed serious 
adverse events, total incidence of adhesions, reoperation time, small bowel obstruction from 
any cause, site-specific incidence of adhesions, and adhesion score. 
Statistical analysis 
We used the Mantel-Haenszel method for dichotomous data, presented as relative risks 
(RR) with 95% CIs. We used the inverse variance method to pool continuous data; results are 
presented as standardised mean difference with 95% CIs. We assessed statistical 
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heterogeneity with Cochran's test and I2. In the absence of statistical heterogeneity we used a 
fixed-effect model, otherwise we used a random-effects model. We did the analyses with 
Review Manager (version 5.1) and R (version 2.12.0). (26) 
We did three subgroup analyses. First, we compared the pooled results of trials with a low 
overall risk of bias with the pooled results from trials with a high overall risk of bias. Second, 
we compared the pooled results of trials with a low risk of funding bias with trials with an 
unclear or high risk for funding bias (trials sponsored by industry). Third, trials with clinical 
heterogeneity were not pooled into one overall effect estimate. Clinical heterogeneity was 
assessed by subgroup according to the type of operation (upper alimentary tract, lower 
alimentary tract or colorectal, abdominal wall, gynaecological, or urological surgery). All 
subgroup analyses were tested for interactions. 
The full review protocol is registered with PROSPERO (number CRD42012003321) and 
shown in the appendix. 
Role of the funding source 
There was no funding source for this study. RPGtB and HvG had full access to all data in 
the study and had final responsibility for the decision to submit for publication. 
Results 
Our search returned 1840 results, from which we included 33 trials assessing 5381 patients 
in our systematic review (Fig 1, table 1). Five trials either reported on outcomes not included 
in the predefined outcomes or had incomplete outcome data. Thus, 28 trials assessing 5191 
patients were included in the meta-analyses. 20 trials were of gynaecological surgery, nine of 
colorectal surgery, and one each of gastric, hepatic, general paediatric, and small bowel 
obstruction surgery. 
Outcome measures were reoperation for adhesive small bowel obstruction (six trials), 
serious adverse events (14 trials), overall incidence of adhesions (six trials), operation time 
(three trials), small bowel obstruction by any cause (five trials), site-specific incidence of 
adhesions (ten trials), and adhesion score (13 trials). These outcome measures were ranked 
according to their clinical relevance for the patient according to Grading of Recommendations 
Assessment, Development and Evaluation with reoperation for adhesive small bowel 
obstruction as the highest relevance and adhesion score as the lowest (table 2). 
Roughly two-thirds of trials adequately generated an allocation sequence (Fig 2). Most 
studies had adequate allocation concealment and masking of the outcome assessors. Follow-
up methods and description of reasons for loss to follow-up were adequate in the majority of 
trials. The risk of outcome bias through selective reporting was low for some studies. The 
primary endpoint was changed during one trial.(53) The timing of second look procedures 
varied widely in the study by Tinelli and colleagues.(11) One trial was stopped prematurely 
because of organisational difficulties.(57) 
Overall, four trialshad a low risk of bias based on all six domains (figure 2). (1;8;9;55) 
Industry sponsored 16 trials (57%) and sponsoring was not reported for seven trials (25%). 
Two trials assessing hyaluronate carboxymethylcellulose were initiated and sponsored by 
independent parties.(39;42) Another three trials were investigator driven, but the 
manufacturer supplied the adhesion barrier.(38;48;57) The results from investigator-driven 
trials were similar to the results from industry-sponsored trials (appendix). 
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Figure 1 Study selection 
 
The risk of random error (SE) was small for adhesion score in eight trials, and overall 
incidence of small bowel obstruction by any cause in one trial. Funnel plots appeared to be 
symmetrical: trials did not report extreme values (outside 95% CI) by most analyses 
(appendix). Three additional trials from grey literature and trial registries had limited 
available outcome data. Their findings accorded with the results of published studies 
(appendix). 
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Table 2 Predefined outcomes ranked according to Grading of Recommendations Assessment, 
Development and Evaluation by relevance according to the patients' perspective 
Critical for decision 
making 
9 Reoperation for adhesive small bowel obstruction 
8 Serious Adverse Events 
Important for 
decision making 
6 Total incidence of adhesions 
5 Operation time of reoperation 
4 Small bowel obstruction(any cause)* 
Limited importance 2 Site specific incidence of adhesions 
1 Adhesion score 
* Includes small bowel obstructions not caused by adhesions
Oxidised regenerated cellulose is a solid barrier in the form of a knitted fabric. After 
application on the injured peritoneum it swells and becomes a gel. The gel breaks down to 
monosaccharides and is metabolised by glycosidases of peritoneal macrophages within 4 days 
to 2 weeks.(58;59) Oxidised regenerated cellulose was compared with no adhesion barrier in 
11 trials (1184 patients).(8;9;11;27- 29;31-35) All trials were of gynaecological patients. Two 
trials had low risk of bias.(8;9) Eight trials were explicitly industry-sponsored and 
sponsorship was unclear for three trials. In eight studies (408 patients), each patient served as 
their own control by having one side of the pelvis randomly assigned to receive an adhesions 
barrier. The remaining three trials included 776 patients in a parallel group design. 
Figure 3 shows the results of our meta-analysis. Figure 4 shows overall results from the 
included trials of oxidised regenerated cellulose. No trials reported data for the effect of 
oxidised regenerated cellulose on reoperations for adhesive small bowel obstruction. Evidence 
shows the beneficial effects of oxidised regenerated cellulose on the incidence of adhesions 
and adhesion scores from trials with low risks of both systematic and random error. No 
evidence exists for a beneficial effect on the incidence of serious adverse events (appendix). 
No trials reported data for pregnancy rate with oxidised regenerated cellulose. Incidence of 
serious adverse events after myomectomy was much the same between the two groups in one 
trial (RR 0.80, 95% CI 0.46–1.39).(11) Postoperative fever was the only serious adverse event 
recorded in both groups. 
With regard to outcomes important for decision making, the overall incidence of adhesions 
reported by three trials (578 patients) was significantly reduced in the treatment group (RR 
0.51, 95% CI 0.31–0.86; Fig 3) with a number needed to treat of 6 (95% CI 3.37–21.00). The 
intervention effect increased when only trials with low risk of bias were assessed. No data 
were available for operation time and small bowel obstruction for any cause. Use of oxidised 
regenerated cellulose significantly reduced the site-specific incidence of adhesions (RR 0.66, 
95% CI 0.59 to 0.74) and adhesion scores (standardised mean difference [SMD] −3.74, 95% 
CI −5.71 to −1.77). 
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Figure 2 Methodological quality of trials included in meta-analysis. 
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Figure 3 Results of key comparisons of four adhesion barriers 
Random effect applied for the incidence of adhesions after application of oxidised regenerated cellulose and the 
incidence of serious adverse events after application of hyaluronate carboxymethylcellulose; fixed effects 
applied for the incidence of serious adverse events after application of icodextrin and the incidence of adhesions 
after application of polyethylene glycol. Only subtotals were pooled for hyaluronate carboxymethylcellulose and 
icodextrin because of heterogeneity in types of operations. The appendix shows forest plots for other 
comparisons. 
 
Hyaluronate carboxymethylcellulose is a solid adhesion barrier in the form of a thin 
translucent membrane. The membrane adheres well to moist tissue surfaces and forms a 
viscous gel in 1–2 days. The barrier is absorbed from the abdominal cavity within 7 days, and 
is metabolised and cleared via the kidney in a maximum of 28 days.(60) 
Nine trials (3052 patients) assessed hyaluronate carboxymethylcellulose (1517 patients) 
compared with no adhesion barrier (1535 patients).(1;36-39;41-44) One trial had risk of low 
bias.(1) Three trials were investigator driven, four were sponsored by industry, and in two 
trials the sponsor was not specified. Six trials were of colorectal surgery and one each was of 
gynaecological, hepatic, and gastric surgery. 
 
166 
 
Figure 4 Outcomes of oxidised regenerated cellulose versus no adhesion barrier 
Benefit (A) and no effect or harm (B). Systematic error: 1a is meta-analysis of low-bias risk randomised 
controlled trial, 1b a low-risk bias randomised controlled trial, 1c is meta-analysis of all randomised controlled 
trials, and 1d a high-risk bias randomised controlled trial. Standard error less than 0.20 is low risk for random 
error, 0.20–1.00 is moderate risk, and greater than 1.00 is high risk. Studies with a high risk for random error are 
outside the range and are considered irrelevant for decision making. Results most important for clinical decision 
making are the highest bars in the upper-left part of the plot. 
Figure 5 Outcomes of hyaluronate carboxymethylcellulose versus no adhesion barrier 
Benefit (A) and no effect or harm (B) 
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Figure 5 shows overall results for hyaluronate carboxymethylcellulose. Some evidence 
suggests that hyaluronate carboxymethylcellulose reduces the incidence of reoperations for 
adhesive small bowel obstruction. Five trials evaluated this outcome, three in colorectal 
surgery, and one each in hepatic and gastric surgery. Hyaluronate carboxymethylcellulose 
significantly reduced the incidence of reoperations for adhesive small bowel obstruction in 
colorectal surgery (RR 0.49, 95% CI 0.28–0.88). The difference in the incidence of 
reoperation related to adhesive small bowel obstruction was not significant in hepatic surgery 
(RR 0.13, 95% CI 0.01–2.95) and gastric surgery (RR 0.35, 95% CI 0.01–8.50). Operation 
time also seems to be reduced by use of hyaluronate carboxymethylcellulose. 
Seven trials studied the incidence of serious adverse events, five for colorectal surgery and 
one each for hepatic and gastric surgery. Differences between groups for the incidences of 
serious adverse events were all non-significant (figure 3). 
A post-hoc analysis of one trial with low risk of bias showed that hyaluronate 
carboxymethylcellulose wrapped around a new bowel anastomosis seemed to result in a 
higher incidence of serious adverse events: abscesses, fistulas, and anastomotic leakages.(1) 
In more recent trials, the practice of wrapping hyaluronate carboxymethylcellulose around 
anastomoses has been abandoned.(39;42) There were no data for pregnancy rate. 
In one trial of hyaluronate carboxymethylcellulose investigating two-stage hepatic surgery, 
operation time was significantly shorter in the hyaluronate carboxymethylcellulose group at 
reoperation (SMD −2.30, 95% CI −3.16 to −1.43). We report no significant difference for the 
outcome of small bowel obstruction from any cause in either gastric or colorectal surgery. 
Our meta-analysis showed that hyaluronate carboxymethylcellulose significantly reduced 
the incidence of site-specific adhesions (RR 0.71, 95% CI 0.54–0.95). Adhesion score was 
significantly reduced in one trial of gynaecological surgery (SMD −1.41, 95% CI −1.80 to 
−1.02), but not for colorectal surgery (−0.86, −1.96 to 0.24). 
Icodextrin is a water-soluble glucose polymer derived from cornstarch. It is a liquid 
adhesion barrier in a 4% solution. Before the icodextrin breaks down into oligosaccharides 
and is metabolised, the colloidal osmotic activity causes the fluid to reside in the abdominal 
cavity for 3–5 days.(61;62) 
Four trials (764 patients) randomly assigned patients to icodextrin (386 patients), no 
adhesion barrier (90 patients), or placebo (282 patients).(46-49) The study of Kössi and 
colleagues was unclear about whether six patients were allocated to treatment or control.(48) 
No trials had a low risk of bias. 
Most outcome data were not included in the Manhattan plot because of the high risk of 
random errors (appendix). Reoperation for adhesive small bowel obstruction did not differ 
significantly between groups (RR 0.33, 95% CI 0.03–3.11). Icodextrin has no beneficial 
effects on the number of serious adverse events (Fig 3). There is evidence of a moderate risk 
for random error that icodextrin reduces the incidence of small bowel obstruction. There is 
insufficient evidence to assess whether icodextrin has a beneficial effect on the incidence of 
adhesions or operation time (SMD −0.48, 95% CI −1.44 to 0.49). 
Incidence of serious adverse events was similar among the groups in gynaecological 
surgery (RR 1.00, 95% CI 0.76–1.30) and lower alimentary tract surgery (0.98, 0.63–
1.52).(46;48;49) There were no data for pregnancy rate. 
Overall incidence of adhesions and operation time did not differ significantly for 
icodextrin. Icodextrin significantly reduced the incidence of small bowel obstruction by any 
cause (RR 0.20, 95% CI 0.04–0.88). There were no data for incidences of site-specific 
adhesions and we report no significant difference for adhesion score (SMD −0.29, 95% CI 
−2.97 to 2.39). 
The polyethylene glycol adhesion barrier consists of two liquid precursor solutions that 
quickly react after being sprayed in the abdomen, forming a hydrogel. One of the precursors 
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 contains a small amount of methylene blue, enabling the area covered and the thickness of the 
hydrogel layer to be seen during laparoscopy. The gel is degraded through hydrolysation and 
cleared via the kidneys in around 7–8 days.(63) 
Four trials (191 patients) assessed polyethylene glycol in 111 patients and placebo in 80 
patients.(53;54;55) One trial had a low risks of bias for all six bias risk domains.(55) No data 
were available for reoperation for adhesive small bowel obstruction. No data were available 
about the effect of polyethylene glycol on pregnancy rate. The incidence of serious adverse 
events did not differ in three trials of gynaecological surgery (RR 0.55, 95% CI 0.16–1.87) 
and colorectal surgery (1.11, 0.43–2.85).   
Groups did not differ significantly for incidence of adhesions (RR 0.78, 95% CI 0.60 to 
1.01). Polyethylene glycol had a beneficial effect on operation time in one trial with a low risk 
of systematic error (SMD −0.84, 95% CI −1.49 to −0.19). No data were available for small 
bowel obstruction by any cause and incidence of site-specific adhesions. 
Polyethylene glycol significantly reduced adhesion scores both in gynaecological surgery 
(SMD −0.71, 95% CI −1.21 to −0.22) and in one trial of colorectal surgery with low risk of 
bias (SMD −1.71, 95% CI −2.45 to −0.97); however, the studies assessing these outcomes had 
high risk of random error. 
 
Discussion 
Sufficient evidence exists to suggest that oxidised regenerated cellulose and hyaluronate 
carboxymethylcellulose reduce adhesion formation. There is evidence that hyaluronate 
carboxymethylcellulose reduces the number of reoperations for adhesive bowel obstruction 
and operative time. Oxidised regenerated cellulose reduces the incidence of adhesions in 
gynaecological surgery, but no data were available about the effect on reoperations for 
adhesive bowel obstruction. Icodextrin had no effect on the incidence of reoperation for 
adhesive small bowel obstruction in one small trial, and no data for the primary outcome were 
available for polyethylene glycol. None of the four barriers investigated increased serious 
adverse events. 
28 trials had been done, which is high for surgical research. Detailed assessment of the risk 
of bias showed that these trials had a low risk of both systematic and random errors compared 
with other surgical research—eg, robotic surgery, laparoscopic cholecystectomy, and fast-
track surgery.(22;64) 
Despite the large number of trials, outcome comparisons included only a few trials and 
results per comparison can easily be dominated by a single large trial. The different types of 
barrier used, the large clinical heterogeneity, and the different outcome parameters reported, 
hinder the pooling of results from multiple trials and made subgroup analyses necessary. 
Therefore, we assessed the potential benefits and harm of adhesion barriers by the error-
matrix approach with visualisation in a Manhattan plot. This approach has the advantage over 
standard forest plots that several outcomes can be integrated and shown in one figure. 
Only 14 trials reported outcomes that are critical or important when considering whether to 
apply adhesion barriers—reoperation for adhesive small bowel obstruction, total incidence of 
adhesions, operation time of reoperation, and small bowel obstruction (any cause). 
Implementation of these outcome measures is one of the biggest challenges in the design of 
trials of new adhesion barriers.(65) Completion of future trials will be challenging because of 
the need for many patients to assess clinically critical outcomes, multicausality of some 
outcomes (eg, pregnancy rate), and to provide long-term follow-up data (eg, for adhesive 
small bowel obstruction). The risk of publication bias cannot be fully excluded—we identified 
some trials that have not been published yet. However, we do not believe that results of these 
trials will alter conclusions: the results of unpublished studies matched those of published 
reports and funnel plots showed no publication bias. Most of the trials were sponsored by 
169 
 
industry, which might have resulted in publication bias of positive results and overestimation 
of intervention effects. However, this effect seems unlikely because data of investigator-
driven trials compare favourably with industry-sponsored trials and risk of publication bias 
was low. 
Although serious adverse events were reported for half the trials, safety data for some 
barriers are scarce. Few adverse events were reported for oxidised regenerated cellulose, 
probably because the barrier was only studied in gynaecological surgery, in which little 
bleeding occurs. Previous studies showed that oxidised regenerated cellulose barriers cause an 
inflammatory response when in contact with blood.(66;67) Additional safety information for 
icodextrin comes from a large registry including over 4000 patients who had general and 
gynaecological surgery.(68;69) The data support the good safety profile of icodextrin. 
Three Cochrane reviews have addressed adhesion prevention for gynaecological and open 
colorectal surgery.(14-16) The present study aggregates the evidence from these three reviews 
and includes additional evidence from trials of gastric and hepatic surgery as well as two trials 
of colorectal surgery that were missed by previous reviews.(43;55) Additionally, previous 
reviews did not rank different outcomes, despite the variety of consequences from a patient's 
perspective, and thus—for example—hiding the specific effect on adhesion incidence and 
type of small bowel obstruction.(14) An adhesion barrier cannot reduce the incidence of 
bowel obstruction secondary to tumour or hernia. In addition, we deemed operation time to be 
an important clinical outcome because evidence suggests that prolonged adhesiolysis 
increases the risk of inadvertent organ injury.(5;56) Compared with previous reviews, we did 
a more comprehensive and clinically meaningful analysis, which included risk of bias, risk of 
random error, a grey literature search, and an analysis of the role of sponsorship. The error 
matrix approach provides more detailed and clearer evidence of benefit and harm of an 
intervention. As more studies are done, clinical evidence increases and becomes more 
difficult to overview. The Manhattan plot helps to judge the relevance and strength of the 
evidence available for each specific adhesion-related outcome for a single intervention. 
Oxidised regenerated cellulose reduces adhesion formation in fertility surgery. The 
implications for clinical practice remain unclear because none of the trials assessed pregnancy 
rate. With regard to the robustness of data for prevention of adhesion formation and safety, 
future studies should assess whether oxidised regenerated cellulose reduces reoperation-
associated complications. 
Hyaluronate carboxymethylcellulose reduces operation time in two-stage liver surgery and 
has a modest reduction effect on adhesive small bowel obstruction. The number needed to 
treat to prevent one case of adhesive small bowel obstruction is high for this rare but 
potentially life-threatening complication of general and gynaecological surgery. However, 
routine use in high-risk surgeries for bowel obstruction is warranted on the basis of our 
efficacy and safety results. We expect that with increasing evidence on clinical and 
socioeconomic effect of adhesiolysis, the use of hyaluronate carboxymethylcellulose to 
prevent organ injury during repeated open surgery will spread.(5;56) 
Indications for the use of an adhesion barrier also depend on its formulation. Both oxidised 
regenerated cellulose and hyaluronate carboxymethylcellulose are solid barrier films and 
difficult to apply during laparoscopic surgery. Icodextrin and polyethylene glycol are easier to 
apply at laparoscopy. Formulation could also affect efficacy and adverse events. The solid and 
viscous gel barriers are thought to be more effective at preventing adhesion at sites of severe 
peritoneal injury and adhesiolysis, whereas liquid barriers provide better protection for injured 
surfaces—eg, by retractors or desiccation—distant from the region of surgical dissection. 
However, no clear evidence supports this hypothesis. Two adhesion barrier gels based on 
hyaluronic acid were associated with serious adverse events.19 We doubt whether the gel 
formulation contributed to these adverse events because the hyaluronate 
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 carboxymethylcellulose film also becomes gelatinous after application. More likely, chemical 
adjuvants—the ferric ions—increase adverse tissue reactions.(70) 
Results from our study could be used to develop guidelines for the use of barriers to 
prevent adhesion-related complications. Thus far, guidelines are only available for 
gynaecological surgery.(71) 
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Abstract 
Postoperative adhesions are the most frequent complication of peritoneal surgery, causing 
small bowel obstruction, female infertility and chronic pain. This pilot study assessed the 
efficacy of a sprayable polyethylene glycol (PEG) barrier in the prevention of de novo 
adhesions. 16 patients undergoing laparoscopic gynecological surgery were randomly 
assigned by shuffled sealed envelopes to receive either the adhesion barrier or no adhesion 
prevention. Incidence and severity of adhesions were scored at eight sites in the pelvis and 
reassessed by second look laparoscopy. Adhesion prevention was considered successful if no 
de novo adhesion were found at second look laparoscopy. One patient was excluded before 
randomization. Nine patients were randomized to treatment and six patients to control group. 
De novo adhesions were found in 0/9 patients who received the PEG barrier compared to 4/6 
without adhesion prevention (0% vs. 67%, P = 0.01). Reduction in adhesion score was 
significantly greater in patients receiving PEG barrier (−2.6 vs. −0.06, P = 0.03). Meta-
analysis of three randomized trials demonstrated that PEG barrier reduces the incidence of 
adhesions (odds ratio [OR] = 0.27; 95% CI 0.11–0.67). From this study, PEG barrier seems 
effective in reducing postoperative formation of de novo adhesions. 
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Background 
Adhesions develop after gynaecological surgery in the pelvic cavity in almost all cases and 
cause significant morbidity .(1) In a large population-based study of gynaecological pelvic 
surgery, the readmission rate directly or probably related to adhesions was 13.9%, and the 
introduction of less invasive techniques, such as laparoscopy, did not seem to reduce this 
adhesion related morbidity.(2) The incidence of adhesive small bowel obstruction (ASBO) 
after oncologic gynaecological surgery is about 11%.(3) Adhesions are the leading cause of 
secondary female infertility worldwide, and an important cause of chronic pelvic pain.(4-7) In 
addition, adhesiolysis during reoperation is time-consuming and exposes the patient to the risk 
of unintended injury such as enterotomy.(1;8) 
Adhesion barriers or anti-adhesive agents are needed because refinements in surgical 
techniques do not seem to be sufficient in reducing adhesion-related morbidity. Several 
products have come to the market ranging from membranes for selective coverage of injured 
peritoneal areas to liquids for broad nonspecific coverage. An important drawback of the 
available membranous adhesions barriers is the difficulty of handling them during 
laparoscopic procedures. Alternatives to membranes for laparoscopic use are sprays that are 
easily applied intraperitoneally through trocars at sites that need to be covered. Recently, a 
sprayable polyethylene glycol (PEG) anti-adhesion barrier was developed for anti-adhesive 
purposes (SprayGel; Confluent Surgical Inc., Waltham, MA). The PEG adhesion barrier 
consists of two liquid precursor solutions that quickly react to form a hydrogel after being 
sprayed and mixed in the abdomen. One of the precursors contains a small concentration of 
methylene blue allowing visualization of the area covered and the thickness of the hydrogel 
layer during laparoscopy. The hydrogel is biodegradable and physically separates the injured 
peritoneal sites in order to promote adhesion free peritoneal regeneration. 
The PEG anti-adhesion spray proved to be effective in rodent and porcine models with 
75% reduction of the incidence of adhesions in a rat cecal abrasion model and 60% reduction 
in a porcine uterine horn model.(9;10) Four human randomized controlled trials (RCTs) have 
been performed: two in patients undergoing laparoscopic or open myomectomy and two in 
patients undergoing loop ileostomy closure.(11-14) No RCT has included patients undergoing 
laparoscopic surgery alone, and all RCTs included a specific group of patients rather than 
investigating the various common types of laparoscopic benign gynaecological surgery. The 
use of PEG spray was correlated with a reduction in extend and tenacity of adhesions in these 
RCTs. However, reductions in adhesion incidence — in contrast to reduction in adhesion 
extend or tenacity — is particularly important for predicting the value of an anti-adhesive 
product reducing ASBO and unintended organ injury during adhesiolysis. We undertook a 
small prospective randomized controlled study to evaluate the PEG spray on adhesion 
formation in women undergoing common laparoscopic gynaecological procedures. In 
addition, we performed a meta-analysis of reported studies, including the present one, 
focusing on the efficacy of PEG spray in reducing the incidence of adhesions. 
Materials and methods 
The study was a randomized single-blinded (patient) study. Patients who were scheduled 
for laparoscopic treatment of benign gynaecologic disease involving ovaries, pelvic sidewalls, 
fallopian tubes or uterus were assessed for eligibility between September 2002 and March 
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2004. Inclusion criteria were as follows: age ≥18 years; the patient might benefit from and 
agrees to return for second look laparoscopy (SLL); and the patient agrees to use 
contraception until SLL was conducted. 
Pregnant and lactating patients were excluded, as well as patients with known or suspected 
malignancy. Peroperative exclusion criteria were endometriosis classified as stage IV, using 
the Revised American Society for Reproductive Medicine Classification of Endometriosis 
scoring system and if complete adhesiolysis was not possible.(15) 
At the end of index laparoscopic surgery and before removal of all instruments, patients 
were randomly assigned — via shuffled sealed envelopes — to treatment with PEG or no 
treatment groups. The PEG barrier was sprayed at all sites of surgical injury with the potential 
for adhesion formation. SLL was planned to evaluate adhesion formation. The surgeon 
performing SLL was blinded for the treatment group. 
The study protocol was approved by the local Medical Ethical Committee and designed 
according to the ethical considerations described in the revised version of the Declaration of 
Helsinki (October 2008, Seoul). All patients gave written informed consent. The study was 
investigator-driven. PEG was kindly donated by Confluent, Surgical Inc (Waltham, MA, 
USA). The trial was registered at clinical trials.gov with identifier: NCT01187680. 
Adhesion scoring 
The incidence of patients with and without any adhesion was assessed in both initial and 
second look laparoscopies. All surgical procedures were performed by the same surgeons (EB 
and HV). Adhesions at SLL were classified as de novo adhesions or reformed adhesions. De 
novo adhesions are adhesions that are newly formed following the first laparoscopy at sites 
without any former adhesions. Reformed adhesions are adhesions that formed at the sites of 
adhesiolysis during the first laparoscopy.(16) 
Adhesions were graded using the Local Adhesion Barrier Scoring System (LABS) score, 
based on the modified version of the American Fertility Society score system.(17) The LABS 
is an integrated score system comprising the adhesion’s morphology and extend of the site 
covered with adhesions (Table 1). The LABS score differs from the modified version of the 
American Fertility Society score system; adhesions are scored at a lower number of sites that 
are more specific to gynaecologic surgery. Adhesions were systematically evaluated for 
incidence and LABS score at eight sites: both left and right tubes, ovaries and pelvic sidewall 
and the anterior and posterior uterus. For each patient, the total LABS score was calculated as 
the mean of LABS scores at these eight separate locations. 
 
Table 1 Local Adhesion Barrier Scoring (LABS) system 
LABS adhesion score 
Tenacity Extend Score 
None None (0% covered) 0 
Mild Localized (<33% covered)) 1 
Mild Moderate  (33%- 67% covered) 2 
Mild Extensive (>67% covered) 4 
Severe Localized (<33% covered)) 4 
Severe Moderate  (33%- 67% covered) 8 
Severe Extensive (>67% covered) 16 
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Safety aspects 
All patients were treated in day care. Postoperatively, patients were controlled for 
temperature, pain, hemodynamic changes and signs of bleeding in the recovery area. 
Outcomes 
The primary outcome for this pilot study was the number of patients with de novo 
adhesions. Secondary outcomes were change in the number of sites covered with adhesions 
and change in LABS adhesion score. 
The number of patients with any adhesions is the most preferable outcome of adhesion 
prevention studies. However, as the sample size of this pilot study would be inadequate to 
provide in sufficient power on this outcome, we addressed this outcome in meta-analysis of 
systematically searched studies on PEG adhesion barrier. 
Power analysis 
Based on animal studies, the incidence of de novo adhesions was estimated at 30% in the 
PEG group and 90% in the control group.(10) Fourteen patients in each arm of the study were 
needed to detect such difference with 80% power and 5% two-tailed significance threshold at 
1:1 randomization. Accounting for loss to follow-up, a minimum of 30 patients were to be 
randomized. 
Statistical analysis 
All statistical tests performed were two-tailed with significance was determined at the 5% 
level. Unpaired t-test was used for the testing of continuous data and Fisher’s exact test for 
dichotomous data. All statistical analyses were performed using SPSS 16.0.2 (SPSS inc., 
Chicago, ILL). 
Meta-analysis 
A comprehensive search of Pubmed and Embase search was performed on July 1, 2011 to 
identify papers published in peer-reviewed journals from RCTs in surgical or gynaecological 
patients for the intervention with PEG and outcome adhesions. In Pubmed, randomized trials 
were identified via the Cochrane Highly Sensitive Search Strategy for identifying randomized 
trials (sensitivity- and precision-maximizing version).(18) We selected randomized trials in 
Embase using the top performing search strategy (minimizing difference between sensitivity 
and specificity version) described by Wong et al.(19) Relevant RCTs were searched for data 
on the number of patients with any adhesions. The incidence of adhesions was expressed in 
odds ratio (OR) for meta-analysis. A fixed-effects model was applied for meta-analysis. In the 
presence of significant heterogeneity, the random-effects model was applied. Heterogeneity 
was tested with Cochrane Q-test and I2 test. An I2 value ≥50% or P value <0.05 was 
considered significant. Meta- analysis was carried out using Review Manager 5.0 (The 
Cochrane Collaboration, Copenhagen, Denmark). 
End of study 
The study was prematurely ended due to financial and organizational reasons. During the 
conduct of the study, the clinical trial insurance unexpectedly required a separate fee for both 
laparoscopic procedures in each patient. 
 
Results 
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A total of 16 eligible patients gave informed consent. Fifteen underwent successful 
laparoscopic gynaecological or fertility surgery and were randomized. One patient had severe 
pelvic adhesions that could not be lysed completely and was excluded before randomization. 
There were no significant differences between the PEG and control group at index 
laparoscopy in age, type of surgical procedure, history of prior surgery, Chlamydia serology 
and smoking status at baseline (Table 2). Adhesiolysis was performed in 14 patients. 
 
Table 2 Baseline characteristics 
 PEG Control P value 
Number of randomized patients 9 6  
Age  30.1±5.7a  34.5±4.3a 0.12 
Type of surgerical procedures performed    
  Adhesiolysis 8 (89%) 5 (83%) >0.99 
  Salpingotomy/ Salpingectomy 4 (44%) 2 (33%) >0.99 
  Cystectomy 2 (22%) 3 (50%) 0.33 
Prior surgery 
* Laparotomy 
* Laparoscopy 
 
0/9 (0%) 
5/9 (56%) 
 
0/6 (0%) 
5/6 (83%) 
 
>0.99 
 0.58 
Positive chlamydia serology 4/9 (44%) 1/6(17%) 0.58 
Smoker 1/9 (11%) 0/6 (0%) >0.99 
Completed SLL 9 (100%) 6 (100%) >0.99 
a= Mean ± SD 
 
At index laparoscopy, there was a non-significant trend towards more sites covered with 
adhesions (5.1 ± 2.3 vs. 3 ± 2.2; P = 0.10) and higher LABS score (3.7 ± 2.8 vs. 2.4 ± 3.0; P = 
0.40) in the PEG group (Table 3). Time of surgery was comparable between the PEG and 
control group at index laparoscopy. Time period between initial and second look 
laparoscopies was similar for both groups: 27.9 ± 11.5 days in the PEG group and 28.0 ± 17.6 
in the control group (P > 0.99). 
All 15 randomized patients underwent SLL. De novo adhesions were found in 0/9 patients 
in the PEG group (0%) compared to 4/6 (67%) of patients in the control group (P = 0.01). 
Patients in the PEG group had a decrease in LABS score compared to an increase in the 
control group (−2.6 ± 2.1 vs. 0.1 ± 1.7; P = 0.03). This decrease was most prominent at the 
ovaries and fallopian tubes sites. The change in the number of sites covered with adhesions 
was −2.4±2.0 for patients treated with PEG spray compared to 0.8 ± 2.3 for control patients (P 
= 0.01). There were no significant differences in the absolute incidence, sites covered with 
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adhesions and LABS scores between the PEG group and controls at SLL (Table 4). There 
were no post- operative complications in both groups. 
Table 3 Adhesions at initial laparoscopy 
PEG Control P value 
Patients with any adhesion 8/9 (89%) 5/6 (83%) >0.99 
Adhesion sites 5.1±2.3a 3±2.2a 0.10 
LABS- score (Mean) 
• Left Ovary
• Right Ovary
• Left Fallopian Tube
• Right Fallopian Tube
• Left Pelvic Side Wall
• Right Pelvic Side Wall
• Anterior Uterus
• Posterior Uterus
3.7±2.8a 
5.1±4.9 
5.8±6.0 
6.4±5.8 
6.2±5.7 
3.3±3.2 
1.6±2.8 
0.2±0.7 
1.2±1.7 
2.4±3.0a 
2.0±3.3 
4.0±6.2 
2.0±3.3 
3.5+6.3 
1.3±3.3 
4.3±6.5 
0.0±0.0 
2.7±2.1 
0.44 
0.17 
0.59 
0.08 
0.42 
0.27 
0.36 
0.35 
0.19 
Time of surgery (min) 151.9±29.5a 146.7±47.8a 0.82 
Time to SLL* (days) 27.9±11.5 a 28.0±17.6a >0.99 
* SLL = second look laparscopy
a= Mean ± SD 
Although no significant differences were found in the incidence of adhesions at any of the 
specific sites at SLL, the effect of PEG appeared maximal at the ovaries. The incidence of 
adhesions around the ovaries was reduced between index laparoscopy and SLL in the PEG 
treated group by 33% and 44% for the right and left ovaries, respectively. On the contrary, a 
17% and 33% increase in incidence of adhesions around the right and left ovaries, 
respectively, was seen in control patients. 
Meta-analysis of adhesion incidence 
A total of 85 papers from peer-reviewed journals were identified using the search strategy. 
Five papers were identified studying the efficacy of PEG on adhesion formation after 
peritoneal surgery in an RCT.(11-14;20) The number of patients with any adhesions could be 
assessed from three papers investigating patients undergoing myomectomy.(11;13;20) One 
paper was excluded because it described an interim analysis and results from the completed 
study were described in another paper.(11;20) Thus, two RCTs and the present study 
remained for meta-analysis. In all here studies a trend towards a lower overall incidence of 
adhesions was demonstrated in PEG treated patients. Pooled data, using a fixed effects model, 
showed a significant reduction of the incidence of adhesions with an OR of 0.27 (95% CI 
0.11–0.67; P = 0.005, Fig 1). 
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Table 4 Adhesions at second look laparoscopy 
Outcome: PEG Control P- Value 
Patients with any adhesion 7/9 (78%) 6/6 (100%) 0.49  
Patients with de novo adhesions 0/9 (0%) 4/6 (67%) 0.01 
Adhesions (number of sites) 2.7 ± 2.4a 3.8 ± 1.7a 0.29 
∆ Adhesions (number of sites)* -2.4 ± 2.0a 0.8 ± 2.3a 0.01 
LABS- score (Mean) 
• Left Ovary 
• Right Ovary 
• Left Fallopian Tube 
• Right Fallopian Tube 
• Left Pelvic Side Wall 
• Right Pelvic Side Wall 
• Anterior Uterus 
• Posterior Uterus 
1.2±1.3a 
0.7±0.9 
2.9±5.2 
2.2±3.3 
2.3±2.8 
1.0±2.6 
0.0±0.0 
0.0±0.0 
0.3±0.5 
2.4±2.4a 
2.2±3.0 
5.5±6.4 
1.7±1.4 
2.8±6.5 
0.7±1.0 
4.0±6.7 
0.0±0.0 
2.5±3.1 
0.29 
0.28 
0.43 
0.66 
0.86 
0.74 
0.20 
1.00 
0.15 
∆ LABS- scoreb (Mean) 
• Left Ovary 
• Right Ovary 
• Left Fallopian Tube 
• Right Fallopian Tube 
• Left Pelvic Side Wall 
• Right Pelvic Side Wall 
• Anterior Uterus 
• Posterior Uterus 
-2.6±2.1a 
-4.4±5.1 
-2.9±4.8 
-4.2±5.0 
-3.9±4.0 
-2.3±2.8 
-1.6±2.8 
-0.2±0.7 
-0.9±1.5 
0.1±1.7a 
0.2±2.2 
1.5±5.3 
-0.3±4.0 
-0.7±1.2 
-0.7±3.7 
-0.3±0.8 
0.0±0.0 
-0.2±2.7 
0.03 
0.03 
0.13 
0.12 
0.05 
0.38 
0.24 
0.35 
0.57 
a= Mean ± SD  
b∆= difference between index laparoscopy and second look laparoscopy 
 
 
 
Figure 1 Results from meta-analysis on the efficacy of PEG adhesion barrier reducing the 
total incidence of adhesions 
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 Discussion and conclusion 
From this study, PEG anti-adhesion barrier seems effective in the prevention of de novo 
adhesions in common gynaecological laparoscopic procedures, but especially in fertility 
enhancing procedures. Furthermore, there was a significant difference in change of LABS 
score favouring patients treated with PEG adhesion barrier. Meta-analysis also showed a 
significant reduction in the total incidence of adhesions. 
The PEG anti-adhesion barrier has a set of unique characteristics compared to other 
existing barriers. The formula of two liquid PEG precursors that rapidly polymerize into a 
solid hydrogel, allows the surgeon to laparoscopically apply a barrier with the characteristics 
of a site specific barrier and the ease of application of a liquid.(12) Most site specific barriers 
are solid membranes that are difficult to apply laparoscopically. Site specific adhesion barriers 
seem most efficacious against adhesion (re)formation as they remain on the exact place of 
application during mesothelial healing. In the study of Ferland et al. both uterine horns and 
opposing peritoneum in a porcine model were abraded. One side was randomly assigned to 
coverage with a 1- to 2-mm-thick layer of PEG adhesion barrier. The barrier remained in 
place, and at SLL a significantly lower incidence of adhesion was found at the treated sides, 
demonstrating that the PEG adhesion barrier acts as a site-specific adhesion barrier.(10) The 
methylene blue dye makes it easy to assess if an area is sufficiently covered with the PEG 
anti-adhesion barrier. PEG molecules polymerize without the need of an external energy 
source or excess heat production and the hydrogel remains intact for 5–6 days, which is long 
enough for peritoneal layers to heal.(21) When degrading, the hydrogel falls apart in water-
soluble PEG molecules that are easily resorbed and cleared in the urine.(22) 
Although a small number of patients could be included in this trial, our findings support 
those of earlier studies demonstrating that PEG spray is a highly efficacious site specific 
barrier for laparoscopic use. The incidence of adhesions could be assessed from two previous 
RCTs in patients undergoing myomectomy.(11;13) In the present study and the two RCTs, a 
trend towards a lower overall incidence of adhesions was demonstrated in PEG treated 
patients. Pooled data showed a significant reduction of the incidence of adhesions in our 
meta-analysis. Complete adhesion prevention is of particular importance as it is the only 
means of providing a definitive protection against all adhesion related complications, such as 
infertility, ASBO and inadvertent enterotomies. 
A limitation of this study is the analysis of adhesion prevention and not the clinical 
complications of adhesions, such as infertility or ASBO. Infertility as an endpoint is difficult 
to assess because failure to attain pregnancy is a multi-factorial endpoint. To assess the 
efficacy of adhesion barriers on fertility, a randomised trial is required in subfertile patients 
due to tubal pathology, which compares use of a barrier to no treatment after adhesiolysis and 
compares time to natural conception. Oxidized regenerating cellulose (Interceed®, Ethicon, 
Sommerville, NJ) is the only adhesion barrier that was proven to increase pregnancy rate in an 
RCT.(23) However, oxidized regenerating cellulose has limitations because it is difficult to 
handle laparoscopically and can cause adverse adhesiogenic effects in the presence of 
blood.(24;25) Studies evaluating the efficacy of adhesion barriers in reducing the number of 
ASBO and enterotomies are rare. The incidence of these complications is relative low, thus a 
large number of patients is needed to demonstrate a significant effect. Modified sodium 
hyaluronic acid (HA) and carboxymethylcellulose (Seprafilm®; Genzyme Corporation, 
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Cambridge, MA) reduced the number of ASBO requiring reoperation or found at autopsy by 
45% in a study of 1,701 patients who underwent benign colorectal surgery.(26) This barrier 
has limitations because it cannot easily be applied at laparoscopy. 
Change in adhesion score can be difficult to interpret as an outcome measure for adhesion 
prevention because the adhesion score at baseline influences the maximal effect. However, in 
our study, not only the size but also the direction of the effect differed between the groups. 
There was a marked decrease in LABS adhesion score in PEG treated group, while patients in 
the control group had a slight increase in adhesion score. 
To study the efficacy of adhesion barriers by means of a second look procedure is 
becoming increasingly difficult. First, it is deemed more and more unethical to perform an 
invasive second procedure just for scientific purposes. Second, the benefit of SLL as part of 
fertility surgery is questionable. Today, women have more access to alternative treatment 
modalities to become pregnant such as in vitro fertilization.(27) Future adhesion prevention 
studies expectedly have to rely on non-invasive techniques to evaluate adhesion formation. 
For long, this has been considered impossible but recent studies show promising results of 
cine-MRI as a non-invasive diagnostic tool for the detection of adhesions.(28) More 
experience is needed to delineate the value of cine-MRI as an alternative to SLL in adhesion 
prevention studies. 
Sprayable barriers that can be introduced via a laparoscopic trocar and handled with ease in 
the abdominal-pelvic cavity are of surplus value in the therapeutic arsenal of adhesion 
preventive agents. Clinical trials have demonstrated that laparoscopy only reduces the extend 
of adhesions but does not decrease the incidence of adhesions.(29;30) Maximal efforts to 
prevent adhesion formation in fertility surgery should therefore comprise laparoscopy as well 
as an adhesion barrier. Although a large number of agents show adhesion reduction in animal 
models, only a few demonstrated such effects in RCT in humans.(31/33) PEG is one of a few 
barriers that has been evaluated in both gynaecological and gastrointestinal patients and was 
found to be effective in both our study and previous RCTs.(11;13;14;20) However, more 
research is needed to investigate the effect on adhesion related complications, such as ASBO 
and infertility. 
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Abstract 
Since the landmark SCAR studies elucidated the impact of adhesions on readmissions for 
long-term complications of abdominal surgery, adhesions are widely recognized as one of the 
most common causes for complications following abdominal surgery. Concurrently, interest 
in adhesion prevention revived and several new adhesion barriers were developed. Although 
these barriers have now been around for more than a decade, adhesion prevention is still 
seldom applied. The main reasons why adhesion prevention is not applied seem a continuing 
lack of awareness of the burden of adhesion related complications, questions on the 
indications and cost-efficacy of adhesion barriers, and safety concerns. New epidemiologic 
data warrant a paradigm shift in our understanding of  the socioeconomic burden of adhesion 
related complications and the indications for adhesion prevention strategies. Increasing 
evidence from cohort studies and systematic reviews show that difficulties during 
reoperations, rather than small bowel obstructions, account for the majority of adhesion 
related morbidity. New cost-efficacy models that include the potential benefits of adhesion 
prevention in reoperations and fertility treatments are expected to indicate that prevention is 
also cost-effective in high risk surgeries, and will be applicable to a broader group of patients. 
More effort should be put into improvement of research on adhesion prevention from 
molecule to man to population. Animal models need to be better standardized and powered to 
generate more meaningful and robust results. There is a need for non- invasive techniques to 
assess adhesion formation in clinical trials. Cine-MRI holds promise, but needs further 
development. 
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 INTRODUCTION 
The SCAR group’s 1991 landmark study strongly suggested, based on hospital admission 
data, that adhesion formation is the most common cause of long-term complications after 
abdominal surgery. Concurrently, interest in adhesion prevention revived, and the biomedical 
industry developed several barriers to prevent adhesion formation.(1-3) The new barriers 
which came to the market consistently reduced the incidence of post-surgical adhesions in 
randomized trials.(4-6) However, these findings have not led to broad and routine use of 
adhesion barriers in general, urological, or gynaecological surgery. 
The main reason why adhesion prevention is not widely practiced seems to be a lack of 
awareness regarding the burden adhesions place on patients and society. Less than 10% of 
surgeons and gynaecologists routinely inform their patients about the risks of adhesions 
during informed consent.(7;8) Surgeons and gynaecologists also underestimate the number of 
hospital readmissions related to adhesions, as well as the incidences of adhesion-related bowel 
obstructions, and infertility following abdominal operations.(7;9) The consequences and 
complications of adhesions during reoperations are especially underexposed in the literature. 
Despite the growing evidence that the disease burden related to adhesiolysis and bowel 
injuries made during reoperations might exceed that of adhesive small bowel obstruction in 
terms of incidence and socioeconomic costs.(10;11) 
The second reason underlying reluctant use of anti-adhesion barriers is that many questions 
remain regarding adhesion prevention strategies in general and adhesion barriers in particular. 
Despite previous Cochrane reviews showing a potential reduction of postoperative adhesion 
formation, surgeons question if adhesion barriers are effective at reducing adhesive small 
bowel obstruction and adhesion-related infertility, or if the ‘effect size’ is large enough for 
routine application. (7;9;12;13) Some believe that adhesion barriers might actually harm 
patients because single bands of adhesions resulting from incomplete adhesion prevention put 
a patient at greater risk for strangulated bowel obstruction than multiple matted adhesions do. 
Such concerns persist despite epidemiological studies which have refuted these 
arguments.(14;15) Aside from safety concerns, medical professionals and policy makers both 
question the cost- effectiveness of adhesion barriers. Finally, many physicians question the 
need for adhesion prevention in the era of minimally invasive abdominal surgery. 
Taken together, these questions and arguments warrant revisiting the epidemiologic 
evidence concerning adhesion formation and prevention. In this article, we discuss up-to-date 
evidence on the morbidity of adhesions, and comprehensively assess the impact of surgical 
techniques and adhesions barriers on adhesion formation and clinical endpoints. Further, we 
provide directives for future studies to improve patient outcomes regarding adhesions. 
 
ADHESION BURDEN 
Unlike other postoperative complications such as wound infection or anastomotic leakage, 
adhesion formation places patients at lifelong risk for various clinical disorders. These 
complications include small bowel obstruction, female infertility, difficulties during 
reoperations, and chronic pain.(15)  
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SBO as an outcome of adhesion-related morbidity 
Most studies of adhesion-related morbidity focus on adhesive small bowel obstruction 
(SBO) (Figure 1).(15) Although adhesive SBO is relatively rare, it inflicts considerable harm 
on those impacted, resulting in eight days of hospitalization on average, and an in-hospital 
mortality rate of 3% per episode.(16-19) The risk of SBO is highest following colorectal and 
oncologic gynaecological surgery.(2;3;15;20) The overall incidence of bowel obstruction 
following abdominal surgery is estimated at 9%, with adhesions being the single most 
common cause of obstruction (56% of cases).(15)Recurrence of SBO is also considerable; 
12% of conservatively treated patients are readmitted within one year, rising to 20% after five 
years. The risk of recurrence is slightly lower after operative treatment, at 8% after one year 
and 16% after five years.(21) 
 
 
Figure 1 Number of included articles in a recent systematic review on adhesion-related 
morbidity, sorted by type of adhesion-related complication, covering articles published in past 
two decades. 
 
Dark= Articles publishing data on adhesion-related morbidity as a primary or main secondary outcome 
light= Articles publishing data on adhesion=related morbidity as a additional outcome 
Derived from: ten Broek RP, Issa Y, van Santbrink EJ et al. Burden of adhesions in abdominal and pelvic surgery: systematic 
review and met-analysis BMJ 2013;347:f5588 
 
Sikirica et al. estimated in-hospital annual costs of adhesions in the United States to be 
$2.3 billion, comparable to the total medical costs of peptic ulcer disease and eclipsing the in-
hospital costs of rheumatoid arthritis.(22-24) Costs associated with the treatment of an 
adhesive small bowel obstruction are estimated to be $3,000 per episode with conservative 
treatment and $10,000 with operative treatment.(25;26) The additional costs incurred by 
operative treatment are partially due to complications of adhesiolysis. The incidence of bowel 
injuries during adhesiolysis for SBO is estimated to be between 6% and 20%.(27-29) 
 
Adhesiolysis complications as an outcome of adhesion-related morbidity  
Bleeding, trocar injury, conversion from laparoscopy to laparotomy, and damage to 
peritoneal organs such as the bowel, liver, spleen, bladder, and ureter are well-known 
operative complications of adhesiolysis. Epidemiological data on these complications, 
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 however, are relatively scarce. Our group was the first to comprehensively study the incidence 
of inadvertent enterotomy in reoperations. A retrospective analysis of 270 reoperations 
revealed an unintended enterotomy in nearly 20% of patients.(10) More recently, we 
demonstrated in a large prospective cohort study that adhesiolysis requires a median of 20 
minutes of operative time and is associated with a 10% risk of iatrogenic bowel injury.(11) 
This fifty percent difference between studies is explained by the different case mix of 
abdominal procedures in each study, and by the decision not to count perforations close to 
pre-existing bowel fistulas in the prospective analysis. 
Although bowel injury is relatively rare in gynaecological laparoscopies, one study 
reported an 11% incidence of bowel injuries during gynaecological laparoscopy following 
major open gynaecological or general surgery.(30) In a subgroup of our prospective LAPAD 
(LAParotomy or LAParoscopy and ADhesiolysis) study population, median adhesiolysis time 
was 11 minutes (range 0- 177 minutes) in 103 patients with a history of gynaecological 
operations, while the incidence of bowel injury was 11%. Most of these bowel injuries 
occurred in women who had undergone colorectal surgery (54.5%) or abdominal wall surgery 
(36.4%). 
In a second study, we demonstrated that the number of previous laparotomies, the 
anatomical site of operation (lower gastrointestinal tract and abdominal wall), the presence of 
bowel fistulas, and an incision through a pre-existing scar were independent risk factors for 
bowel injury.(31) A clinical scoring system and nomogram for the risk of bowel injuries was 
developed based on these four risk factors, with a 50% predicted risk of bowel injury when all 
four risk factors are present. The scoring system needs validation in an external cohort. 
In repeat caesarean sections adhesiolysis increases the risk of bladder injury six-fold 
compared to primary sections.(32) Moreover, when compared to primary caesarean section, 
delivery of the infant was delayed by about six minutes during repeat caesarean sections, and 
its one-minute Apgar score was significantly lower.(33)  
Performing adhesiolysis results in significant postoperative morbidity and mortality, both 
from bowel injuries and from other complications. Inadvertent enterotomies alone are 
associated with an in-hospital mortality rate of 8%. Bowel injuries aside, adhesiolysis also 
increases the risk of postoperative wound infections (6.5% vs. 2.5%), abscesses (2.7% vs. 
0.7%) and sepsis (2.9% vs. 0.7%). The increase in direct hospital costs associated with 
adhesiolysis are estimated at $4,000 per operation, rising to almost $30,000 if a bowel injury 
occurs.(11)  
Taken together, these recent epidemiological data on adhesiolysis morbidity and 
procedural costs indicate that adhesiolysis is comparable to one episode of SBO. The 
incidence of adhesiolysis, however, is much more frequent than SBO. Today, as many as 
40%-66% of elective procedures in general surgery are reoperations.(6;11;34) This number is 
expected to rise as life expectancies increase and more advanced surgical and 
anesthesiological techniques emerge. Thus, adhesiolysis might actually be the largest 
adhesion-related complication in terms of morbidity and socioeconomic costs. 
 
Secondary infertility as an outcome of adhesion-related morbidity 
Adhesions of the fallopian tubes are a leading cause of acquired female infertility. 
Adhesions are found during diagnostic laparoscopy in approximately 20-40% of female 
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patients with infertility.(35;36) However, it is difficult to distinguish how many of these 
adhesions are postsurgical and how many are due to pelvic inflammatory disease or 
endometriosis. In a recent meta-analysis, we showed that fertile female patients undergoing 
proctocolectomy for inflammatory bowel disease have a significantly lower pregnancy rate 
compared to non-operated patients (OR 0.15; 95% CI: 0.08- 0.29).(15) In addition, as many as 
20-30% of these previously operated patients sought fertility treatment.(37;38) 
The most commonly used fertility treatments are reconstructive microsurgery with 
peritubal adhesiolysis and in vitro fertilization (IVF). The use of reconstructive microsurgery 
has declined over recent years in favour of IVF; however, reconstructive fertility treatment 
offers a number of potential benefits over IVF. Adhesiolysis is a curative treatment providing 
couples with unlimited attempts to conceive naturally. Costs of reconstructive surgery are also 
lower, and serious adverse events related to IVF such as ovarian hyperstimulation syndrome 
are avoided.(39)  
The varying results of peritubal adhesiolysis are the driving force behind the declining use 
of reconstructive surgery in the treatment of adhesion-related infertility. Pregnancy rates 
ranging from 20% to 80% have been reported following peritubal adhesiolysis.(40-43) 
Pregnancy rates seem to be highest in patients with  filmy adhesions, decreasing to 20% in 
patients with dense adhesions. The use of adhesion barriers may help to preserve fertility and 
improve peritubal adhesiolysis outcomes, although these outcomes have not yet been studied 
in a randomized trial. The cost-effectiveness of adhesion barriers in fertility surgery has also 
not been evaluated.(44)  
 
Chronic pain as an outcome of adhesion-related morbidity 
While adhesions and chronic pain often coincide following abdominal surgery, the 
causative role of adhesions in chronic pain is debated. In a trial randomizing between 
laparoscopic adhesiolysis and no treatment beyond pneumoperitoneum for chronic pain 
related to adhesions, both groups experienced long term pain relief. These findings further fed 
the debate.(45) In 2004 Demco et al. addressed the ongoing controversy concerning adhesions 
and pain in a series of pain mapping experiments.(46) They found that touching and moving 
adhesions elicited a clear pain sensation which was most prominent for filmy adhesions 
connected to mobile organs.(46) Disruption of painful filmy adhesions by pneumoperitoneum 
may explain the long term pain relief of control patients in the aforementioned trial. Recent 
long-term follow-up data from a trial randomizing between an adhesion barrier film and no 
specific adhesion prevention, showed a lower number of patients with chronic abdominal 
complaints in the adhesion barrier group.(47) 
 
Paradigm shift regarding adhesion impact 
The new epidemiological data on the burden of adhesiolysis during reoperations represent 
a paradigm shift in our understanding of adhesion-related morbidity and strategies for 
adhesion prevention (Table 1). Previous cost models for adhesion barriers that focused on 
prevention of SBO demonstrated that these agents might be cost- effective for selected 
patients.(25) However, since a drawback of attempting to prevent SBO is that obstruction can 
be caused by just a single adhesive band, prevention of SBO therefore requires total adhesion 
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 prevention in the whole peritoneal cavity. This is relatively difficult to achieve without 
compromising safety of the barrier. 
A more complete cost-effectiveness model would also account for the additional costs 
incurred by reoperations, fertility problems, and chronic visceral pain treatments. It is 
expected that such a complete model would reveal that barriers are cost-effective in most 
patients who undergo abdominal surgery because reduction of adhesion formation would 
already provide benefit. 
The extent of difficulties encountered during reoperations correlate to the extent and 
severity of adhesion formation. Evidence shows that an increase in time needed to perform an 
adhesiolysis—a surrogate for the extent and severity of adhesions—is correlated with an 
increased risk for inadvertent bowel injury.(11;48) Thus, while optimization of surgical 
technique and use of adhesion-reducing agents may not completely prevent adhesion 
formation in operations with extensive peritoneal damage and subsequent risk of SBO, 
reducing the extent and severity of adhesions is likely to have a beneficial effect on the 
outcomes of future operations and on fertility. In a recent trial, the application of an adhesion 
barrier for two-stage liver surgery resulted in reduced operative times and a trend toward 
fewer complications from the second procedure.(49) 
 
Table 1 
Summary of current insights in adhesion-related morbidity 
The incidence of postoperative bowel obstruction is 9% (7%-10%), depending on the type of 
operation. Most of these obstructions are caused by adhesions (56%; 49%-64%). 
Adhesiolysis requires 20 minutes of operative time and is associated with a 10% risk of 
iatrogenic bowel injury. The additional direct hospital costs of adhesions are approximately  
$ 4,000. 
Bowel injury results in 8% mortality and requires additional bowel resections and 
anastomosis in 60% of cases. 
Pregnancy rates drop to 50% after proctocolectomy and result in high use of fertility 
treatments (20-30% of fertile-aged female patients). 
Colorectal, abdominal wall, and oncological gynaecologic surgery yield the highest risk for 
adhesion-related complications. 
What needs further investigation 
Impact of adhesions on quality of life, indirect costs, return to work, etc. 
Impact of adhesiolysis and subsequent complications on quality of oncological resections and 
adjuvant treatment. 
Extent of adhesion formation after major laparoscopic surgery (e.g. laparoscopic colorectal 
surgery).  
Burden of adhesions after peritoneal surgery in urology. 
 
ADHESION PREVENTION 
Surgical technique 
The first step in preventing post-operative adhesions is minimization of injury to serosal 
surfaces and the parietal peritoneum. However, it is difficult to substantiate “good surgical 
technique”, and claims thereof are based primarily on personal preferences and experiences 
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rather than published data. Comparison of surgical techniques is also difficult to achieve in a 
randomized trial aside from laparoscopy versus open surgery. 
We recently performed a systematic review and meta-analysis on the impact of different 
surgical techniques on adhesion formation.(50) There is some evidence that laparoscopy and 
not closing the peritoneum each have a beneficial effect on the incidence of adhesions. No 
effect could be demonstrated, however, for clinically important outcomes such as reoperations 
for bowel obstruction and pregnancy rate. In the SCAR studies, laparoscopy failed to 
demonstrate consistent beneficial effects on adhesion-related morbidity in gynaecological 
surgery, except for in the subgroup of minor surgical procedures.(3) Additionally, no 
beneficial effect was demonstrated in a three-year follow-up study of patients who were 
randomized to laparoscopic or open colorectal surgery.(51) However, a meta-analysis of non-
randomized studies shows that laparoscopy in general does seem to have a slight lowering 
effect on the incidence of small bowel obstruction.(15) 
From a pathophysiological point of view, minimally invasive techniques reduce the extent 
and severity of adhesion formation. Nonetheless, all peritoneal trauma has the potential to 
result in adhesion formation. In laparoscopy, the same amount of dissection needs to be 
performed as in open surgery, creating large peritoneal wound surfaces during colorectal and 
oncological surgery. This might explain why laparoscopy was only beneficial for adhesion-
related outcomes after minor surgical procedures in the SCAR studies. Additionally, 
pneumoperitoneum itself may contribute to adhesion formation. In a series of experiments on 
the role of pneumoperitoneum on adhesion formation, the group from Leuven demonstrated 
that factors such as pressure and duration of pneumoperitoneum, mesothelial cell hypoxia 
(caused by the use of pure CO2), reactive oxygen species (pneumoperitoneum with more than 
4% oxygen), desiccation, and mesothelial trauma all modulated local tissue response.(52) The 
local tissue response elicits release of inflammatory cytokines, growth factors, and enzymes 
such as matrix metalloproteases, TGF-beta1, TGF-beta3, tachykinins, and INF-gamma, all of 
which are known for their role in adhesion formation.(53-56) A key factor in the local tissue 
response is a decreased fibrinolysis capacity due to increased levels of plasminogen activator 
inhibitor activity(PAI) and decreased levels of tissue-type plasminogen activator (tPA), 
leading to permanent fibrinous attachments.(54)  
Adhesion formation in laparoscopy might be reduced by conditioning the 
pneumoperitoneum.(52) In a human pilot study, Koninckx et al. demonstrated a significant 
reduction in the incidence of adhesions when the pneumoperitonuem was conditioned using a 
gas mixture of 86% CO2, 10% N2O, and 4% O2, combined with cooling and humidification 
of the gas with 2–3 ml/min of Ringer’s lactate and 1,000 IU of Heparin/L.(57) Furthermore, 
the type of coagulation device might impact laparoscopic adhesion formation. An ultrasonic 
device, commonly used in laparoscopic procedures, produces less extensive damage than 
electrocautery.(58;59) Such factors seem to be of limited importance in short laparoscopic 
procedures with low complexity, but have considerable effects on the levels of tPA in 
prolonged laparoscopic procedures.(60;61) 
In summary, despite benefits reported in experimental animal and clinical studies, 
laparoscopy does indeed induce adhesion formation. This evidence contradicts the general 
statement that an adhesion prevention agent is not necessary in laparoscopic 
surgery.(14;15;50;52) 
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Agents to prevent adhesion formation – the pre-clinical phase 
Approximately 60 to 80 animal studies that investigate the efficacy of existing and newly-
developed adhesion reducing agents are published annually (data not shown). The most 
commonly used models are the caecal abrasion, uterine horn, and ischemic button models. A 
commonality among these models is that a standardized lesion is made to the peritoneum, and 
adhesions are then scored seven to twenty-one days later after sacrificing the animals. 
Although these methods of studying adhesion formation and barrier efficacy may seem to be 
sufficient, animal models have many drawbacks, and translating results to clinical practice is 
cumbersome.  
To highlight some of the drawbacks of these animal models, we evaluated thirteen studies 
investigating the efficacy of hyaluronate carboxymethylcellulose using a caecal abrasion 
model. When we compare the incidences of adhesions in these studies, a large variation is 
found in both control and experimental groups (Figure 2). Two methodological flaws 
contribute to this wide variation; the first is lack of standardization. There is (too) much 
variation, for example, in techniques used for abrasion and additional peritoneal lesions, day 
of sacrifice, methods of scoring adhesions, and research conditions. The second flaw is that 
most studies are not powered at all, or are powered to score characteristics of adhesions rather 
than the incidence of adhesions. Using an adhesion score might seem attractive because it 
reduces the sample size required to demonstrate differences between groups with sufficient 
power. However, such scores are highly subjective, and most models only induce relatively 
mild “de novo” adhesions which are not very challenging to prevent. Many patients, on the 
other hand, already have adhesions from prior surgery, making reformation after lysis more 
difficult to prevent. Another problem with translating the results of animal studies is the 
inability to investigate clinically relevant endpoints such as SBO and fertility. Reduction of 
adhesion score alone in an animal model, therefore, is by no means a guarantee of success in 
clinical studies. Indeed, many agents showing promising results in animal models have not 
shown significant effects in clinical studies.(12;13) 
 
Agents to prevent adhesion formation – clinical application 
Available adhesion-reducing agents can be grossly divided into three groups: systemic 
pharmacological agents, intraperitoneal pharmaceuticals, and local adhesion barriers. 
Systemic agents targeting inflammatory response—mainly steroids—have been quickly 
abandoned, since the use of steroids did not result in reduced adhesion scores at second look 
surgery, nor was there a benefit on pregnancy rate in randomized trials.(62;63)On the 
contrary, serious side effects were reported with peri-operative use of steroids, including 
wound healing problems and suppression of the pituitary- adrenal axis.  
One of the first agents applied as a local pharmaceutical to prevent adhesions in a clinical 
study was heparin, which proved unsuccessful.(12) Recombinant plasminogen activator (rPA) 
holds promise as a local acting adhesion formation-reducing agent. Plasminogen activator 
plays a key role in activating fibrinolysis. The innate human fibrinolytic response is often 
insufficient to prevent adhesion formation following peritoneal trauma.(64) Stimulating 
fibrinolytic activity with rPA in rodents reduces the incidence of  both adhesion formation 
andperitoneal abscesses, and is safe for use in bowel anastomosis models.(65;66) Experience 
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with the use of rPA in humans is still limited to pilot and dose-finding gynaecological 
studies.(67) 
 
 
A. 
 
B. 
Figure 4 
A.  Incidence of adhesions in control groups of animal studies for the efficacy of hyaluronate 
carboxymethylcellulose using cecal abrasion model 
B. Incidence of adhesions in treatment groups of animal studies for the efficacy of 
hyaluronate carboxymethylcellulose using caecal abrasion model 
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 Most of our clinical experience in adhesion prevention is with the use of adhesion barriers. 
Adhesion barriers are produced in several forms: solid membranes, gels, and liquids. The 
concept behind barriers is that they do not actively interact with inflammation and wound 
healing. Rather, they act as a spacer which separates injured surfaces of the peritoneum, 
allowing these surfaces to heal without forming fibrinous attachments which eventually lead 
to adhesions. In order to accomplish this task, such barriers should ideally be inert to the 
human immune system and be slowly degradable. Since the entire surface of the peritoneum 
quickly epithializes—unlike skin, which does so gradually from the borders— the time 
required for regeneration is approximately seven days irrespective of the size of the peritoneal 
injury.(56) Abdominal  inflammation and other complications, however, might prolong 
peritoneal healing, thereby necessitating a barrier that is effective for more than a week. 
Four adhesion barriers have been approved for clinical use by legislative authorities in the 
United States and Europe: hyaluronate carboxymethylcellulose (Seprafilm®, Sanofi, Paris, 
France), oxidized regenerated cellulose (Interceed®, Johnson & Johnson, New Jersey, NY, 
USA), icodextrin 4% solution (Adept®, Baxter, Deerfield, IL, USA), and polyethylene glycol 
(PEG) (Spraygel®, Sprayshield®, Confluent Surgical, Waltham, MA, USA).  
Oxidized regenerated cellulose and hyaluronate carboxymethylcellulose are both solid 
barrier films, and are difficult to apply during laparoscopic surgery. On the other hand, 
icodextrin is a fluid and PEG is a spray, making them easy to apply during laparoscopy. 
Formulation seems to impact the efficacy and adverse events profiles of barriers. It is 
generally believed that the solid and viscous gel barriers better prevent adhesion formation at 
sites of peritoneal injury and adhesiolysis, while liquid barriers better protect injured surfaces 
distant from surgical dissection areas (caused by retractors or desiccation, for example). 
However, there is no clear evidence for this hypothesis, even from animal experiments. 
Despite the numerous clinical trials which have assessed the performance of these four 
barriers, their use remains somewhat controversial. For one of the most extensively studied 
barriers— hyaluronate carboxymethylcellulose—a trend toward increased abscess formation 
has been reported.(4;6) However, the increase was not significant in the final analyses of 
these studies, and was related only to a subgroup of patients where the barrier was wrapped 
around a fresh bowel anastomosis. The finding was also not reproduced in more recent studies 
where the barrier was not applied over a bowel anastomosis.(68-70) Nonetheless, the 
possibility continues to raise concern.  
Regarding reoperations, a potential increase in abscess formation might actually be 
outweighed by the risks of adhesiolysis and SBO due to adhesion reformation. Unfortunately, 
most trials do not separately report  barriers’ efficacy for the subgroup of patients with pre-
existing adhesions. In a recent systematic review, the controversy was addressed using a new 
method known as the error-matrix approach.(71) This method has been designed specifically 
for situations in which the benefits and harms of an intervention become difficult to 
weigh.(13) As the  number of studies increases, published clinical evidence continues to 
expand but also becomes increasingly difficult to overview. Like with adhesion barriers, 
multiple trials with different outcome measures for efficacy and safety are often published for 
a single intervention. In a classic meta-analysis, the balanced results of a comparison need to 
be extracted from a large number of forest plots, each considering one specific outcome 
measure and including only a selection of the studies included. For example, in the review 
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conducted by Kumar and colleagues, ten different comparisons were made for five trials 
evaluating hyaluronate carboxymethylcellulose in general surgery alone.(72) 
The error-matrix approach aides the process of reviewing the entirety of available evidence 
by assessing three dimensions: systematic error, random error, and design error. Systematic 
error is the risk of bias, and can be assessed using the Cochrane Collaboration’s tool for bias 
risk assessment.(14)  Random error is the risk of drawing a false conclusion based on sparse 
data, and is presented as the standard error (SE). Finally, among the many variables that 
should be considered in the design of a study, the relevance of different outcome measures are 
of central importance. Therefore, design error (external validity) is assessed by prospectively 
ranking the outcomes for their relevance to the patient. These three dimensions of error can be 
presented in a three-dimensional plot so that the relevance and strength of evidence for 
different benefits and harms of an intervention can be judged at a single glance. 
Using the error-matrix approach, we found modest benefits for the use of oxidized 
regenerated cellulose and hyaluronate carboxymethylcellulose cellulose. Oxidized 
regenerated cellulose reduces adhesion formation following fertility surgery, but the impact 
on subsequent pregnancies has not been studied (Figure 3). Hyaluronate 
carboxymethylcellulose reduces operative time during two-stage liver surgery, and has a 
modest effect on the incidence of adhesive small bowel obstruction in colorectal surgery 
(Figure 4). Icodextrin (fluid) and PEG (spray) are easy to apply during laparoscopy, but their 
performance on clinically important outcomes is equivocal.(7;9) 
 
THE AGENDA FOR THE FUTURE 
Patient information 
Patients undergoing abdominal surgery should be informed about the risk of adhesion-
related complications. Surprisingly, patients are seldom informed about these risks despite the 
high incidence of adhesion-related complications. (73;74) In contrast, bile duct injury is 
mentioned in 82% of informed consents for laparoscopic cholecystectomy, whilst its 
incidence is far below one percent.(49;50) Epidemiologic data demonstrates that the 
complication rate of adhesiolysis during repeat surgery is well above the threshold at which 
no information is deemed negligence.  
Clinical guidelines for adhesion prevention 
The epidemiologic data on the burden of adhesiolysis and related complications has major 
implications for future adhesion prevention policies. To date, physicians and legislative 
bodies have focused on prevention of SBO as the main indicator of clinical success in 
adhesion prevention; however, morbidity and costs of adhesiolysis might exceed those of 
SBO. Reducing morbidity from adhesiolysis-related complications also appears to be a more 
feasible outcome of adhesion prevention for guidelines and clinical studies. Unfortunately, 
few comparative trials have investigated the impact of adhesion barriers on adhesiolysis-
related outcomes.(25)  
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Figure 3. Manhattan plots summarizing benefits and harm of oxidized regenerated cellulose 
versus no adhesion barrier 
Quick guide: 
Systematic error (bias), plotted on the Y-axis, is measured by the level of evidence in which: 1A represents the meta-analysis 
of low-bias risk  RCTs; 1B is a low-risk  bias RCT; 1C is a meta-analysis of all RCTs, and 1D is a high- bias risk bias RCT. 
The X-axis represents random error measured by standard error (SE). A low risk for random error is defined as SE<0.20, and 
moderate risk as SE <1.00. Studies with a high risk for random error (SE>1.00) fall outside the range of the plot and are 
considered irrelevant for decision-making. Design error is plotted on the Z-axis, representing the relevance of the clinical 
outcome.  
 
Results most important for clinical decision-making are plotted as the highest bars in the upper-left part of the plot. 
a. Outcomes with benefit of oxidized regenerated cellulose versus none or placebo.  
b. Outcomes with no difference or harm of oxidized regenerated cellulose versus none or placebo.  
 
To find the evidence for oxidized regenerated cellulose influencing the incidence of adhesions, go to the green bars in figure 
3 and read (1) Level of evidence (the risk of systematic error) and (2) standard error (the risk of random error). 
 
From these Manhattan figures, one can see at a glance that there is evidence that oxidized regenerated cellulose shows benefit 
on the incidence of adhesions and on adhesions score with low risk of systematic error and low risk of random error. 
 
A more detailed explanation of the error- matrix approach and Manhattan figures can be found elsewhere: 
Keus F, Wetterslev J, Gluud C, van Laarhoven CJ. Evidence at a glance: error matrix approach for overviewing available 
evidence. BMC Med Res Methodol 2010; 10:90. 
Reprinted from the Lancet with permission from Elsevier: ten Broek RP, Stommel MW, Strik C et al. Benefits and harms of 
adhesion barriers for abdominal surgery: a systematic review and meta-analysis. Lancet 2014;383;48-59. 
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Figure 4 Manhattan plots summarizing benefits and harm comparing Hyaluronate 
carboxymethylcellulose versus no adhesion barrier 
Manhattan-like three-dimensional matrix for hyaluronate carboxymethylcellulose, building upon the risks of systematic error, 
random error, and design error. The evidence with the lowest systematic, random, and design error is represented by the 
tallest bars, located on ‘the upper left side’. A. Outcomes with benefit of hyaluronate carboxymethylcellulose versus none or 
placebo. B. Outcomes with harm of hyaluronate carboxymethylcellulose versus none or placebo.  
 
From these Manhattan figures, one can see at a glance that there is evidence that hyaluronate carboxymethylcellulose trials 
show a beneficial effect on the incidence of reoperation for adhesive small bowel obstruction and operative time with low 
risk of systematic error and moderate risk of random error. There is no evidence of a beneficial effect on the incidence of 
serious adverse events in a large number of trials with varying risk of random error. Further, there is evidence that 
hyaluronate carboxymethylcellulose reduces the incidence of site-specific adhesions (blue bars) and adhesion scores (purple 
bars). 
 
Reprinted from the Lancet with permission from Elsevier: ten Broek RP, Stommel MW, Strik C et al. Benefits and harms of 
adhesion barriers for abdominal surgery: a systematic review and meta-analysis. Lancet 2014;383;48-59. 
 
Research on SBO prevention requires that a large number of patients be followed for many 
years. Most existing studies on prevention of SBO are therefore underpowered. Because of 
the relatively low incidence of SBO, many adhesion prevention agents are also unlikely to pay 
off in cost models when only counting the socioeconomic effects of SBO prevention.(49)  
Prevention of difficulties during adhesiolysis, on the other hand, can be studied in two-
stage operations.(15) Adhesiolysis-related complications are also more correlated to severity 
of adhesions. New cost-efficacy models that include the potential benefits of adhesion 
prevention in reoperations and fertility treatments are expected to indicate that prevention is 
also cost-effective in high risk surgeries, and will be applicable to a broader group of patients. 
Such high risk procedures include two-stage surgery, abdominal wall surgery, colorectal 
cancer surgery, and surgery with secondary prevention of adhesions (e.g. surgery for small 
bowel obstruction and fertility surgery).(56;75-77)  
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 Challenges in adhesion prevention research 
Despite the availability of a number of effective adhesion barriers, there is still a need for 
new and better agents for use in open and laparoscopic surgery. The development of new 
adhesion prevention agents faces several challenges in the coming decade, starting with the 
phase of pre-clinical studies. Animal models should be better standardized, and the studies 
should be performed with sample sizes that have sufficient power. Improving animal studies 
would avoid perpetuating the excess of duplicate studies with contradicting results, and would 
enhance translational value by using more meaningful outcomes, such as incidence of 
adhesions and secondary prevention of adhesions. 
Research on the pathophysiology of adhesions has revealed a large number of adhesion 
formation mediators, including collagen I, fibronectin, matrix metalloproteinase-1 (MMP-1), 
tissue inhibitor of metalloproteinase-1 (TIMP-1), transforming growth factor (TGF)-β1, 
cyclooxygenase-2 (COX-2), interleukin (IL)-10, and the tissue plasminogen activator (tPA) 
and plasminogen activator inhibitor type-1 (PAI-1) ratio.(67;78)  Although these studies have 
enhanced our understanding of adhesion formation, they have not yet resulted in clinically 
effective targeted therapies.(67) Clinical studies with rPA are still in their infancy, however, 
and some promising animal experiments are currently being performed with intraperitoneal 
therapy targeting the Neurokinin 1 receptor. (79;80),(15) Clinical trials are needed to 
demonstrate if such targeted therapies are effective in reducing postoperative adhesion 
formation. Moreover, widespread implementation will require extensive research on safety 
and potential harmful effects under different circumstances such as bowel anastomosis, 
peritonitis, and blood contamination. 
At present, there are few pivotal studies which have used outcomes of clinical importance 
to the patient such as pregnancy rate, adhesive small bowel obstruction, and chronic pain. The 
difficulty with measuring these outcomes in clinical trials is the large time span in which these 
outcomes develop.(50;81) To study such endpoints, large numbers of patients need to be 
randomized and followed for many years. Because of these difficulties, scoring of adhesions 
during a second look operation has been popularized as a proxy for the risk of adhesion-
related complications. With the growing epidemiologic knowledge that adhesiolysis-related 
complications are the most important complication from adhesions, we believe this proxy 
should also be an acceptable efficacy outcome for regulatory bodies. Again, however, 
incidence of adhesions should be the preferred outcome measure rather than subjective 
adhesion scores.  
 
Non invasive diagnosis of adhesions 
Diagnosis of adhesion-related complications is challenging, given that second look surgery 
and emergent reoperation are the only current means of establishing the incidence of 
adhesions and adhesive small bowel obstruction. The number of planned second procedures 
has declined both in female patients following fertility surgery or myomectomy, and in 
patients who are scheduled for two-stage benign colorectal surgery with planned enterostomy 
take down. (82-84) Obviously, performing a diagnostic second operation solely for the 
purpose of research is ethically unacceptable since it exposes the patient to risk for 
inadvertent organ injury. Furthermore, adhesions lysed during the second procedure might re-
form.  
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Cine-MRI might eventually replace the second look operation as a non-invasive alternative 
for diagnosis of adhesions, and as an outcome for clinical studies on adhesion prevention. 
'Visceral slide' of bowel loops adjacent to the abdominal wall on ultrasound or cine-MRI has a 
high prognostic value for adhesions. Ultrasound does not enable ‘visualizing’ adhesions 
deeper in the abdominal cavity. By contrast, the full abdominal cavity can be imaged with 
cine-MRI. However, results need to be validated with intra- operative findings before cine-
MRI can be accepted as a valid non-invasive tool with which to map adhesions.   
 
Summary 
The biggest challenges in adhesion research for the coming decade are: 
- Development of evidence-based clinical guidelines for adhesion prevention 
- Development of efficacious adhesion-preventing agents suitable for both open and 
laparoscopic use 
- Standardization of both preclinical and clinical adhesion studies 
- Development and validation of non-invasive diagnostic tools for adhesions, such as cine-
MRI 
 
CONCLUSIONS 
Despite mounting evidence that adhesions are the most common complication in 
abdominal surgery, little progress has been made over the past two decades both in preventing 
adhesions and in informing patients about their risks. There is increasing evidence that 
difficulties related to adhesiolysis in reoperations are the biggest adhesion-related 
complication. Now that the efficacy of adhesion barriers has been established for reducing the 
incidence of adhesion-formation, research should focus on implementation strategies and on 
selecting patient groups that will benefit most. Additional research also remains necessary to 
develop new, cost-effective barriers that are suitable for laparoscopic use. Finally, both animal 
and clinical studies on adhesion formation need a higher degree of standardization so that 
advances in adhesion prevention strategies can be implemented faster and with broader 
acceptance in clinical practice.   
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SUMMARY 
215 
Abdominal surgery is frequently performed by a multitude of specialists, such as general, 
vascular, urological and gynaecological surgeons. From the SCAR study it is known that 55 
000 patients undergo abdominal surgery in one year in Scotland, which number is more than 
one per cent of the entire population. In the Netherlands more than 24 000 operations of the 
lower gastro- intestinal tract are performed annually, procedures with high risk of adhesion 
formation. 
Adhesions form in 60% to 90% of patients after abdominal surgery. Postoperative adhesions 
cause a life-long risk of different complications including small bowel obstruction, difficulties 
at re-operations, chronic abdominal pain, and secondary female infertility. These 
complications can be found after all types of abdominal surgery, performed by surgeons, 
gynaecologists or urologists. Till date most reports on the clinical and socioeconomic impact 
of adhesion related complications had their focus on adhesive small bowel obstruction. 
Adhesiolysis at repeat surgery received much less attention in literature. Underestimation of 
adhesiolysis related morbidity may account for the paucity of reports on this consequence of 
adhesions. 
Since the 90's several adhesion barriers have been developed and marketed but prevention of 
adhesion formation is seldom applied. Many questions still exist among surgeons and 
gynaecologists on the efficacy and safety of adhesion barriers.  
In the current thesis the awareness of adhesion related complications by clinicians is 
addressed, the impact of adhesions at repeat surgery is extensively studied and the current 
knowledge of adhesion prevention is systematically reviewed.  
 
Part I: awareness of adhesion related complications.  
CHAPTER 2 described the results of a systematic review and meta-analysis of 196 cohort 
studies on the incidence of various adhesion related complications. Almost 1 in 10 patients 
had an episode of small bowel obstruction after abdominal operation. In patients with a 
known cause, adhesions were the single most common cause of bowel obstruction. The 
incidence of adhesive small bowel obstruction was 2% (95% confidence interval 2% to 3%; 
I2=93%); presence of adhesions was generally confirmed by emergent reoperation. Operative 
time was significantly prolonged in patients with previous surgery, and performing 
adhesiolysis caused a significant risk of iatrogenic bowel injury. The review provides detailed 
knowledge analysed in a systematic way of the disease burden of adhesions. Complications of 
postoperative adhesion formation are frequent, have a large harmful effect on patients’ health, 
and increase workload in clinical practice.   
 
In CHAPTER 3 we presented the results of a questionnaire testing the knowledge of Dutch 
surgeons of adhesion related complications and exploring their attitude towards adhesions and 
anti- adhesion agents. The questionnaire was returned by more than 500 surgeons and 
residents. Knowledge scores (mean test score percentage 37.6) were low illustrating the 
underestimation of the incidence and impact of adhesions. Two thirds of all respondents 
(67.7%) agreed that adhesions exert a clinically relevant and negative effect. A majority of 
surgeons (55.9%) used anti-adhesion agents in the past, but only a minority (13.4%) did so in 
the previous year. Less than 10% of surgeons routinely inform their patients on the risks of 
adhesions. In conclusion, the magnitude of the clinical burden of postoperative adhesions is 
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 underestimated and informed consent is provided inadequately by Dutch surgeons. 
Application of an adhesion barrier is not routine. 
 
CHAPTER 4 explored how accurate adhesion related complications during reoperations are 
described in operative reports as a proxy for the awareness level of the clinical burden of 
adhesions. For this purpose we compared real-time observations from a research database 
with the operative reports of 755 procedures. Sensitivity and specificity for the incidence of 
adhesions was 85.1 and 72.4 per cent respectively. Six of 43 inadvertent enterotomies, and 17 
of 48 other organ injuries, had not been reported. Documentation of inadvertent enterotomies 
was missing more often in delayed reports (2 of 3 versus 1 of 10 in reports dictated with no 
delay; P=0.022). Performing adhesiolysis and subsequent organ injury are often neglected in 
operative reports. 
 
Part II: difficulties of adhesions during reoperations 
CHAPTER 5 and 6 described the findings of the LAPAD study. The LAPAD study is a 
prospective cohort study designed to assess data on adhesiolysis and inadvertent organ injury 
that were gathered by direct observation during operation. Further, detailed medical history 
and postoperative course data were registered. CHAPTER 5 described the results for the 
whole cohort of operations through an abdominal incision, in CHAPTER 6 we focussed on 
patients undergoing abdominal wall reconstruction.  
A total of 755 surgeries in 715 patients were included. Adhesiolysis was required in 475 
(62.9%) operations. Median adhesiolysis time was 20 minutes (range: 1–177). Fifty patients 
(10.5%) who underwent adhesiolysis inadvertently incurred a bowel defect, compared to zero 
without adhesiolysis (P < 0.001). In univariate and multivariate analyses, adhesiolysis was 
associated with an increase of sepsis incidence [odds ratio (OR): 5.12; 95% confidence 
interval (CI): 1.06–24.71], intra-abdominal complications (OR: 3.46; 95% CI: 1.49–8.05) and 
wound infection (OR: 2.45; 95% CI: 1.01–5.94), longer hospital stay (2.06 ± 1.06 days), and 
higher hospital costs [$18,579 (15,204–21,954) vs $14,063 (12,471–15,655)]. Mortality after 
adhesiolysis complicated by a bowel defect was 4 out of 50 (8%), compared with 7 out of 425 
(1.6%) after uncomplicated adhesiolysis (OR: 5.19; 95% CI: 1.47–18.41).  
Adhesiolysis was required in 124 (93.2%) of 133 abdominal wall reconstruction, with a mean 
adhesiolysis time of 35.7 ± 29.8 minutes. Thirty-three enterotomies were made in 17 patients 
(12.8%). Two patients had a delayed diagnosed bowel perforation. Adhesiolysis time, hernia 
size greater than 10 cm, and fistula were significant predictive factors in univariate analysis. 
In multivariate analysis, only adhesiolysis time was a significant and independent predictive 
factor for enterotomy (P = 0.004). 
Adhesiolysis and inadvertent bowel injury have a harmful effect on the convalescence after 
abdominal surgery. Adhesiolysis is complicated by an inadvertent bowel injury in 10 percent 
of operations. Bowel injuries are associated with higher postoperative mortality, longer 
hospital stay and increased health care utilization. 
 
In CHAPTER 7 we described the development of a prediction model, scoring the risk for 
inadvertent enterotomy based on preoperative factors. The number of previous laparotomies, 
anatomical site of the operation, presence of bowel fistula and laparotomy via a pre-existing 
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median scar were independent predictors of bowel injury. A scoring system and nomogram 
were constructed incorporating these four risk factors. The area under the receiver operating 
characteristic curve was 0.85. The predicted risk in patients positive on all four risk factors 
was 50%. The nomogram accurately predicts the risk for bowel injury and can readily be used 
to identify high- risk patients. 
 
Part III: Adhesion prevention 
In CHAPTER 8 evidence for the impact of different surgical techniques on adhesion 
formation was reviewed in a systematic way from randomized trials. Surgical technique has 
been poorly investigated in relation to adhesion formation. A total of 27 papers were included, 
most of them of low quality. None of the techniques that were compared significantly reduced 
the incidence of adhesive small bowel obstruction. In a small low quality trial, the pregnancy 
rate increased after subserous fixation of suture knots. The incidence of adhesions was lower 
after laparoscopic then after open surgery [relative risk (RR) 0.14; 95% confidence interval 
(CI): 0.03-0.61] and when the peritoneum was not closed (RR 0.36; 95% CI 0.21-0.63). 
None of the different techniques reduced the incidence of clinical outcomes critical for 
decision making, such as small bowel obstruction and infertility. The meta-analysis provides 
some evidence to the surgical principle that less invasive techniques, less foreign bodies and 
less ischemia reduce the incidence, extent and severity of adhesions. 
  
In CHAPTER 9 we compared the peritoneal tissue damage caused by two popular hemostatic 
devices, monopolar electrocautery and ultrasonic dissection. 18 Wistar rats underwent a 
median laparotomy and had a peritoneal microdialysis catheter implanted in the left lateral 
sidewall. The animals were randomly assigned to receive two standard peritoneal incisions 
parallel to the catheter by either ultrasonic dissection or electrocautery. After the operation, 
samples of microdialysis dialysate were taken every two hours until 72 hours postoperatively. 
The mean lactate–pyruvate ratio (LPR), lactate–glucose ratio (LGR), and glycerol 
concentration were significantly higher in the electrocautery group than in the ultrasonic 
dissection group until 34, 48, and 48 hours after surgery respectively. The mean areas under 
the curve (AUC) of LPR, LGR, and glycerol concentration also were higher in the 
electrocautery group than in the ultrasonic dissection group, indicating more ischemic 
peritoneal damage from electrocautery. Using ultrasonic dissection might aid in reducing 
adhesion formation. 
 
In CHAPTER 10 we evaluated the evidence of benefits and harm of four commercially 
available adhesion barriers. In this systematic review and meta-analysis, we searched 
PubMed, CENTRAL, and Embase for randomised clinical trials assessing use of oxidised 
regenerated cellulose, hyaluronate carboxy methylcellulose, icodextrin, or polyethylene glycol 
in abdominal surgery. We compared use of a barrier with no barrier for nine predefined 
outcomes, graded for clinical relevance. The primary outcome was reoperation for adhesive 
small bowel obstruction. We assessed systematic error, random error, and design error with 
the error matrix approach. The risks of systematic and random errors were low. No trials 
reported data for the effect of oxidised regenerated cellulose or polyethylene glycol on 
reoperations for adhesive small bowel obstruction. Oxidised regenerated cellulose reduced the 
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 incidence of adhesions (relative risk [RR] 0.51, 95% CI 0.31–0.86). Some evidence suggests 
that hyaluronate carboxymethylcellulose reduces the incidence of reoperations for adhesive 
small bowel obstruction (RR 0.49, 95% CI 0.28–0.88). For icodextrin, reoperation for 
adhesive small bowel obstruction did not differ significantly between groups (RR 0.33, 95% 
CI 0.03–3.11). No barriers were associated with an increase in serious adverse events. 
Oxidised regenerated cellulose and hyaluronate carboxymethylcellulose can safely reduce 
clinically relevant consequences of adhesions. 
 
In CHAPTER 11 the results of a small pilot study on the efficacy of polyethylene glycol 
(PEG) adhesion barrier in gynaecological laparoscopies are described. The trial was aborted 
after including only 16 patients for organizational difficulties. Still we found some evidence 
for the efficacy of PEG adhesion barrier. At second look operation, the incidence of de novo  
adhesion was lower in the PEG group (0/9 vs. 4/6; P=0.01). Reduction in adhesion score was 
significantly greater in patients receiving PEG barrier (-2.6 vs. -0.06, P = 0.03). More 
importantly, the paper illustrates the difficulties in organizing a randomized trials of adhesion 
barriers. The number of planned second look procedures is rapidly declining in fertility 
surgery, making it difficult to include sufficient numbers of patients. Also the additional costs 
and ethical considerations for patients participating in such trials and undergoing a second 
operations for in part research purpose should be taken into account when designing such 
trials. 
 
CHAPTER 12 is the discussion and future perspectives of this thesis. It highlights the 
developments in the field of adhesion research for the past decade. Although adhesion barriers 
have now been around for more than a decade, adhesion prevention is seldom applied. The 
main reasons for this seem a continuing lack of awareness regarding the burden of adhesion 
related complications, questions on the indications and cost-efficacy of adhesions barriers, 
and safety concerns. New epidemiologic data warrant a paradigm shift in our understanding 
of  the socioeconomic burden of adhesion related complications and the indications for 
adhesion prevention strategies. Increasing evidence from cohort studies and systematic 
reviews show that difficulties during reoperations rather than small bowel obstructions 
account for the majority of adhesion related morbidity. New cost-efficacy models that include 
the potential benefits of adhesion prevention in reoperations and fertility treatments are 
expected to indicate that prevention is also cost-effective in high risk surgeries for adhesion 
formation and should be applied to a broader group of patients. More effort should be put into 
improvement of research on adhesion prevention from molecule to man to population. Animal 
models need to be better standardized and powered to generate more meaningful and robust 
results. There is a need for non- invasive techniques to assess adhesion formation in clinical 
trials. Cine-MRI holds promise, but needs further development. 
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Summary in Dutch (Nederlandse samenvatting) 
221 
Buikoperaties worden vaak uitgevoerd door diverse specialisten, onder wie algemeen 
chirurgen, vaatchirurgen, urologen en gynaecologen. Het is precieze aantal buikoperaties is 
moeilijk in te schatten. Tijdens de SCAR studie onderging ruim één procent (55.000) van de 
totale bevolking van Schotland binnen een jaar tijd voor het eerst een buikoperatie. In 
Nederland worden ieder jaar meer dan 24.000 operaties van de onderste tractus digestivus 
verricht. Deze procedures zijn bekend vanwege hun hoge risico op adhesie vorming. 
Adhesies vormen zich in 60% tot 90% van de patiënten die een buikoperatie hebben 
ondergaan. Daarmee zou adhesie vorming als een normaal onderdeel van het genezingsproces 
van een buikoperatie kunnen worden gezien. Echter, adhesies hebben vaak secundaire 
gevolgen. Deze gevolgen zijn divers en kunnen soms pas vele jaren na de oorspronkelijke 
operatie optreden. De belangrijkste daarvan zijn een obstructie van de darm; complicaties bij 
heroperaties; chronische pijn; en onvruchtbaarheid bij vrouwen. Deze gevolgen van adhesies 
komen voor na alle soorten buikoperaties. Tot op heden is het onderzoek naar verklevingen 
vooral gericht op de morbiditeit en maatschappelijke gevolgen van een acute darmobstructie. 
De problemen bij heroperaties door het moeten verrichten van een adhesiolyse, zijn veel 
minder belicht in de medische literatuur. Het lijkt erop dat de gevolgen van adhesiolyse vaak 
worden onderschat. 
Sinds de jaren ’90 zijn er diverse middelen ontwikkeld om adhesie vorming te voorkomen of 
te remmen, ook wel adhesie ‘barriers’ genoemd. Deze worden echter maar zelden toegepast. 
Dit komt waarschijnlijk omdat  chirurgen en gynaecologen veel vragen hebben over de 
veiligheid en effectiviteit van deze middelen. 
In dit proefschrift beschrijven wij: het bewustzijn (awareness) van zorgverleners ten aanzien 
van complicaties gerelateerd aan adhesies, de gevolgen van adhesies bij heroperaties, en 
preventie van adhesies. 
 
Deel 1: ‘Awareness’ van complicaties gerelateerd aan adhesies 
In HOOFDSTUK 2 beschreven wij in een systematische review en meta-analyse de resultaten 
van 196 studies over de prevalentie van één of meer complicaties gerelateerd aan adhesies. 
Negen procent (95% betrouwbaarheidsinterval [BI]: 7%- 10%) van de patiënten die een 
buikoperatie hebben ondergaan ontwikkelen hierna een darmobstructie. Vaak kan de oorzaak 
niet betrouwbaar worden vastgesteld. Sommige oorzaken, zoals adhesies, zijn alleen zeker als 
er wordt geopereerd. De prevalentie van een darmobstructie die met zekerheid is veroorzaakt 
door adhesies is daarom lager, 2% (95% BI: 2%- 3%). De darmobstructies die met zekerheid 
door adhesies zijn veroorzaakt betreffen wel 56% (95% BI: 49%- 64%) van alle gevallen van 
ileus waarin de oorzaak bekend is. Hiermee zijn adhesies met afstand de meest voorkomende 
oorzaak voor acute darmobstructie. Bij heroperaties verlengt een adhesiolyse de operatietijd 
met gemiddeld 15 min (95% BI: 9.3- 21.1 min). Bij 6% (95% BI: 4% - 8%) veroorzaakt het 
verrichten van een adhesiolyse zelfs onbedoelde darmschade. Vrouwelijke patiënten met 
inflammatoire darmziekte die zijn geopereerd worden significant minder vaak zwanger dan 
patiënten die alleen medicamenteus zijn behandeld (50% [95% BI: 37%-63%] vs. 82%[95% 
BI: 70%- 94%]). In deze review hebben wij systematisch en gedetailleerd de gevolgen van 
adhesievorming beschreven. Complicaties van verklevingen komen vaak voor en hebben een 
negatief effect op de gezondheid van patiënten en veroorzaken een toename van 
gezondheidszorgkosten. 
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HOOFDSTUK 3 beschrijft de resultaten van een enquête onder Nederlandse chirurgen met 
een kennistoets over adhesies en vragen over de attitude van chirurgen ten aanzien van 
adhesies en adhesiepreventie. Ruim 500 chirurgen en assistenten in opleiding hadden de 
enquête volledig ingevuld. Op de kennistoets over de gevolgen van adhesies was het 
gemiddelde percentage goede antwoorden slechts 37.6%. Bovendien betroffen de meeste 
foutieve antwoorden een onderschatting van de ernst van het probleem. Wel was 67.7% van 
de chirurgen het erover eens dat adhesies belangrijke negatieve gevolgen hebben voor 
patiënten die een buikoperatie ondergaan. Anti- adhesie middelen zijn weinig toegepast. 
Hoewel 55.9% van de chirurgen aangeeft ooit een anti- adhesie middel te hebben gebruikt, 
had slechts 13.4% dit in het afgelopen jaar gedaan. Bovendien bleken er veel vragen te 
bestaan over de indicaties voor het gebruik van anti- adhesie middelen. Nog geen 10% van de 
chirurgen bespreekt routinematig de risico’s van adhesies met zijn patiënten. Concluderend 
onderschatten Nederlandse chirurgen de gevolgen van adhesies en bespreken zij ook zelden 
met patiënten de risico's van adhesies. Adhesie barriers worden niet routinematig gebruikt.  
 
In HOODSTUK 4 bestudeerden wij hoe betrouwbaar het voorkomen van adhesies en het 
verrichten van een adhesiolyse tijdens een operatie worden beschreven in het operatieverslag, 
als afgeleide maat voor de awareness van adhesies. Hiertoe vergeleken wij de officiële 
operatieverslagen van 755 operaties met de bevindingen die tijdens deze operaties werden 
geregistreerd door de onderzoekers van de LAPAD studie in een real- time database. De 
sensitiviteit en specificiteit van adhesies in operatieverslagen bedroegen respectievelijk 85.1% 
en 72.4%. Bovendien werden 6 van de 43 enterotomiën en 17 van de 48 andere orgaanletsels 
niet vermeld. Bij operatie verslagen die te laat waren gedicteerd was het percentage gemiste 
enterotomiën hoger (2/3 tegenover 1/10 bij tijdig gedicteerde verslagen; P=0.022) . Het 
verrichten van adhesiolyse en daarop volgende orgaanschade wordt te vaak niet vermeld in 
operatieverslagen. 
 
Deel 2: Problemen die adhesies veroorzaken bij heroperaties 
In HOOFDSTUK 5 en 6 beschrijven wij de resultaten van de LAPAD studie. In deze studie 
brachten wij voor het eerst de problemen van heroperaties op systematische en prospectieve 
wijze in kaart. Twee jaar lang werden alle patiënten gevolgd die waren opgenomen op de 
afdeling heelkunde van het RadboudUMC voor het ondergaan van een electieve buikoperatie. 
Relevante medische gegevens werden verzameld voor, tijdens en na de operatie. Tijdens de 
operaties werd door een kleine toegewijde groep onderzoekers, aanwezig op de 
operatiekamers, gegevens over de incidentie en ernst van adhesies geregistreerd in een real- 
time database. Ook werd het al of niet verrichten van adhesiolyse geregistreerd en de tijdsduur 
van deze adhesiolyse gemeten. Op basis van deze gegevens kon een zeer nauwkeurig beeld 
van de impact van adhesies op het verloop van de operatie en postoperatieve complicaties 
worden verkregen. HOOFDSTUK 5 beschrijft de resultaten van de gehele groep. 
HOOFDSTUK 6 richt zich op de subgroep van patiënten die een buikwandreconstructie 
onderging. 
In totaal werden 755 operaties, verricht bij 715 patiënten, geïncludeerd. Adhesiolyse werd 
verricht in 475 (62.9%) van alle operaties. De mediane adhesiolyse tijd bedroeg 20 minuten 
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(variërend van 1 tot 177 minuten). Vijftig operaties (10.5%) werden gecompliceerd door 
onbedoelde darmschade. Darmschade trad alleen op bij patiënten die adhesiolyse hadden 
ondergaan (P<0.001). Zowel in de univariaat als multivariaat analyse was adhesiolyse (met of 
zonder darmschade) geassocieerd met een toegenomen incidentie van sepsis (Odds Ratio 
[OR]: 5.12; 95% BI: 1.06- 24.7), intra- abdominale complicaties (OR 3.46; 95% BI: 1.49-
8.05) en wondinfectie (OR 2.45; 95% CI: 1.01- 5.94). Boven was de gemiddelde 
ziekenhuisduur 2 dagen langer en waren de ziekenhuiskosten hoger [$18,579 (15,204–21,954) 
vs $14,063 (12,471–15,655)]. Na onbedoelde darmschade was het risico op overlijden tijdens 
de opname significant hoger (8% vs. 1.6%; OR 5.19; 95% BI: 1.47-18.41). 
Bij 124 van de 133(93.2%) buikwandreconstructies werd adhesiolyse verricht. De gemiddelde 
adhesiolyse tijd bedroeg 35.7 ± 29.8 minuten. In totaal werden 33 enterotomiën gemaakt in 17 
patiënten (12.8%). Verder hadden 2 patiënten darmschade die pas postoperatief werd 
gediagnosticeerd. De tijdsduur van adhesiolyse, een buikwandbreuk groter dan 10 cm, en 
fistels waren risicofactoren voor darmschade. In de multivariaat analyse was alleen de 
tijdsduur van adhesiolyse een onafhankelijke voorspeller voor darmschade (P=0.004). 
Het verrichten van adhesiolyse en daaropvolgend orgaanschade heeft een groot negatief effect 
op het herstel van patiënten die een buikoperatie ondergaan. Adhesiolyse gaat gepaard met 
onbedoelde darmschade in ongeveer 1 op 10 operaties. Darmschade gaat gepaard met hogere 
sterfte na operatie, een langere ligduur en hogere ziektekosten. 
 
HOOFDSTUK 7 beschrijft de ontwikkeling van een scoremodel, gebaseerd op de LAPAD 
studie, om het risico op een enterotomie pre- operatief in te schatten. Onafhankelijke 
voorspellende variabelen voor het risico op een enterotomie zijn: het aantal buikoperaties in 
de voorgeschiedenis, de anatomische locatie van de geplande operatie, aanwezigheid van 
entero- cutane fistels en een buikoperatie door een bestaand litteken van een mediane 
laparotomie. Op basis van deze variabelen werd een model gemaakt om het risico op 
enterotomie te voorspellen. Het model geeft een nauwkeurige voorspelling van de patiënten 
met een hoog risico op darmschade. De ‘area under the receiver operating characteristic 
curve’ was 0.85. Het voorspelde risico op darmschade in de hoogste risicogroep was 50%. 
Van dit model is ook een nomogram gemaakt wat makkelijk gebruikt kan worden in de 
voorlichting van patiënten en voor het identificeren van patiënten met een hoog risico op 
darmschade. 
 
Deel 3: Preventie van adhesies 
In HOOFDSTUK 8 beschrijven wij een meta- analyse van alle gerandomiseerde onderzoeken 
die verschillende chirurgische technieken vergelijken op uitkomsten gerelateerd aan adhesies. 
Er werden 27 studies geïncludeerd, de kwaliteit van de meeste van deze studies was laag en er 
konden vaak geen duidelijke conclusies worden getrokken. Het risico op darmobstructie is in 
geen van de studies onderzocht. In een kleine studie binnen de fertiliteitschirurgie was de kans 
op zwangerschap groter wanneer de hechtingen subsereus werden gefixeerd. De incidentie 
van verklevingen lijkt lager na een laparoscopische ingreep vergeleken met een open buik 
operatie [Relatief risico (RR) 0.14; 95% betrouwbaarheidsinterval (BI): 0.03-0.61], en 
wanneer het peritoneum niet wordt gesloten aan het eind van een ingreep (RR 0.36; 95% BI 
0.21-0.63). 
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 Geen van de vergeleken technieken toonde duidelijk bewijs op klinisch harde eindpunten 
zoals ileus of zwangerschappen. Wel wordt enig bewijs gevonden dat minimaal invasieve 
technieken, beperking van vreemd lichaam, en het verminderen van ischemische schade, de 
incidentie en uitgebreidheid van verklevingen beperkt. 
 
HOOFDSTUK 9 beschrijft een dierstudie waarin twee veel gebruikte moderne instrumenten 
om te prepareren en bloedingen te verzorgen in de buikchirurgie worden vergeleken op de 
schade die ze aanrichten aan het peritoneum. De eerste is een diathermisch mes, waarbij 
energie wordt afgegeven in de vorm van hoogfrequente stroom. Het tweede instrument is een 
‘ultrasonore dissectie haak’, waarbij energie in de vorm van een ultrageluidstrilling wordt 
afgegeven. 18 Wistar ratten werden gerandomiseerd voor het ondergaan van een 
gestandaardiseerde procedure met of diathermie of ultrasonore dissectie. De schade aan het 
peritoneum werd gemeten met microdialyse waarbij iedere 2 uur, tot 72 uur na de ingreep, 
markers van peritoneale schade werden bepaald in het dialysaat. Deze markers betroffen de 
lactaat-pyruvaat ratio (LPR), lactaat-glucose ratio (LGR) en glycerol concentratie. De LPR, 
LGR en glycerol concentratie waren significant hoger in de diathermie groep tot 
respectievelijk 34, 48 en 48 uur na de ingreep. De ‘area under curve’ van de LPR, LGR en 
glycerol concentratie was ook significant hoger in de diathermie groep, wat erop duidt dat de 
peritoneale schade ten gevolge van diathermie groter is dan die van ultrasonore dissectie. Het 
gebruik van een ultrasonore dissectie kan dus nuttig zijn om adhesie vorming te beperken. 
 
In HOOFDSTUK 10 deden we een systematische review en meta-analyse over de voor- en 
nadelen van vier commercieel beschikbare adhesie barriers. Voor deze analyse hebben wij 
gebruik gemaakt van een nieuwe meta-analyse techniek, namelijk de error-matrix approach. 
Deze techniek heeft als voordeel dat er snel een overzicht kan worden gegeven van alle voor- 
en nadelen van een interventie, in tegenstelling tot klassieke meta-analyse technieken waarbij 
per analyse steeds slechts één uitkomst wordt geëvalueerd. In totaal 9 vooraf gedefinieerde 
uitkomsten werden bestudeerd. Heroperatie voor een darmobstructie veroorzaakt door 
adhesies was de primaire uitkomst. Na een uitgebreide search in Pubmed, EMBASE en 
CENTRAL werden 28 gerandomiseerde onderzoeken met 5.191 patiënten geïncludeerd. Het 
risico op systematische fouten was laag. 'Hyaluronate carboxymethylcellulose' verminderde 
het risico op heroperaties voor darmobstructie  (RR 0.4 9, 95% BI: 0.28- 0.88). 'Oxidised 
regenerated cellulose' verminderde de incidentie van adhesies in gynaecologische operaties 
(RR 0.51, 95% BI: 0.31- 0.86). ' Geen van de vier barriers was geassocieerd met een toename 
in chirurgische complicaties. 
Gebruik van deze barriers is veilig en leidt niet tot een verhoogde incidentie van complicaties. 
’ Oxidised regenerated cellulose’  en 'hyaluronate carboxymethylcellulose' hebben beide 
bewezen het risico op klinisch relevante gevolgen van adhesies te verminderen. 
 
HOOFDSTUK 11 beschrijft een kleine studie naar de effectiviteit van het anti- adhesie 
middel polyethylene glycol. De studie moest vervroegd worden afgebroken wegens 
organisatorische redenen, nadat 16 patiënten waren geïncludeerd. In deze kleine groep werden 
toch aanwijzingen gevonden voor effectiviteit van dit middel. De incidentie van nieuwe 
adhesies was lager tijdens de tweede kijkoperatie (0/9 vs. 4/6; P=0.01), en de afname in 
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adhesie score groter (-2.6 vs. -0.06; P=0.03).  Belangrijker is echter dat deze studie de 
moeilijkheden onderstreept bij het uitvoeren van studies met anti- adhesie middelen in de 
huidige tijd. Het aantal geplande kijkoperaties nam de afgelopen jaren sterk af, ook in de 
fertiliteitschirurgie, waardoor het includeren van voldoende patiënten waarbij adhesie 
vorming tijdens een tweede operatie kan worden beoordeeld steeds lastiger wordt. Verder 
vereisen verzekeringen voor proefpersonen een polis voor beide ingrepen. Voor nieuwe 
studies moet gekeken worden naar nieuwe (niet- invasieve) uitkomsten om adhesie vorming 
te beoordelen. 
 
HOOFDSTUK 12 vormt de discussie van dit proefschrift. Er wordt een overzicht gegeven 
van de ‘highlights’ op het gebied van adhesieonderzoek in het afgelopen decennium, zoals 
beschreven in dit proefschrift en daarbuiten. Hoewel adhesie barriers in het afgelopen 
decennium commercieel beschikbaar waren, zijn deze zelden gebruikt. Belangrijkste redenen 
lijken het onderschatten van de gevolgen van adhesies, vragen rondom veiligheid van adhesie 
barriers, en vragen omtrent kosteneffectiviteit. De groeiende kennis over de impact van 
adhesiolyse tijdens heroperaties, noopt tot een verandering in de benadering van adhesies en 
preventie daarvan. Niet ileus, maar adhesiolyse veroorzaakt de meeste morbiditeit en 
maatschappelijke kosten gerelateerd aan adhesies. Nieuwe onderzoeken en kostenmodellen 
zouden daarom ook deze uitkomsten moeten meenemen. Verder is het ook noodzaak om het 
onderzoek naar adhesies preventie te verbeteren, vanaf het laboratorium naar de patiënt en tot 
op populatie niveau. Dierstudies moeten beter gestandaardiseerd worden en uitgevoerd met 
voldoende proefdieren, zodat zij betere en meer betrouwbare resultaten kunnen laten zien. 
Voor klinisch onderzoek is er een grote behoefte aan niet- invasieve diagnostiek van adhesies. 
Cine- MRI is veelbelovend, maar moet nog verder worden ontwikkeld voor het aantonen van 
adhesies. 
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